<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
COMBICHEM, INC.
-------------------------------------------
(Name of Issuer)
COMMON STOCK, $0.001 PAR VALUE
-------------------------------------------
(Title of Class of Securities)
20009P-10-3
-------------------------------------------
(CUSIP Number)
DONALD P. MCAVINEY, ESQ.
E.I. DU PONT DE NEMOURS AND COMPANY
DUPONT PHARMA, INC.
DPC NEWCO, INC.
1007 MARKET STREET
WILMINGTON, DELAWARE 19898
(302) 774-9564
-------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
COPIES TO:
JUSTIN P. KLEIN, ESQ.
BALLARD SPAHR ANDREWS & INGERSOLL, LLP
1735 MARKET STREET, 51/ST/ FLOOR
PHILADELPHIA, PENNSYLVANIA
(215) 864-8606
October 5, 1999
-------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13(g), check the
following box. [_]
<PAGE>
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Section 240.13d-7(b) for
other parties to whom copies are to be sent.
- -----------------------------------------
CUSIP No. 20009P-10-3
- -----------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
E.I. DU PONT DE NEMOURS AND COMPANY
- -----------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [_]
(b) [_]
- -----------------------------------------
3 SEC USE ONLY
- -----------------------------------------
4 SOURCE OF FUNDS
WC
- -----------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
- -----------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
- -----------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
7 SOLE VOTING POWER
- 4,977,849 -
--------------------------------
8 SHARED VOTING POWER
- 0 -
--------------------------------
9 SOLE DISPOSITIVE POWER
- 0 -
--------------------------------
10 SHARED DISPOSITIVE POWER
- 0 -
- -----------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,662,280(1)
2
<PAGE>
- -----------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[_]
- -----------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
46.1%
- -----------------------------------------
14 TYPE OF REPORTING PERSON
CO
- -----------------------------------------
(1) See Items 4 and 5 hereof.
- -----------------------------------------
CUSIP No. 20009P-10-3
- -----------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
DUPONT PHARMA, INC.
- -----------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [_]
(b) [_]
- -----------------------------------------
3 SEC USE ONLY
- -----------------------------------------
4 SOURCE OF FUNDS
WC
- -----------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [_]
- -----------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
- -----------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
7 SOLE VOTING POWER
4,977,849
--------------------------------
3
<PAGE>
8 SHARED VOTING POWER
- 0 -(1)
--------------------------------
9 SOLE DISPOSITIVE POWER
- 0 -
--------------------------------
10 SHARED DISPOSITIVE POWER
- 0 -
- -----------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,622,280(1)
- -----------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[_]
- -----------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
46.1%
- -----------------------------------------
14 TYPE OF REPORTING PERSON
CO
- -----------------------------------------
(1) See Items 4 and 5 hereof.
- -----------------------------------------
CUSIP No. 20009P-10-3
- -----------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
DPC NEWCO, INC.
- -----------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [_]
(b) [_]
- -----------------------------------------
3 SEC USE ONLY
- -----------------------------------------
4 SOURCE OF FUNDS
AF
- -----------------------------------------
4
<PAGE>
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [_]
- ------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
- ------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
7 SOLE VOTING POWER
4,977,849
---------------------------------------------------------
8 SHARED VOTING POWER
- 0 -(1)
--------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
- 0 -
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
- 0 -
- -----------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,977,849(1)
- -----------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[_]
- -----------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
35.7%
- -----------------------------------------
14 TYPE OF REPORTING PERSON
CO
- -----------------------------------------
(1) See Items 4 and 5 hereof.
ITEM 1. Security and Issuer
This statement on Schedule 13D (this "Schedule 13D") relates to the shares
of common stock, $0.001 par value ("Issuer Common Stock"), of Combichem, Inc., a
Delaware corporation (the "Issuer" or "CombiChem"). The principal executive
offices of the Issuer are located at 9050 Camino Sante Fe, San Diego,
California 92121.
5
<PAGE>
ITEM 2. Identity and Background
(a)-(c) This Statement is filed by E.I. du Pont de Nemours and Company, a
Delaware corporation ("Parent"), DuPont Pharma, Inc., a Delaware corporation
("Purchaser"), and DPC Newco, Inc., a Delaware corporation ("Merger Sub")
(collectively, the "DuPont Companies"). Parent is a global science and
technology based company serving worldwide markets including food and nutrition,
healthcare, agriculture, fashion and apparel, home and construction, electronics
and transportation. Parent operates in more than 65 countries and has
approximately 97,000 employees. Together, Parent and Purchaser operate a
worldwide business that focuses on research, development and delivery of
pharmaceuticals to treat unmet medical needs in the fights against HIV
infection, cardiovascular disease, central nervous system disorders, cancer,
arthritis and related disorders and is also a leader in medical imaging. Merger
Sub is newly formed by Purchaser in connection with the Offer (as defined below)
and the transactions contemplated thereby. The principal business offices of
each of DuPont, Parent and Merger Sub are located at 1007 Market Street,
Wilmington, Delaware, 19898. DuPont directly owns all the outstanding capital
stock of Parent. Parent directly owns all the outstanding capital stock of
Merger Sub. It is not anticipated that, prior to the consummation of the Offer
and the Merger (as defined below), Merger Sub will have any significant assets
or liabilities or will engage in any activities other than those incident to the
Offer and the Merger.
(d)-(e) During the five years prior to the date hereof, none of the DuPont
Companies nor, to the best of their knowledge, any executive officer or director
of any of the DuPont Companies (who are listed on Schedule I to the Offer to
Purchase filed as part of the Schedule 14D-1 (as defined below)), (i) has been
convicted in criminal proceeding (excluding traffic violations or similar
misdemeanors) or (ii) has been a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction, as a result of which such person
was or is subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to, federal or
state securities laws or finding any violation with respect to such laws.
ITEM 3. Source and Amount of Funds or Other Consideration
The total amount of funds required by Merger Sub to purchase all of
CombiChem Common Stock and to pay related fees and expenses is approximately
$100 million. Merger Sub intends to obtain all of such funds from Purchaser
which in turn would obtain such funds from Purchaser's or Parent's existing
working capital.
ITEM 4. Purpose of Transaction
Parent, Merger Sub, and the Issuer entered into an Agreement and Plan of
Merger (the "Merger Agreement") as of October 5, 1999 providing for, among other
things, the commencement by Merger Sub of a tender offer to purchase all of the
Issuer's outstanding shares for $6.75 per share in cash without interest (the
"Offer") and the merger of Merger Sub with and into Issuer (the "Merger").
Simultaneously with the execution and delivery of the Merger Agreement, Parent
and Merger Sub entered into a Shareholders Agreement dated October 5, 1999 (the
"Shareholders Agreement"), with certain shareholders of the Issuer (the "Major
Stockholders") who, as of September 27, 1999, own 4,549,541 shares of Issuer
Common Stock and warrants and options exercisable for an additional 428,258
shares of Issuer Common Stock in the aggregate. Under the Shareholders
Agreement, the Issuer Stockholders have agreed, subject to the terms thereof, to
tender all of their shares of Issuer Common Stock to Merger Sub pursuant to the
tender offer described in the Merger Agreement, and to vote their shares in
favor of the merger described in the Merger Agreement. The Major Stockholders
6
<PAGE>
have also granted Merger Sub a proxy to vote their shares, representing
approximately 33.7% of the issued and outstanding shares of Issuer Common
Stock as of September 27, 1999, in favor of the Merger. Simultaneously with the
execution and delivery of the Merger Agreement, Parent also entered into a Stock
Option Agreement (the "Option Agreement") pursuant to which Issuer granted to
Parent an option to purchase 2,684,431 shares of Issuer Common Stock, subject to
the terms thereof. If this option were to be exercised and these shares were
issued to Parent and outstanding, such shares would, together with the shares
subject to the Shareholders Agreement (including shares issuable upon exercise
of warrants and options held by the Major Stockholders), represent approximately
46.1% of the issued and outstanding shares of Issuer Common Stock as of
September 27, 1999. As permitted by each of the Merger Agreement, the
Shareholders Agreement and the Option Agreement, Parent assigned all of its
rights thereunder to Purchaser and Purchaser agreed to assume all of the
obligations of Parent thereunder.
The foregoing summaries of the Shareholders Agreement and Company Option
are qualified in their entirety by reference to such agreements, which have been
filed as exhibits to this Schedule 13D.
Except as indicated in this Schedule 13D or as disclosed in the Schedule
14D-1 of the DuPont Companies filed with the Securities and Exchange Commission
on October 12, 1999 (the "Schedule 14D-1"), the contents of which are
incorporated herein by reference, the DuPont Companies currently have no
specific plans or proposals that relate to or would result in any of the matters
described in subparagraphs (a) through (f) of Item 4 of Schedule 13D.
ITEM 5. Interest in Securities of the Issuer
(a) As a result of entering into the Shareholders Agreement, the DuPont
Companies may be deemed to own beneficially 4,977,849 shares of Issuer Common
Stock. The DuPont Companies do not own any shares of Issuer Common Stock and,
except as set forth in this Schedule 13D, are not the "beneficial owner" of any
such shares, as such term is defined in the Securities Exchange Act of 1934 or
the rules and regulations thereunder.
(b) Pursuant to the Shareholders Agreement, the DuPont Companies possess
shared power to vote, or direct the vote of, the shares of Issuer Common Stock
held by the Major Stockholders.
(c) Except as set forth herein, none of the DuPont Companies beneficially
owns any shares of Issuer Common Stock and none of the DuPont Companies, or any
executive officer or director of any of the DuPont Companies (who are listed on
Schedule I to the Offer to Purchase filed as part of the Schedule 14D-1), has
engaged in any transaction in any such shares during the sixty day period
immediately preceding the date hereof except as described herein.
(d) and (e) Not applicable.
ITEM 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer
Except as described in this Schedule 13D or in the Schedule 14D-1, none of
the DuPont Companies or any executive officer or director of any of the DuPont
Companies (who are listed on Schedule I to the Offer to Purchase filed as part
of the Schedule 14D-1) has any other contracts, arrangements, understandings or
relationships with any persons with respect to any securities of the
7
<PAGE>
Issuer. The description of the transactions discussed in Item 4 is further
described in the Schedule 14D-1 and in the exhibits to the Schedule 14D-1,
including the Merger Agreement, the Shareholders Agreement, the Option Agreement
and the Joint Press Release issued by the Issuer and Parent, on October 5, 1999.
Such documents are incorporated herein by reference for all of the terms and
conditions of such documents.
ITEM 7. Material to be Filed as Exhibits
Exhibit 1 - Agreement and Plan of Merger dated as of October 5,1999, among
Parent, Merger Sub and the Company.
Exhibit 2 - Shareholders Agreement dated as of October 5, 1999, among the
persons listed on Schedule 1 thereto, Parent and Merger Sub.
Exhibit 3 - Stock Option Agreement dated as of October 5, 1999, between
Parent, Merger Sub and Company.
Exhibit 4 - Joint Filing Agreement.
SIGNATURE
After due inquiry and to the best of the undersigned's knowledge and
belief, the undersigned certify that the information set forth in this statement
is true, complete and correct.
Dated: October 15, 1999
E.I. DU PONT DE NEMOURS AND COMPANY
By: /s/ John P. Jessup
--------------------------
Name: John P. Jessup
Title: Vice President and Controller
DUPONT PHARMA, INC.
By: /s/ A. Lloyd Adams
--------------------------
Name: A. Lloyd Adams
Title: Vice President and
Assistant Treasurer
DPC NEWCO, INC.
By: /s/ Steven J. Capolarello
-------------------------
Name: Steven J. Capolarello
Title: Vice President and
Treasurer
8
<PAGE>
EXHIBIT INDEX
Exhibit 1 - Agreement and Plan of Merger dated as of October 5,1999, among
Parent, Merger Sub and the Company.
Exhibit 2 - Shareholders Agreement dated as of October 5, 1999, among the
persons listed on Schedule 1 thereto, Parent and Merger Sub.
Exhibit 3 - Stock Option Agreement dated as of October 5, 1999, between
Parent, Merger Sub and Company.
Exhibit 4 - Joint Filing Agreement.
9
<PAGE>
Exhibit 1
AGREEMENT AND PLAN OF MERGER
among
COMBICHEM, INC.,
E. I. DU PONT DE NEMOURS AND COMPANY
and
DPC NEWCO, INC.
Dated as of October 5, 1999
<PAGE>
Table of Contents
Section Page
- -------- ----
ARTICLE I
The Tender Offer
<TABLE>
<CAPTION>
<S> <C> <C>
1.1. The Offer.................................................... 2
1.2. SEC Filings.................................................. 4
1.3 Company Action............................................... 5
1.4 Composition of the Company Board............................. 5
ARTICLE II
The Merger; Closing; Effective Time
2.1. The Merger................................................... 6
2.2. Closing...................................................... 6
2.3. Effective Time............................................... 6
ARTICLE III
Certificate of Incorporation and Bylaws of the Surviving Corporation
3.1. The Certificate of Incorporation............................. 7
3.2. The Bylaws................................................... 7
ARTICLE IV
Officers and Directors of the Surviving Corporation
4.1. Directors.................................................... 7
4.2. Officers..................................................... 7
ARTICLE V
Effect of the Merger on Capital Stock; Exchange of Certificates
5.1. Effect on Outstanding Securities............................. 7
5.2. Surrender and Payment........................................ 9
5.3. Adjustment of Merger Consideration........................... 10
5.4. Merger Without Meeting of Stockholders....................... 11
ARTICLE VI
Representations and Warranties
6.1. Representations and Warranties of the Company................ 11
6.2. Representations and Warranties of Parent and Merger Sub...... 28
</TABLE>
i
<PAGE>
<TABLE>
<CAPTION>
ARTICLE VII
Covenants
<S> <C> <C>
7.1. Company Interim Operations................................... 30
7.2. Acquisition Proposals........................................ 32
7.3. Company Stockholder Approval; Proxy Statement................ 33
7.4. Approvals and Consents; Cooperation.......................... 35
7.5. Filings; Other Actions; Notification......................... 36
7.6. Access....................................................... 37
7.7. De-registration.............................................. 37
7.8. Publicity.................................................... 37
7.9. Benefits..................................................... 37
7.10. Expenses..................................................... 39
7.11. Indemnification; Directors' and Officers' Insurance.......... 39
7.12. Antitakeover Statutes........................................ 40
ARTICLE VIII
Conditions
8.1. Conditions to Each Party's Obligation to Effect the Merger... 40
ARTICLE IX
Termination
9.1. Termination by Mutual Consent................................ 41
9.2. Termination by Either Parent or the Company.................. 41
9.3. Termination by the Company................................... 42
9.4. Termination by Parent........................................ 43
9.5. Effect of Termination and Abandonment........................ 44
</TABLE>
ii
<PAGE>
<TABLE>
<CAPTION>
ARTICLE X
Miscellaneous and General
<S> <C> <C>
10.1. Survival.................................................... 44
10.2. Modification or Amendment................................... 45
10.3. Waiver of Conditions........................................ 45
10.4. Counterparts................................................ 45
10.5. Governing Law and Venue; Waiver of Jury Trial............... 45
10.6. Notices..................................................... 46
10.7. Entire Agreement............................................ 47
10.8. No Third Party Beneficiaries................................ 47
10.9. Obligations of Parent and of the Company.................... 47
10.10. Severability................................................ 47
10.11. Specific Performance........................................ 48
10.12. Interpretation.............................................. 48
10.13. Assignment.................................................. 48
10.14. Captions.................................................... 48
</TABLE>
Annex A - Conditions to the Offer
Schedules and Exhibits
----------------------
Schedule 6.1(a) Subsidiaries
Schedule 6.1(b) Outstanding Stock Options and Warrants
Schedule 6.1(d)(ii) Consents and Waivers
Schedule 6.1(f) Certain Changes
Schedule 6.1(h)(i) Compensation and Benefit Plans
Schedule 6.1(n)(i) Intellectual Property
Schedule 6.1(n)(ii) Exceptions to IP Ownership
Schedule 6.1(n) (xvi) Employees Not Subject to Confidentiality Agreements
Schedule 6(o)(ii) Year 2000 Testing and Analysis
Schedule 6(o)(iii) Year 2000 Plan
Schedule 6.1(p)(i) Labor Matters
Schedule 6.1(r) Company Material Contracts
Schedule 6.1(w) Employment Agreements with Key Employees
Schedule 7.1 Company Interim Operations
Schedule 7.11(a) Indemnification Agreements
Exhibit 8.1(f) Opinion of Counsel to the Company
iii
<PAGE>
Cross-Reference of Defined Terms
--------------------------------
Term Defined in
- ---- ----------
Acquisition Proposal Section 7.2(b)
Acquisition Transaction Section 7.2(a)
Action Annex A
Agreement Introductory paragraph
Antitakeover Statute Section 6.1(j)
Audit Date Section 6.1(f)
Business Days Section 1.1(a)
Bylaws Section 3.2
Certificate Section 5.1(a)(ii)
Certificate of Merger Section 2.3
Charter Section 3.1
Closing Date Section 2.2
Closing Section 2.2
COBRA Section 6.1(h)(i)
Code Section 6.1(h)(ii)
Common Stock Recitals
Company Introductory paragraph
Company Disclosure Schedules Section 6.1
Company 401(k) Section 7.9(b)
Company Intellectual Property Section 6.1(n)(ii)
Company Material Adverse Effect Section 6.1(a)
Company Material Contracts Section 6.1(u)
Company Option Section 6.1(b)
Company Owned IP Section 6.1(n)(i)
Company Reports Section 6.1(e)
Company Requisite Vote Section 6.1(c)(i)
Company Stockholders Meeting Section 7.3(a)
Compensation and Benefit Plan Section 6.1(h)(i)
Constituent Corporations Introductory paragraph
Contracts Section 6.1(d)(ii)
Controlled Group Affiliate Section 6.1(h)(i)
Current Employees Section 7.9(b)
Depositary Section 5.2(a)
DGCL Recitals
DLJ Section 1.2(b)
Dissenting Shares Recitals
DPC Section 7.6
Effective Time Section 2.3
Employees Section 6.1(h)(i)
Employment Agreements Recitals
iv
<PAGE>
Environmental Law Section 6.1(k)
ERISA Section 6.1(h)(i)
ESPP Section 6.1(b)
Exchange Act Section 1.1(a)
Excluded Shares Section 5.1(a)(i)
Foreign Authority Section 9.2
Foreign Merger Laws Section 9.2
GAAP Section 6.1(e)
Governmental Entity Section 6.1(d)(i)
Hazardous Substance Section 6.1(k)
HSR Act Section 1.1(b)(ii)
Intellectual Property Rights Section 6.1(n)(ix)
Knowledge Section 6.1(g)
Laws Section 6.1(i)
Letter of Transmittal Section 5.2(b)
Merger Recitals
Merger Consideration Section 5.1(a)(i)
Merger Sub Introductory paragraph
Minimum Condition Section 1.1(b)(i)
MNDA Section 7.6
Offer Recitals
Offer Conditions Section 1.1(b)(i)
Offer Documents Section 1.2(a)
Order Section 8.1(c)
Parent Introductory paragraph
Parent Companies Section 5.1(a)(i)
Parent Representatives Section 7.6
Payment Fund Section 5.2(a)
Pension Plan Section 6.1(h)(ii)
Person Section 5.2(b)
Preferred Shares Section 6.1(b)
Price Per Share Recitals
Proxy Statement Section 7.4(b)
Schedule 14D-l Section 1.2(a)
Schedule 14D-9 Section 1.2(b)
Scheduled Expiration Date Section 1.1(b)(ii)
SEC Section 1.1(b)(ii)
Share Recitals
Shareholders Agreement Recitals
Software Section 6.1(o)(iv)
Stock Option Agreement Recitals
Stock Plans Section 6.1(b)
Subsidiary Section 6.1(a)
Superior Proposal Section 7.2(c)
v
<PAGE>
Surviving Corporation Section 2.1
Taxes Section 6.1(m)
Tax Returns Section 6.1(m)
Terminating Company Breach Section 9.4(b)
Terminating Parent Breach Section 9.3(b)
Third Party Licenses Section 6.1(n)(ii)
Voting Debt Section 6.1(b)
Warrants Section 5.1(a)(iii)
Warrant Spread Section 5.1(a)(iii)
vi
<PAGE>
AGREEMENT AND PLAN OF MERGER
----------------------------
THIS AGREEMENT AND PLAN OF MERGER (this "Agreement"), dated as of
October 5, 1999, among CombiChem, Inc., a Delaware corporation (the "Company"),
E. I. du Pont de Nemours and Company, a Delaware corporation ("Parent"), and DPC
Newco, Inc., a Delaware corporation and a wholly owned subsidiary of Parent
("Merger Sub," the Company and Merger Sub sometimes being hereinafter
collectively referred to as the "Constituent Corporations").
RECITALS
WHEREAS, the respective Boards of Directors of Parent, Merger Sub and
the Company have each approved the Offer (as defined herein) and the Merger (as
defined herein) and have determined that it is in the best interests of their
respective companies and stockholders for Parent to acquire the Company upon the
terms and subject to the conditions set forth herein;
WHEREAS, in furtherance of such acquisition, Parent proposes to cause
Merger Sub to make a tender offer (as it may be amended from time to time as
permitted under this Agreement, the "Offer") to purchase all of the outstanding
shares of common stock, $.001 par value per share ("Common Stock"), of the
Company (each a "Share" or collectively, the "Shares") at a price per Share of
U.S. $6.75 net to the seller in cash (such price, or any higher price paid in
the Offer, the "Price Per Share"), upon the terms and subject to the conditions
set forth in this Agreement;
WHEREAS, the Board of Directors of the Company has unanimously
approved this Agreement, the Offer and the Merger, has determined that the Offer
and the Merger are fair to and in the best interests of the Company's
stockholders, declared the Merger advisable and has resolved to recommend that
the Company's stockholders accept the Offer, tender their Shares thereunder and
adopt this Agreement;
WHEREAS, contemporaneously with the execution and delivery of this
Agreement, the Company is entering into a stock option agreement with Parent
(the "Stock Option Agreement"), pursuant to which the Company has granted to
Parent an option to purchase up to 2,684,431 shares of Common Stock (19.9% of
the outstanding Shares) under the terms and conditions set forth in the Stock
Option Agreement, at a price of $6.75 per Share;
WHEREAS, contemporaneously with the execution and delivery of this
Agreement, certain employees of the Company are entering into employment
agreements with the Company (the "Employment Agreements");
WHEREAS, contemporaneously with the execution and delivery of this
Agreement, certain holders of Shares are entering into an agreement with Parent
(the "Shareholders Agreement") pursuant to which such holders shall agree to
take certain actions to support the transactions contemplated by this Agreement;
and
1
<PAGE>
WHEREAS, in order to complete such acquisition, the respective Boards
of Directors of Parent, Merger Sub and the Company have each approved the merger
of Merger Sub with and into the Company, with the Company surviving (the
"Merger"), upon the terms and subject to the conditions of this Agreement and in
accordance with the Delaware General Corporation Law (the "DGCL"), whereby each
issued and outstanding Share not owned directly or indirectly by Parent or the
Company and, except Shares, if any, held by persons who object to the Merger and
comply with all the provisions of Delaware law concerning the right of holders
of Shares, to dissent from the Merger and require appraisal of their Shares
("Dissenting Shares"), will be converted into the right to receive the Price Per
Share.
NOW, THEREFORE, in consideration of the premises, and of the
representations, warranties, covenants and agreements contained herein and in
the Stock Option Agreement, the parties hereto, intending to be legally bound
hereby, agree as follows:
ARTICLE I
The Tender Offer
1.1. The Offer.
---------
(a) Subject to the provisions of this Agreement (including,
without limitation, Annex A attached hereto), and provided that this Agreement
has not been terminated in accordance with Article IX hereof, as promptly as
practicable but in no event later than five business days, as defined in Rule
14d-1(e)(6) ("Business Days") under the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), after the announcement of this Agreement, Merger
Sub will commence the Offer.
(b) (i) The obligation of Merger Sub to accept for payment,
purchase and pay for any Shares tendered pursuant to the Offer shall be subject
to the satisfaction or waiver of the conditions set forth in Annex A attached
hereto (the "Offer Conditions") (including the Offer Condition that at least
that number of Shares equivalent to a majority of the total Shares issued and
outstanding on a fully diluted basis on the date such shares are purchased
pursuant to the Offer shall have been validly tendered and not withdrawn prior
to the expiration of the Offer (the "Minimum Condition")). Merger Sub expressly
reserves the right to modify the terms of the Offer and to waive any condition
of the Offer, except that, Merger Sub will not, without the prior written
consent of the Company (i) decrease the amount or change the form of
consideration payable in the Offer, (ii) decrease the number of Shares sought in
the Offer, (iii) impose additional conditions to the Offer, (iv) change any
Offer Condition or amend any other term of the Offer if any such change or
amendment would be materially adverse in any respect to the holders of Shares
(other than Parent or Merger Sub), (v) except as provided below, extend the
Offer if all of the Offer Conditions have been satisfied or (vi) amend or waive
the Minimum Condition.
2
<PAGE>
(ii) Subject to the terms and conditions hereof, the Offer
shall expire at midnight, New York City time, on the date that is twenty (20)
Business Days after the Offer is commenced (within the meaning of Rule 14d-2
under the Exchange Act) (the "Scheduled Expiration Date"); provided, however,
that without the consent of the Company, Merger Sub may (x) extend the Offer, if
on the Scheduled Expiration Date of the Offer any of the Offer Conditions shall
not have been satisfied or waived, for one (1) or more periods (none of which
shall exceed ten (10) Business Days), provided that Merger Sub may not extend
the expiration of the Offer past sixty (60) days from the date of this
Agreement, unless the waiting period applicable to the transactions contemplated
by this Agreement under the Hart-Scott-Rodino Antitrust Improvements Act of
1976, as amended (the "HSR Act"), has not terminated or expired in which case
Merger Sub may not extend the offer past the date set forth in Section 9.2(i),
or (y) extend the Offer for such period as may be required by any rule,
regulation, interpretation or position of the Securities and Exchange Commission
("SEC") or the staff thereof applicable to the Offer or (z) extend the Offer for
one (1) or more periods (each such period to be for not more than five (5)
Business Days and such extensions to be for an aggregate period of not more than
fifteen (15) Business Days beyond the latest expiration date that would
otherwise be permitted under clause (x) or (y) of this sentence) if on such
expiration date the Offer Conditions shall have been satisfied or waived, but
there shall not have been tendered that number of Shares which would equal more
than ninety percent (90%) of the Shares issued and outstanding on a fully-
diluted basis. Parent shall cause Merger Sub to, and agrees to use its best
efforts to, consummate the Offer as soon as legally permissible, subject to
Merger Sub's right to extend the Offer as provided in this Section 1.1(b)(ii).
(iii) Merger Sub agrees that if all of the Offer Conditions are
not satisfied on the Scheduled Expiration Date, then, provided that all such
conditions are and continue to be reasonably probable of being satisfied by the
date that is forty-five (45) days after the commencement of the Offer, Merger
Sub shall extend the Offer for one period of not more than five (5) Business
Days if requested to do so by the Company; provided that Merger Sub shall not be
required to extend the Offer beyond forty-five (45) days after commencement of
the Offer or, if earlier, the date of termination of this Agreement in
accordance with the terms hereof.
(iv) On the terms of the Offer and subject to the satisfaction
or waiver of the Offer Conditions and the terms of this Agreement, Merger Sub
shall (A) be obligated to purchase all Shares validly tendered and not withdrawn
on the earliest date that all of the Offer Conditions are satisfied or waived
and (B) pay for all Shares validly tendered and not withdrawn pursuant to the
Offer that Merger Sub becomes obligated to purchase pursuant to the Offer as
soon as practicable after the expiration of the Offer. Notwithstanding any other
provision of this Agreement, the Stock Option Agreement or the Shareholders
Agreement, any reference to a majority of the total issued and outstanding
shares or Shares, or shares or Shares outstanding on a fully diluted basis, or
similar references, shall, for purposes of such agreements, exclude from the
determination thereof any shares of Common Stock issuable upon exercise of or
subject to the Stock Option Agreement and any reference to beneficial ownership
of shares of Common Stock or similar references shall, for purposes of such
agreements, exclude from the determination thereof any shares of Common Stock
issuable upon exercise of or subject to the
3
<PAGE>
Stock Option Agreement and/or the Shareholders Agreement.
1.2. SEC Filings.
-----------
(a) As promptly as practicable, but in no event later than the
fifth Business Day after the announcement of this Agreement and the Offer,
Parent and Merger Sub shall file with the SEC a Tender Offer Statement on
Schedule 14D-l with respect to the Offer (as supplemented or amended from time
to time, the "Schedule 14D-l") to provide for the purchase of the issued and
outstanding Shares in accordance with the terms hereof. The Schedule 14D-l, the
Offer to Purchase and related summary advertisement and Letter of Transmittal
(which documents, as supplemented or amended from time to time, together
constitute the "Offer Documents") will comply as to form and content in all
material respects with the applicable provisions of the federal securities laws.
The Company and its counsel shall be given an opportunity to review and comment
upon the Offer Documents and any amendment or supplement thereto prior to the
filing thereof with the SEC and Parent and Merger Sub shall consider such
comments in good faith. Parent and Merger Sub agree to provide to the Company
and its counsel any comments which Parent, Merger Sub or their counsel may
receive from the Staff of the SEC promptly after receipt thereof, and any
proposed responses thereto, with respect to the Offer Documents and any
amendment or supplement thereto. Parent, Merger Sub and the Company agree to
correct promptly any information provided by any of them for use in the Offer
Documents which shall have become false or misleading in any material respect,
and Parent and Merger Sub further agree to take all steps necessary to cause the
Schedule 14D-l as so corrected to be filed with the SEC and to disseminate any
revised Offer Documents to the Company's stockholders, in each case as and to
the extent required by the applicable provisions of the federal securities laws.
(b) The Company Board shall recommend acceptance of the Offer to
its stockholders in a Solicitation/Recommendation on Schedule 14D-9 (as
supplemented or amended from time to time, the "Schedule 14D-9"), provided,
however, that the Company Board may thereafter amend or withdraw its
recommendation if it has received an Acquisition Proposal (as defined herein)
which in accordance with Section 7.2 is a Superior Proposal (as defined herein).
On the date the Offer Documents are filed with the SEC, the Company shall file
the Schedule 14D-9, which will comply as to form and content in all material
respects with the applicable provisions of the federal securities laws. The
Company will cooperate with Parent and Merger Sub in mailing or otherwise
disseminating the Schedule 14D-9 with the appropriate Offer Documents to the
stockholders of the Company. Parent and its counsel shall be given an
opportunity to review and comment upon the Schedule 14D-9 and any amendment or
supplement thereto prior to the filing thereof with the SEC, and the Company
shall consider any such comments in good faith. The Company agrees to provide to
Parent and Merger Sub and their counsel any comments which the Company or its
counsel may receive from the Staff of the SEC promptly after receipt thereof,
and any proposed responses thereto, with respect to the Schedule 14D-9 and any
amendment or supplement thereto. The Company, Parent and Merger Sub agree to
correct promptly any information provided by any of them for use in the Schedule
14D-9 which shall have become false or misleading in any material respect, and
the Company further
4
<PAGE>
agrees to take all steps necessary to cause such Schedule 14D-9 as so corrected
to be filed with the SEC and disseminated to the Company's stockholders, in each
case as and to the extent required by the applicable provisions of the federal
securities laws. Parent, Merger Sub and the Company each hereby agree to
provide promptly such information necessary to the preparation of the exhibits
and schedules to the Schedule 14D-9 and the Offer Documents which the respective
party responsible therefor shall reasonably request. The Company represents
that Donaldson, Lufkin & Jenrette Securities Corporation ("DLJ") has delivered
to the Company Board a written opinion, as of the date hereof, that, subject to
the assumptions and qualifications set forth in such opinion, the consideration
to be paid in the Offer and the Merger is fair to the holders of the Shares from
a financial point of view. The Company hereby consents to the inclusion in the
Offer Documents of the recommendations and approvals referred to in this Section
1.2, unless the Company Board has changed or withdrawn its recommendation after
receipt of an Acquisition Proposal that in accordance with Section 7.2 is a
Superior Proposal.
1.3. Company Action. In connection with the Offer, the Company
--------------
shall promptly furnish Merger Sub with such information (including a list of the
record holders of the Common Stock and their addresses, as well as mailing
labels containing the names and addresses of all record holders of Shares, any
non-objecting beneficial owner lists and lists of security positions of Shares
held in stock depositories in the Company's possession or control, in each case
as of a date not more than three (3) Business Days before the date of this
Agreement), and shall thereafter render such assistance as Parent, Merger Sub or
their agents may reasonably request in communicating the Offer to the record and
beneficial holders of Shares. Subject to the requirements of applicable law and
except for such steps as are necessary to disseminate the Offer Documents and
any other documents necessary to consummate the Offer and the Merger, Parent and
Merger Sub shall (a) hold in confidence the information contained in any of such
labels and lists, (b) use such information only in connection with the Offer and
the Merger and (c) if this Agreement is terminated, shall, upon request, deliver
to the Company or destroy all copies of such information then in their or their
agents' possession.
1.4 Composition of the Company Board.
--------------------------------
(a) Promptly upon the acceptance for payment of, and payment by Merger
Sub in accordance with the Offer for, not less than that number of Shares equal
to the Minimum Condition, Merger Sub shall be entitled to designate such number
of members of the Company Board, rounded up to the next whole number, equal to
that number of directors which equals the product of the total number of
directors on the Company Board (giving effect to the directors elected pursuant
to this sentence) multiplied by the percentage that such number of Shares owned
in the aggregate by Merger Sub or Parent, upon such acceptance for payment,
bears to the number of Shares outstanding. Upon the written request of Merger
Sub, the Company shall, on the date of such request, (i) either increase the
size of the Company Board or use its reasonable efforts to secure the
resignations of such number of its incumbent directors as is necessary to enable
Parent's designees to be so elected to the Company Board and (ii) cause Parent's
designees to be so elected, in each case as may be necessary to comply with the
foregoing provisions of this Section 1.4(a).
5
<PAGE>
(b) The Company's obligation to cause designees of Merger Sub to
be elected or appointed to the Company Board shall be subject to Section 14(f)
of the Exchange Act and Rule 14f-l promulgated thereunder. The Company shall
promptly take all actions required pursuant to Section 14(f) and Rule 14f-l in
order to fulfill its obligations under this Section 1.4, and shall include in
the Schedule 14D-9 such information with respect to Merger Sub and its designees
as is required under Section 14(f) and Rule 14f-l. Parent and Merger Sub will
supply to the Company in writing and be solely responsible for any information
with respect to any of them and their designees, officers, directors and
affiliates required by Section 14(f) and Rule 14f-l and applicable rules and
regulations.
ARTICLE II
The Merger; Closing; Effective Time
2.1. The Merger. Upon the terms and subject to the conditions set
----------
forth in this Agreement, at the Effective Time (as defined in Section 2.3)
Merger Sub shall be merged with and into the Company. The Company shall be the
surviving corporation in the Merger (sometimes hereinafter referred to as the
"Surviving Corporation") and shall continue to be governed by the laws of the
State of Delaware. The Merger shall have the effects specified in the DGCL.
Parent, as the sole stockholder of Merger Sub, hereby approves the Merger and
this Agreement.
2.2. Closing. The closing of the Merger (the "Closing") shall take
-------
place (i) at the offices of Ballard Spahr Andrews & Ingersoll, LLP, 1735 Market
Street, Philadelphia, Pennsylvania at 10:00 a.m. on the latest to occur of (A)
the business day on which the condition set forth in Section 8.1(a) shall be
satisfied or waived in accordance with this Agreement and (B) the first business
day following the date on which the last to be satisfied or waived of the other
conditions set forth in Article VIII (other than those conditions that by their
nature are to be satisfied at the Closing, but subject to the satisfaction or
waiver of those conditions) shall be satisfied or waived in accordance with this
Agreement, or (ii) at such other place and time and/or on such other date as the
Company and Parent may agree in writing (the "Closing Date").
2.3. Effective Time. As soon as practicable following the Closing,
--------------
the Company will cause a Certificate of Merger (the "Certificate of Merger") to
be executed, acknowledged and filed with the Secretary of State of the State of
Delaware as provided in Section 251 of the DGCL. The Merger shall become
effective at the time when the Certificate of Merger has been duly filed with
the Secretary of State of the State of Delaware or, if agreed to by Parent and
the Company, such later time or date set forth in the Certificate of Merger (the
"Effective Time").
6
<PAGE>
ARTICLE III
Certificate of Incorporation and Bylaws of the Surviving Corporation
3.1. The Certificate of Incorporation. The certificate of
--------------------------------
incorporation of the Company shall be amended as of the Effective Time so that
it is identical to the certificate of incorporation of Merger Sub in effect
immediately prior to the Effective Time, except that Article FIRST of the
Charter shall provide that the name of the Company shall be the name of the
Surviving Corporation, and such certificate shall be the certificate of
incorporation of the Surviving Corporation (the "Charter").
3.2. The Bylaws. The bylaws of Merger Sub in effect immediately
----------
prior to the Effective Time shall be the bylaws of the Surviving Corporation
(the "Bylaws"), until thereafter amended as provided therein or by applicable
law.
ARTICLE IV
Officers and Directors of the Surviving Corporation
4.1. Directors. The directors of Merger Sub immediately prior to
---------
the Effective Time shall, from and after the Effective Time, be the directors of
the Surviving Corporation until their successors have been duly elected or
appointed and qualified or until their earlier death, resignation or removal in
accordance with the Charter and Bylaws. Subject to the consummation of the
Offer and the purchase by Merger Sub of at least that number of shares equal to
the Minimum Condition, prior to the Effective Time, the Company shall take all
actions necessary to obtain any resignations of its directors necessary to give
effect to the provisions of this Section and Section 1.4.
4.2. Officers. The officers of the Company immediately prior to
--------
the Effective Time shall, from and after the Effective Time, be the officers of
the Surviving Corporation until their successors have been duly elected or
appointed and qualified or until their earlier death, resignation or removal in
accordance with the Charter and Bylaws.
ARTICLE V
Effect of the Merger on Outstanding Securities; Exchange of Certificates
5.1. Effect on Outstanding Securities. At the Effective Time, as
--------------------------------
a result of the Merger and without any action on the part of the Company,
Parent, Merger Sub or any holder of any capital stock of the Company:
7
<PAGE>
(a) Merger Consideration.
--------------------
(i) Each Share issued and outstanding immediately prior to
the Effective Time (other than (A) Shares owned by Parent or any direct or
indirect Subsidiary (as defined herein) of Parent (collectively, the "Parent
Companies"), (B) Dissenting Shares, or (C) Shares that are owned by the Company
or any direct or indirect Subsidiary of the Company (and in each case not held
on behalf of third Parties) (collectively, "Excluded Shares")) shall be
converted into, and become exchangeable for the right to receive the Price Per
Share in cash (the "Merger Consideration").
(ii) At the Effective Time, all Shares shall no longer be
outstanding and shall be canceled and retired and shall cease to exist, and each
certificate (a "Certificate") formerly representing any of such Shares (other
than Excluded Shares) shall thereafter represent only the right to receive the
Merger Consideration.
(iii) At the Effective Time, each warrant to purchase shares
of Common Stock listed on Schedule 6.1(b) (the "Warrants") shall be canceled in
exchange for a cash payment of an amount equal to (A) the excess, if any, of (1)
the Price Per Share over (2) the exercise price per share of Common Stock
subject to such Warrant, multiplied by (B) the number of shares of Common Stock
for which such Warrant shall not theretofore have been exercised (the "Warrant
Spread"). Upon surrender to Parent at the address set forth in Section 10.6 of
Warrants and/or such other documents as may reasonably be requested by Parent,
Parent hereby agrees to deliver to the registered holders of such Warrants (as
indicated in the records of the Company) the Warrant Spread. If there is no
excess of the Price Per Share over the exercise price per share of Common Stock
subject to a Warrant, then such Warrant shall be canceled for no consideration.
(iv) At the Effective Time, each outstanding Company Option
(as defined herein) shall be canceled in accordance with Section 7.9(a).
(b) Cancellation of Excluded Shares. Each Excluded Share (other
-------------------------------
than Dissenting Shares) issued and outstanding immediately prior to the
Effective Time, by virtue of the Merger and without any action on the part of
the holder thereof, shall cease to be outstanding and shall be canceled and
retired without payment of any consideration therefor and shall cease to exist.
(c) Merger Sub. As of the Effective Time, each share of Common
----------
Stock, par value $.01 per share, of Merger Sub issued and outstanding
immediately prior to the Effective Time shall continue to remain outstanding and
shall constitute one share of common stock of the Surviving Corporation.
(d) Dissenting Shares. Notwithstanding anything in this
-----------------
Agreement to the contrary, Shares outstanding immediately prior to the Effective
Time and held by a holder who has not voted in favor of the Merger or consented
thereto in writing and who is entitled to
8
<PAGE>
and has demanded appraisal for such shares in accordance with the DGCL, or other
applicable law, shall not be converted into a right to receive the Merger
Consideration, unless such holder fails to perfect or withdraws or otherwise
loses its right to appraisal. If after the Effective Time such holder fails to
perfect or withdraws or loses its right to appraisal, such shares shall be
treated as if they had been converted as of the Effective Time into a right to
receive the Merger Consideration. The Company shall give Parent prompt notice of
any demands received by the Company for appraisal of Shares, and Parent shall
have the right to participate in all negotiations and proceedings with respect
to such demands. The Company shall not, except with the prior written consent of
Parent, make any payment with respect to, or settle or offer to settle, any such
demands, except as otherwise required under applicable law.
5.2. Surrender and Payment.
---------------------
(a) Depositary. Prior to the Effective Time, Parent shall
----------
designate a bank or trust company reasonably acceptable to the Company to act as
agent for the holders of Shares in connection with the Merger (the "Depositary")
to receive the Merger Consideration to which holders of Shares shall become
entitled pursuant to Section 5.1. Prior to the filing of the Certificate of
Merger with the Secretary of State of the State of Delaware, Parent or Merger
Sub shall deposit with the Depositary cash in an aggregate amount equal to the
product of (i) the number of Shares outstanding (and not to be canceled pursuant
to Section 5.1(b)) immediately prior to the Effective Time, multiplied by (ii)
the Merger Consideration. The deposit made by Parent or Merger Sub pursuant to
the preceding sentence is hereinafter referred to as the "Payment Fund." The
Depositary shall cause the Payment Fund to be (i) held for the benefit of the
holders of Shares and (ii) promptly applied to making the payments provided for
in Section 5.1(a). The Payment Fund shall not be used for any purpose that is
not provided for herein.
(b) Exchange Procedures. As soon as reasonably practicable
-------------------
after the Effective Time, Parent shall cause the Depositary to mail to each
holder of record a Certificate or Certificates (i) a letter of transmittal
(which shall specify that delivery shall be effected, and risk of loss and title
to the Certificates shall pass, only upon delivery of the Certificates to the
Depositary) (the "Letter of Transmittal") and (ii) instructions for use in
effecting the surrender of the Certificates in exchange for the Merger
Consideration. Upon surrender of a Certificate for cancellation to the
Depositary, together with such Letter of Transmittal, duly executed, and such
other documents as may reasonably be required by the Depositary, the Depositary
shall pay the holder of such Certificate the Merger Consideration in respect of
such Certificate, less any required withholding taxes, and the Certificate so
surrendered shall forthwith be canceled. If any portion of the Merger
Consideration is to be paid to a person (as defined in the Exchange Act) (a
"Person") other than the registered holder of the shares represented by the
Certificate or Certificates surrendered in exchange therefor, it shall be a
condition to such payment that the Certificate or Certificates so surrendered
shall be properly endorsed or otherwise be in proper form for transfer and that
the Person requesting such payment shall pay to the Depositary any transfer or
other taxes required as a result of such payment to a Person other than the
registered holder of such shares or establish to the satisfaction of the
Depositary that such tax has been paid or is not payable. Until surrendered as
contemplated by this Section 5.2, each Certificate (other
9
<PAGE>
than Certificates representing Dissenting Shares) or Shares to be canceled
pursuant to Section 5.1(b)) shall be deemed at any time after the Effective Time
to represent only the right to receive the Merger Consideration upon such
surrender.
(c) No Further Ownership Rights in Common Stock. All Merger
-------------------------------------------
Consideration paid upon the surrender for exchange of Certificates in accordance
with the terms of this Article V shall be deemed to have been paid in full
satisfaction of all rights pertaining to the Shares theretofore represented by
such Certificates. There shall be no further registration of transfers on the
stock transfer books of the Surviving Corporation of the Shares which were
outstanding immediately prior to the Effective Time. If, after the Effective
Time, Certificates are presented to the Surviving Corporation or the Depositary
for any reason, they shall be canceled and exchanged as provided in this Article
V, except as otherwise provided by law.
(d) Unclaimed Funds. Any portion of the Payment Fund made
---------------
available to the Depositary pursuant to Section 5.2(a) that remains unclaimed by
holders of the Certificates for six (6) months after the Effective Time shall be
delivered to the Surviving Corporation or a United States parent thereof, upon
demand, and any holders of Certificates who have not theretofore complied with
this Article V shall thereafter look only to Parent for payment of their claim
for Merger Consideration.
(e) No Liability. None of Parent, Merger Sub, the Company or the
------------
Depositary shall be liable to any Person in respect of any Merger Consideration
delivered to a public official pursuant to any applicable abandoned property,
escheat or similar law. If any Certificate has not been surrendered prior to
five (5) years after the Effective Time (or immediately prior to such earlier
date on which Merger Consideration in respect of such Certificate would
otherwise escheat to or become the property of any public official), any such
shares, cash, dividends or distributions in respect of such Certificate shall,
to the extent permitted by applicable law, become the property of the Surviving
Corporation, free and clear of all claims or interest of any Person previously
entitled thereto.
(f) Investment of Funds. The Payment Fund shall be invested by
-------------------
the Depositary in accordance with the instructions of Parent and all earnings
thereon shall inure to the benefit of Parent or Merger Sub.
(g) Lost Certificates. In the event that any Certificate shall
-----------------
have been lost, stolen or destroyed, upon the making of an affidavit of that
fact by the Person claiming such Certificate to be lost, stolen or destroyed
and, if required by Parent, the granting of an indemnity reasonably satisfactory
to Parent against any claim that may be made against it, the Surviving
Corporation or the Depositary, with respect to such Certificate, the Depositary
will issue in exchange for such lost, stolen or destroyed Certificate the Merger
Consideration with respect to such Certificate, to which such Person is entitled
pursuant hereto.
5.3. Adjustment of Merger Consideration. In the event that,
----------------------------------
subsequent to the date of this Agreement but prior to the Effective Time, the
outstanding Shares shall have been
10
<PAGE>
changed into a different number of shares or a different class as a result of a
stock split, reverse stock split, stock dividend, subdivision, reclassification,
split, combination, exchange, recapitalization or other similar transaction, the
Merger Consideration shall be appropriately adjusted.
5.4. Merger Without Meeting of Stockholders. In the event that
--------------------------------------
Merger Sub, or any other direct or indirect subsidiary of Parent, shall acquire
at least ninety percent (90%) of the outstanding Shares, the parties hereto
shall take all necessary and appropriate action to cause the Merger to become
effective as soon as practicable after the expiration of the Offer without a
vote of stockholders of the Company, in accordance with Section 253 of the DGCL.
ARTICLE VI
Representations and Warranties
6.1. Representations and Warranties of the Company. The Company
---------------------------------------------
hereby represents and warrants to Parent and Merger Sub, except as specifically
identified in the Schedules described in this Section 6.1 and delivered to
Parent on the date of this Agreement and attached hereto (the "Company
Disclosure Schedules"), as follows:
(a) Organization, Good Standing and Qualification. Each of the
---------------------------------------------
Company and each of its Subsidiaries is a corporation or limited liability
company duly organized, validly existing and in good standing (where such
concept is recognized) under the laws of its respective jurisdiction of
organization. Each of the Company and each of its Subsidiaries has all
requisite corporate or limited liability company power and authority to own and
operate their respective properties and assets and to carry on their respective
businesses as presently conducted. Each of the Company and each of its
Subsidiaries is qualified to do business and is in good standing as a foreign
corporation or limited liability company in each jurisdiction (where such
concept is recognized) where the ownership or operation of its properties or
conduct of its business requires such qualification, except where the failure to
be so qualified or in such good standing, when taken together with all other
such failures, is not reasonably likely to have a Company Material Adverse
Effect (as defined below) or impair the ability of the Company, the Surviving
Corporation, Parent or any of their respective affiliates, following
consummation of the Offer or the Merger, to conduct any material business or
operations in any jurisdiction where they are now being conducted. The Company
has made available to Parent a complete and correct copy of the Company's and
its Subsidiaries' certificates of incorporation and bylaws (or documents of a
similar scope for (i) limited liability companies and (ii) corporations
organized in jurisdictions outside the United States), each as amended to date.
The Company's and its Subsidiaries' certificates of incorporation and bylaws (or
similar documents) so made available are in full force and effect.
As used in this Agreement, (i) "Subsidiary" means, with respect to the
Company, Parent or Merger Sub, as the case may be, any entity, whether
incorporated or unincorporated, of which at least fifty percent (50%) of the
securities or ownership interests having by their terms
11
<PAGE>
ordinary voting power to elect fifty percent (50%) of the board of directors or
other Persons performing similar functions is directly or indirectly owned or
controlled by such party or by one or more of its respective Subsidiaries or by
such party and any one or more of its respective Subsidiaries, and (ii) "Company
Material Adverse Effect" means any change in or effect on the business of the
Company and its Subsidiaries that is, or is reasonably likely to be, materially
adverse to the business, operations or assets (including intangible assets),
liabilities (contingent or otherwise), prospects, condition (financial or
otherwise) of the Company and its Subsidiaries, taken as a whole. In no event
shall any of the following constitute, or be taken into account in determining
whether there has been or is likely to be, a "Company Material Adverse Effect":
(i) an adverse change in the trading price of the Common Stock between the date
of this Agreement and the Effective Time, in and of itself; (ii) any adverse
conditions, events, circumstances, changes or effects attributable to expenses
(including, without limitation, legal, accounting and financing consulting fees
and expenses) incurred directly in connection with the transactions contemplated
by this Agreement; or (iii) any adverse conditions, events, circumstances,
changes or effects resulting from compliance by the Company with, or the taking
of any action required or contemplated by, the terms of this Agreement or any
other agreement entered into by the Company with Parent or Merger Sub in
connection with the transactions contemplated by this Agreement.
Schedule 6.1(a) lists each Subsidiary of the Company and its
jurisdiction of formation. All of the outstanding equity interests in each such
Subsidiary have been validly issued and are fully paid and non-assessable and
owned by the Company free and clear of all pledges, claims, liens, charges,
encumbrances and security interests of any kind or nature whatsoever. Except
for the equity interest in its Subsidiaries, the Company does not own, directly
or indirectly, an ownership interest in any corporation, partnership, joint
venture or other entity.
(b) Capital Structure. The authorized capital stock of the
-----------------
Company consists of 40,000,000 shares of Common Stock, of which 13,489,604
Shares were outstanding as of the close of business on September 27, 1999, and
5,000,000 shares of Preferred Stock, par value $0.001 per share (the "Preferred
Shares"), none of which were outstanding as of the close of business on
September 27, 1999. All of the outstanding Shares have been duly authorized and
are validly issued, fully paid and nonassessable. Other than shares of Common
Stock reserved for issuance pursuant to the Stock Option Agreement, the Company
has no shares of Common Stock or Preferred Shares subject to issuance, except
(i) 3,355,069 shares of Common Stock reserved for issuance under the Company's
1997 Stock Incentive Plan, of which options to acquire 1,213,476 shares of
Common Stock are outstanding as of September 27, 1999, (ii) 150,000 shares of
Common Stock reserved for issuance under the Company's 1997 Employee Stock
Purchase Plan (the "ESPP"), of which 79,967 shares of Common Stock are available
for purchase as of September 27, 1999, (iii) 70,000 shares of Common Stock
reserved for issuance pursuant to options granted other than pursuant to the
Stock Plans, of which options to acquire 70,000 shares of Common Stock are
outstanding as of September 27, 1999 and (iv) 247,220 shares of Common Stock
reserved for issuance upon exercise of the Warrants as of September 27, 1999.
Schedule 6.1(b) sets forth a correct and complete list of (i) each outstanding
option to purchase shares of
12
<PAGE>
Common Stock under the Stock Plans (as defined below) or pursuant to clause
(iii) of the preceding sentence (each a "Company Option"), as of September 27,
1999, including the holder, date of grant, exercise price and number of shares
of Common Stock subject thereto and (ii) each Warrant as of September 27, 1999,
including the holder, exercise price, and number of shares of Common Stock
subject thereto. As of September 27, 1999, there are no shares of capital stock
of the Company authorized, issued or outstanding except as set forth above and,
except as set forth above, there are no preemptive rights or any outstanding
subscriptions, options, warrants, rights, convertible securities or other
agreements or commitments of any character to which the Company is a party or
may be bound relating to the issued or unissued capital stock or other
securities of the Company and the Shares subject to the Stock Option Agreement
shall not be subject to any preemptive rights. The Company does not have
outstanding any bonds, debentures, notes or other obligations, the holders of
which have the right to vote (or convertible into or exercisable for securities
having the right to vote) with the stockholders of the Company on any matter
("Voting Debt"). Except for the Company's 1997 Stock Incentive Plan (including
its predecessor plan, the 1995 Stock Option/Stock Issuance Plan) and the ESPP
(such plans collectively, the "Stock Plans"), at or after the Effective Time,
neither the Surviving Corporation nor Parent nor their respective affiliates
will have any obligation to issue, transfer or sell any shares or securities of
the Surviving Corporation, Parent or any of their respective affiliates pursuant
to any Compensation and Benefit Plan (as defined in Section 6.1(h)(i)) which
obligations were outstanding as of September 27, 1999. On or prior to the
consummation of the Offer, the Company will have taken all actions as are
required to adjust the terms of all outstanding Warrants to provide that the
Warrants may be canceled in accordance with Section 5.1(a)(iii). Since September
27, 1999, the Company has not issued, granted or entered into any agreement
relating to any subscription, option, warrant, right, convertible security or
any agreement or commitment of any character to which the Company is a party or
may be bound relating to the issued or unissued capital stock or other
securities of the Company, except for the Stock Option Agreement.
(c) Corporate Authority; Approval.
-----------------------------
(i) The Company has all requisite corporate power and
authority and has taken all corporate action necessary in order to execute,
deliver and perform its obligations under this Agreement and the Stock Option
Agreement and to consummate the Offer and, subject only to obtaining the
adoption of this Agreement by a majority of the Shares outstanding as of the
record date of the Company's stockholders meeting (the "Company Requisite
Vote"), the Merger. This Agreement and the Stock Option Agreement are valid and
binding agreements of the Company, enforceable against the Company in accordance
with their respective terms subject to (i) applicable bankruptcy, insolvency,
reorganization, fraudulent transfer, moratorium, or similar laws from time to
time in effect affecting creditors' rights generally, and (ii) general
principles of equity, whether such principles are considered in a proceeding at
law or in equity.
(ii) The Company Board has, at a meeting duly called and
held, unanimously (A) approved the acquisition of the Company by Parent on the
terms and subject to
13
<PAGE>
the conditions of this Agreement, (B) approved this Agreement and the Stock
Option Agreement, the Offer and the Merger and the transactions contemplated
hereby in accordance with the DGCL, (C) determined that the Offer and the Merger
are fair to and in the best interests of the Company's stockholders and declared
the Merger advisable, and (D) recommended that the stockholders of the Company
tender their shares of Common Stock into the Offer and adopt this Agreement and
approve the Merger.
(d) Governmental Filings; No Violations.
-----------------------------------
(i) Other than any filings and/or notices required (A)
pursuant to Section 2.3, (B) under the HSR Act, and (C) the Exchange Act and
state securities or "blue sky" laws, no notices or other filings are required to
be made by the Company with, nor are any consents, registrations, approvals,
permits or authorizations required to be obtained by the Company from, any
governmental or regulatory authority, agency, commission, body or other
governmental entity ("Governmental Entity"), in connection with the execution
and delivery of this Agreement and the Stock Option Agreement by the Company and
the consummation by the Company of the Offer and the Merger and the other
transactions contemplated hereby and thereby, except those that the failure to
make or obtain are not, individually or in the aggregate, reasonably likely to
have a Company Material Adverse Effect or prevent, materially delay or
materially impair the ability of the Company to consummate the transactions
contemplated by this Agreement and the Stock Option Agreement.
(ii) The execution, delivery and performance of this
Agreement and the Stock Option Agreement by the Company do not and will not, and
the consummation by the Company of the Offer and the Merger and the other
transactions contemplated hereby and thereby will not, constitute or result in
(A) a breach or violation of, or a default under, the certificate of
incorporation or bylaws of the Company or the comparable governing instruments
of any of its Subsidiaries, (B) a breach or violation of, or a default under,
the acceleration of any obligations or the creation of a lien, pledge, security
interest or other encumbrance on the assets of the Company or any of its
Subsidiaries (with or without notice, lapse of time or both) pursuant to, any
agreement, lease, contract, note, mortgage, indenture or other obligation
("Contracts") binding upon the Company or any of its Subsidiaries or any Law (as
defined in Section 6.1(i)) or governmental or non-governmental permit or license
to which the Company or any of its Subsidiaries is subject, or (C) any change in
the rights or obligations of any party under any of the Contracts; except, in
the case of clause (B) and (C) above, for any breach, violation, default,
acceleration, creation, or change that, individually or in the aggregate, is not
reasonably likely to have a Company Material Adverse Effect or prevent,
materially delay or materially impair the ability of the Company to consummate
the transactions contemplated by this Agreement or the Stock Option Agreement.
Schedule 6.1(d)(ii) sets forth a correct and complete list of all consents and
waivers which are or may be required in connection with the consummation of the
transactions contemplated by this Agreement and the Stock Option Agreement
(whether or not subject to the exceptions set forth with respect to clauses (B)
and (C) in the preceding sentence) under Contracts to which the Company or any
of its Subsidiaries is a party, other than any consent or waiver (other than
consents or waivers pursuant to Contracts relating to indebtedness,
14
<PAGE>
securities or the guarantee thereof) the failure to obtain which is not
reasonably likely to have a Company Material Adverse Effect or prevent,
materially delay or materially impair the ability of the Company to consummate
the transactions contemplated by this Agreement or the Stock Option Agreement.
(e) Company Reports; Financial Statements. The Company and, to
-------------------------------------
the extent applicable, each of its then or current Subsidiaries has made all
filings required to be made by it with the SEC since January 1, 1998
(collectively, including any such reports filed subsequent to the date hereof,
the "Company Reports"). The Company has made available to Parent each
registration statement, report, proxy statement or information statement filed
with the SEC by it since October 15, 1997, including, without limitation, (i)
the Company's Annual Report on Form 10-K for the year ended December 31, 1998,
as amended on April 5, 1999, (ii) the Company's Quarterly Reports on Form 10-Q
for the quarters ended March 31, 1999 and June 30, 1999, (iii) the Company's
Proxy Statement filed on April 6, 1999 and (iv) the Registration Statement on
Form S-8 filed with the SEC on May 13, 1999, all in the form (including
exhibits, annexes and any amendments thereto) filed with the SEC. As of their
respective dates, the Company Reports complied in all material respects with the
requirements of applicable statutes and regulations and did not, and any Company
Reports filed with the SEC prior to the Effective Time of the Offer will not,
contain any untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements made therein,
in light of the circumstances in which they were made, not misleading. Each of
the balance sheets included in or incorporated by reference into the Company
Reports (including the related notes and schedules) presents fairly, or will
present fairly, the financial position of the Company and its Subsidiaries as of
its date and each of the statements of income and of changes in financial
position included in or incorporated by reference into the Company Reports
(including any related notes and schedules) presents fairly, or will present
fairly, the results of operations, retained earnings and changes in financial
position, as the case may be, of the Company and its Subsidiaries for the
periods set forth therein (except as otherwise noted therein and subject, in the
case of unaudited statements, to notes and normal year-end audit adjustments
that will not be material in amount or effect), in each case in accordance with
generally accepted accounting principles ("GAAP") consistently applied during
the periods involved, except, in the case of unaudited financial statements, as
permitted by SEC Form 10-Q, and except as may be noted therein. Other than the
Company Reports specifically recited in clauses (i) through (iv) of the first
sentence of this Section 6.1(e), the Company has not, on or prior to the date
hereof, filed any other definitive reports or statements with the SEC since
December 31, 1998.
(f) Absence of Certain Changes. Since June 30, 1999 (the "Audit
--------------------------
Date"), the Company and its Subsidiaries have conducted their respective
businesses in all material respects only in, and have not engaged in any
material transaction other than according to, the ordinary and usual course of
such businesses and there has not been (i) any change in the financial
condition, properties, business or results of operations of the Company or any
of its Subsidiaries or any occurrence or combination of occurrences that,
individually or in the aggregate, has had or is reasonably likely to have a
Company Material Adverse Effect; (ii) any material damage, destruction or other
casualty loss with respect to any asset or property owned,
15
<PAGE>
leased or otherwise used by the Company or any of its Subsidiaries, that has had
or is reasonably likely to have a Company Material Adverse Effect; (iii) any
declaration, setting aside or payment of any dividend or other distribution in
respect of the capital stock of the Company; or (iv) any change by the Company
in accounting principles, practices or methods. Schedule 6.1(f) contains a
document setting forth the name, title, salary and other compensation of each
employee of the Company as of September 27, 1999. Since the date of such
document, there has not been any increase in the compensation payable or that
could become payable by the Company or any of its Subsidiaries to officers or
key employees of the Company or its Subsidiaries, or any amendment of any of the
Stock Plans or Compensation and Benefit Plans.
(g) Litigation and Liabilities. Except for matters which are
--------------------------
not, individually or in the aggregate, reasonably likely to have a Company
Material Adverse Effect or prevent or materially delay or materially impair the
ability of the Company to consummate the transactions contemplated by this
Agreement and the Stock Option Agreement, there are no (i) civil, criminal,
administrative or regulatory actions, suits, claims, hearings, investigations or
proceedings pending or, to the Knowledge (as defined herein) of the Company,
threatened against the Company or any of its Subsidiaries or (ii) material
obligations or liabilities, whether or not accrued, contingent or otherwise and
whether or not required to be disclosed, including those relating to matters
involving any Environmental Law (as defined in Section 6.1(k)). When used in
this Agreement, "Knowledge" means an individual will be deemed to have
"Knowledge" of a particular fact or other matter if (a) such individual is
actually aware of such fact or other matter or (b) a prudent individual could be
expected to discover or otherwise become aware of such fact or other matter in
the course of conducting a comprehensive investigation concerning the existence
of such fact or other matter. A Person other than an individual will be deemed
to have "Knowledge" of a particular fact or other matter if any individual who
is an officer, director, an employee at the director level or above or the
Company's environmental safety officer has, or at any time, had, "Knowledge" of
such fact or matter, as defined in the previous sentence.
(h) Employee Benefits.
-----------------
(i) The Company Reports accurately describe in all material
respects all material incentive, bonus, deferred compensation, pension,
retirement, profit-sharing, thrift, savings, employee stock ownership, stock
bonus, stock purchase, restricted stock, stock option and other stock based
plans, all employment or severance agreements, plans, policies or arrangements,
other employee benefit plans and any applicable "change of control" or similar
provisions in any plan, agreement, policy or arrangement which covers current or
former employees of the Company and its Controlled Group Affiliates (the
"Compensation and Benefit Plans") or with respect to which the Company or any of
its Controlled Group Affiliates may have any liability and which are required to
be disclosed in the Company Reports. The Compensation and Benefit Plans and all
other benefit plans, agreements, policies or arrangements covering current or
former employees or directors of the Company and its Controlled Group Affiliates
(the "Employees"), including, but not limited to, "employee benefit plans"
within the meaning of Section 3(3) of the Employee Retirement Income Security
Act of 1974, as amended ("ERISA"), are listed in Schedule 6.1(h)(i). True and
complete copies of all documents relating to the
16
<PAGE>
Compensation and Benefit Plans or any other plan, agreement, policy or
arrangement listed in Schedule 6.1(h)(i), including written interpretations
thereof, and such other benefit plans, agreements, policies or arrangements,
including, but not limited to, any trust instruments and/or insurance contracts,
if any, forming a part of any such plans and agreements, and all amendments
thereto have been provided or made available to Parent. The following items have
also been provided or made available to Parent with respect to each Compensation
and Benefit Plan as applicable: (1) copy of the most recent Form 5500 annual
report (including all schedules and financial statements); (2) copy of the most
recent favorable determination letter issued by the Internal Revenue Service
with respect to each such plan; (3) copies of any governmental audit report or
correction program memorandum; (4) any governmental opinion, ruling,
determination or notice of action or disposition with regard to any such plan;
(5) the results of any testing relating to any such plan, including testing of
coverage, non-discrimination requirements, 401(k) and 401(m) compliance, benefit
limitations, etc.; and (6) a schedule of all persons who are receiving, or who
are eligible to elect to receive, health care continuation ("COBRA") coverage
with respect to the Company or a Controlled Group Affiliate.
"Controlled Group Affiliate" means any trade or business
(whether or not incorporated) that is a member of a "controlled group" of which
the Company is a member or under "common control" with the Company (within the
meaning of Section 414(b), (c), (m) or (o) of the Code).
(ii) The Compensation and Benefit Plans have been
administered in material compliance with their terms and all applicable law.
Each Plan which is an "employee pension benefit plan" within the meaning of
Section 3(2) of ERISA ("Pension Plan") and which is intended to be qualified
under Section 401(a) of the Internal Revenue Code of 1986, as amended (the
"Code") is so qualified, and has received a favorable determination letter from
the Internal Revenue Service, and the Company is not aware of any circumstances
likely to result in revocation of any such favorable determination letter. There
is no material pending or threatened litigation, governmental audit or
investigation relating to any Compensation and Benefit Plan. Neither the Company
nor any of its Controlled Group Affiliates has engaged in a transaction with
respect to any Compensation and Benefit Plan that, assuming the taxable period
of such transaction expired as of the date hereof, could subject the Company or
any of its Subsidiaries to a tax or penalty imposed by either Section 4975 of
the Code or Section 502(i) of ERISA.
(iii) Neither the Company nor any of its Controlled
Group Affiliates has, nor has ever had, any obligation or liability with respect
to an employee benefit plan which is subject to Title IV of ERISA, or which is a
"multiemployer plan" within the meaning of Section 3(37) or 4001(a)(3) of ERISA.
There is no entity (other than the Company or any of its Subsidiaries) which is
or was a Controlled Group Affiliate of the Company. No notice of a "reportable
event," within the meaning of Section 4043 of ERISA for which the 30-day
reporting requirement has not been waived, has been required to be filed for any
Compensation and Benefit Plan within the 12-month period ending on the date
hereof.
17
<PAGE>
(iv) All contributions required to be made under the terms
of any Compensation and Benefit Plan have been timely made or accrued on the
Company's financial statements and all insurance premiums required as of the
Closing Date will have been paid.
(v) Neither the Company nor any of its Controlled Group
Affiliates has any obligations for retiree health and life benefits under any
Compensation and Benefit Plan. The Company or its Controlled Group Affiliates
may amend or terminate any Compensation and Benefit Plan at any time without
incurring any material liability thereunder.
(vi) The consummation of the transactions contemplated by
this Agreement will not (x) entitle any Employees to severance pay, (y)
accelerate the time of payment or vesting or trigger any material payment or
funding (through a grantor trust or otherwise) of compensation or benefits
under, materially increase the amount payable or trigger any other material
obligation pursuant to, any of the Compensation and Benefit Plans or (z) result
in payments under any of the Compensation and Benefit Plans which may not be
deductible under Section 162(m) or Section 280G of the Code.
(vii) There are no actions, suits or claims (other than
routine claims for benefits in the ordinary course) pending or, to the Company's
Knowledge, threatened, with respect to the Compensation and Benefit Plans and,
to the Company's Knowledge, there are no such facts which could give rise to any
such actions, suits or claims.
(viii) Each of the Company and its Controlled Group
Affiliates has complied in all material respects with the reporting and
disclosure requirements of ERISA.
(ix) To the Knowledge of the Company, each Compensation
and Benefit Plan which is a "group health plan" (as such term is defined in
section 5000(b)(1) of the Code) complies and has complied with the applicable
requirements of Section 4980B of the Code and Sections 601-609 of ERISA (COBRA),
and Sections 701-734 of ERISA (HIPAA), including without limitation, the
certification requirements under Section 701(e) of ERISA.
(i) Compliance. Neither the Company nor any of its Subsidiaries
----------
is in default or violation of, (i) its certificate of incorporation or bylaws
(or similar documents), (ii) any law, ordinance, rule, regulation, order,
judgment, decree, arbitration award, license or permit of any Governmental
Entity (collectively, "Laws") applicable to the Company or any of its
Subsidiaries or by which its or any of their respective properties are bound, or
(iii) any Contract to which the Company or any of its Subsidiaries is a party or
by which the Company or any of its Subsidiaries or its or any of their
respective properties are bound or affected, except for any such defaults or
violations that, individually or in the aggregate, will not have a Company
Material Adverse Effect, or prevent or materially delay the transactions
contemplated by this Agreement. No change is required in the Company's or any of
its Subsidiaries' processes, properties or procedures in order to comply in all
material respects with any Laws, and the Company has not received any notice of
any material noncompliance with any such Laws that has not been cured.
18
<PAGE>
(j) Antitakeover Statutes. The board of directors of the
---------------------
Company has taken all necessary action to approve the transactions contemplated
by this Agreement, the Stock Option Agreement and the Shareholders Agreement
such that the restrictions under Section 203 of the DGCL shall not apply to such
transactions. No "fair price," "moratorium," "control share acquisition" or
other antitakeover statute or regulation (each, an "Antitakeover Statute") is
applicable to the Company, the Shares, the Offer, the Merger, this Agreement,
the Stock Option Agreement, the Shareholders Agreement or the other transactions
contemplated hereby or thereby.
(k) Environmental Matters. (i) The Company and its Subsidiaries
---------------------
have complied in all material respects at all times with all applicable
Environmental Laws; (ii) to the Company's Knowledge, no property currently or
formerly owned or operated by the Company or any of its Subsidiaries (including
soils, groundwater, surface water, buildings or other structures) has been
contaminated with any Hazardous Substance; (iii) to the Company's Knowledge,
neither the Company nor any of its Subsidiaries is subject to any liability for
Hazardous Substance disposal or contamination on any third party property; (iv)
to the Company's Knowledge, neither the Company nor any of its Subsidiaries is
subject to liability for any release or threat of release of any Hazardous
Substance; (v) neither the Company nor any of its Subsidiaries has received any
notice, demand, letter, claim or request for information indicating that it may
be in violation of or subject to liability under any Environmental Law; (vi)
neither the Company nor any of its Subsidiaries is subject to any order, decree,
injunction or other arrangement with any Governmental Entity or any indemnity or
other agreement with any third party relating to liability under any
Environmental Law; (vii) to the Company's Knowledge, none of the properties of
the Company or any of its Subsidiaries contain any underground storage tanks,
asbestos-containing material, lead products, or polychlorinated biphenyls;
(viii) to the Company's Knowledge, there are no other circumstances or
conditions involving the Company or any of its Subsidiaries that could
reasonably be expected to result in any claims, liability, investigations, costs
or restrictions on the ownership, use, or transfer of any property in connection
with any Environmental Law; and (ix) the Company has delivered to Parent copies
of all environmental reports, studies, assessments, sampling data and other
environmental information in its possession relating to the Company or any of
its Subsidiaries or any of their current or former properties or operations.
"Environmental Law" means any federal, state or local law, regulation,
order, decree, permit, authorization, common law or agency requirement relating
to (A) the protection, investigation or restoration of the environment, health,
safety, or natural resources, (B) the handling, use, presence, disposal, release
or threatened release of any Hazardous Substance or (C) noise, odor, indoor air,
employee exposure, wetlands, pollution, contamination or any injury or threat of
injury to persons or property relating to any Hazardous Substance.
"Hazardous Substance" means any substance that is (A) listed,
classified or regulated pursuant to any Environmental Law; (B) any chemical,
petroleum product or by-product, asbestos-containing material, lead-containing
paint or plumbing, polychlorinated biphenyls, radioactive materials or radon,
pharmaceutical, biological and/or medical waste or
19
<PAGE>
materials; or (C) any other substance which may be the subject of regulatory
action by any Governmental Authority in connection with any Environmental Law.
(l) Opinion of Financial Advisor. The Company's Board has
----------------------------
received the written opinion of DLJ to the effect that, subject to the
assumptions and qualifications set forth in such opinion, as of the date hereof,
the consideration to be received by the holders of Shares pursuant to the Offer
and the Merger is fair to such holders from a financial point of view.
(m) Taxation. The Company and each of its Subsidiaries has
--------
timely filed all Tax Returns required to be filed by it in the manner provided
by law except where the failure to make such timely filing has not had, and
could not reasonably be expected to have, a Company Material Adverse Effect.
All such Tax Returns are true, correct and complete in all material respects.
The Company and each of its Subsidiaries have timely paid all Taxes due or
required to be withheld from amounts owing to any employee, creditor or third
party or have provided adequate reserves in their financial statements for any
Taxes that have not been paid, whether or not shown as being due on any Tax
Returns. (i) No claim for unpaid Taxes (other than for Taxes not yet due) has
become a lien or encumbrance of any kind against the property of the Company or
any of its Subsidiaries or is being asserted against the Company or any of its
Subsidiaries; (ii) no audit, examination, investigation or other proceeding in
respect of Taxes is pending, being conducted, or threatened by a Tax authority
involving the Company or any of its Subsidiaries; (iii) no issues have been
raised by the relevant taxing authority in connection with any examination of
the Tax Returns filed by the Company and its Subsidiaries that have not been
resolved; (iv) no extension or waiver of the statute of limitations on the
assessment of any Taxes has been granted by the Company or any of its
Subsidiaries and is currently in effect; (v) neither the Company nor any of its
Subsidiaries is a party to, is bound by, or has any obligation under, or
potential liability with regards to, any Tax sharing agreement, Tax
indemnification agreement or similar contract or arrangement; (vi) no power of
attorney has been granted by or with respect to the Company or any of its
Subsidiaries with respect to any matter relating to Taxes; (vii) neither the
Company nor any of its Subsidiaries (A) has been a member of an affiliated group
filing a consolidated, combined or unitary Tax Return (other than a group the
common parent of which was the Company), or (B) has any liability for Taxes of
any person (other than the Company or its Subsidiaries) under Treasury
Regulation Section 1.1502-6 (or any other similar provision of state, local or
foreign law), as a transferee or successor, by contract or otherwise; (viii)
neither the Company nor any of its Subsidiaries is a party to any agreement,
plan, contract or arrangement that would result, separately or in the aggregate,
in the payment of any "excess parachute payments" within the meaning of Section
280G of the Code; (ix) neither the Company nor any of its Subsidiaries has any
intercompany gain or loss arising as a result of an intercompany transaction
within the meaning of Treasury Regulation Section 1.1502-13 (or similar
provision under state, local or foreign law) that has not been taken into
account or any excess loss accounts within the meaning of Treasury Regulation
Section 1.1502-19; (x) the Company is not and has not been a United States real
property holding corporation (as defined in Section 897(c)(2) of the Code)
during the applicable period specified in Section 897(c)(1)(ii) of the Code;
(xi) neither the Company nor any of its Subsidiaries has been the subject to a
Tax ruling that has continuing effect; and (xii) neither the Company nor any of
its Subsidiaries has
20
<PAGE>
agreed to include, or is required to include, in income any adjustment under
either Section 481(a) or 482 of the Code (or an analogous provision of state,
local or foreign law) by reason of a change in accounting method or otherwise.
"Taxes" means any taxes of any kind, including but not limited to
those on or measured by or referred to as income, gross receipts, capital,
sales, use, ad valorem, franchise, profits, license, withholding, employment,
payroll, premium, value added, property or windfall profits taxes, environmental
transfer taxes, customs, duties or similar fees, assessments or charges of any
kind whatsoever, together with any interest and any penalties, additions to tax
or additional amounts imposed by any governmental authority, domestic or
foreign.
"Tax Return" means any return, report or statement required to be
filed with any governmental authority with respect to Taxes.
(n) Intellectual Property.
---------------------
(i) Set forth in Schedule 6.1(n)(i) is a correct and
complete list of each of the following items (A) all patents and applications
therefor, registrations of trademarks (including service marks) and applications
therefor, and registrations of copyrights and applications therefor that are
owned by the Company or any of its Subsidiaries or licensed to the Company or
any of its Subsidiaries (collectively, the "Company Owned IP"), (B) all
licenses, agreements and contracts relating to the Company Intellectual Property
(as defined in Section 6.1(n)(ii) of this Agreement) pursuant to which the
Company or any of its Subsidiaries are entitled to use any Company Intellectual
Property owned by any third party (the "Third Party Licenses") and (C) all
agreements under which the Company or any of its Subsidiaries has granted any
third party the right to use any Company Intellectual Property.
(ii) The Company, or its Subsidiaries where expressly
indicated, is the owner of, or is licensed to use, or otherwise possesses
legally enforceable rights in, all intellectual property, including, without
limitation, all patents and patent applications, supplementary protection
certificates and patent extensions, trademarks and trademark applications,
service mark and service mark registrations, logos, commercial symbols, business
name registrations, trade names, copyrights and copyright registrations,
computer software, mask works and mask work registration applications,
industrial designs and applications for registration of such industrial designs,
including, without limitation, any and all applications for renewal, extensions,
reexaminations and reissues of any of the foregoing intellectual property rights
where applicable, inventions, compounds, structures, compound libraries,
biological materials, trade secrets, formulae, know-how, technical information,
research data, research raw data, laboratory notebooks, procedures, designs,
proprietary technology and information held or used in the business of the
Company and its Subsidiaries (hereinafter the "Company Intellectual Property").
(iii) The Company and its Subsidiaries are the sole
legal and beneficial owners of all the Company Intellectual Property (except for
the Company Intellectual
21
<PAGE>
Property that is the subject of any Third Party Licenses).
(iv) The Company has not entered into any agreements,
licenses or created any mortgages, liens, security interests, leases, pledges,
encumbrances, equities, claims, charges, options, restrictions, rights of first
refusal, title retention agreements or other exceptions to title which affect
the Company Intellectual Property or restrict the use by the Company or any of
its Subsidiaries of the Company Intellectual Property, except as provided in
agreements and instruments disclosed in Schedule 6.1(n)(i) and furnished or made
available to Parent prior to the date of this Agreement.
(v) To the Company's Knowledge, the Company and its
Subsidiaries are in compliance in all material respects with the Third Party
Licenses.
(vi) The Company and its Subsidiaries are not, and will
not be as a result of the execution, delivery or performance of this Agreement
or the Stock Option Agreement or the consummation of the Offer and the Merger or
the other transactions contemplated hereby or thereby, in breach, violation or
default of any Third Party Licenses that are material to the conduct of the
business of the Company. The rights of the Company or any of its Subsidiaries to
the Company Intellectual Property are not affected by the execution, delivery or
performance of this Agreement or the Stock Option Agreement or the consummation
of the Offer and the Merger or the other transactions contemplated hereby or
thereby.
(vii) The Company and its Subsidiaries have the right to
license to third parties the use of the Company Owned IP, except as restricted
under Third Party Licenses.
(viii) To the Company's Knowledge, all registrations and
filings relating to the Company Owned IP are in good standing. To the Company's
Knowledge, all maintenance and renewal fees necessary to preserve the rights of
the Company in respect of the Company Owned IP have been made. The
registrations and filings relating to the Company Owned IP are proceeding and
there are no facts of which the Company has Knowledge which could significantly
undermine those registrations or filings.
(ix) To the Company's Knowledge, the manufacturing,
marketing, distribution, sale and use of compounds by the Company or its
Subsidiaries, licensees or sublicensees in the countries where the Company has
conducted such activities, does not infringe the patents, patent applications,
trademarks, trademark applications, service marks, service mark applications,
copyrights, copyright applications, and proprietary trade names, publication
rights, computer programs (including source code and object code), inventions,
know-how, trade secrets, technology, processes, confidential information and all
other intellectual property rights throughout the world (collectively,
"Intellectual Property Rights") of any third party.
22
<PAGE>
(x) There are no allegations, claims or proceedings
instituted, pending or threatened (and the Company is not aware of any basis for
any such allegation, claim or proceeding) which challenge the rights possessed
by the Company or its Subsidiaries to use the Company Intellectual Property or
the validity or effectiveness of the Company Intellectual Property, including
without limitation any interferences, oppositions, cancellations or other
contested proceedings.
(xi) There are no outstanding claims or proceedings
instituted, pending or threatened by any third party challenging the ownership,
priority, scope or validity or effectiveness of any Company Intellectual
Property.
(xii) To the Company's Knowledge, there are no valid
Intellectual Property Rights of any third party that have been infringed by the
identification, development, manufacture, marketing, distribution and sale and
use of any products that have been identified for development by the Company or
any of its Subsidiaries.
(xiii) To the Company's Knowledge, there are no
Intellectual Property Rights of any third party that are infringed by the
continued practice of any technologies previously used or presently in use by
the Company.
(xiv) To the Company's Knowledge, except for matters as
would not have or be reasonably likely to have a Company Material Adverse
Effect, there is no unauthorized use, infringement or misappropriation of the
Company Intellectual Property by any third party, including any employee or
former employee of the Company or any of its Subsidiaries.
(xv) The Company and its Subsidiaries have not granted
any licenses, immunities, options or other rights to the Company Intellectual
Property which could provide a third party with a defense to patent infringement
proceedings, whether domestic or foreign.
(xvi) Commercially reasonable measures have been taken
to maintain the confidentiality of the inventions, trade secrets, formulae,
know-how, technical information, research data, research raw data, laboratory
notebooks, procedures, designs, proprietary technology and information of the
Company and its Subsidiaries, and all other information the value of which to
the Company or any of its Subsidiaries is contingent upon maintenance of the
confidentiality thereof. Without limiting the generality of the foregoing, (A)
each employee of the Company and each consultant to the Company who has had
access to proprietary information with respect to the Company has entered into
an agreement suitable to vest ownership rights to any inventions, creations,
developments, and works in the Company and has entered into an agreement for
maintaining the confidential information of the Company and (B) each officer and
director of the Company has entered into an agreement to maintain the
confidential information of the Company, except for those individuals listed in
Schedule 6.1(n) (xvi) whose involvement in the business of the Company is
described with specificity therein.
23
<PAGE>
(o) Year 2000 Compliance.
--------------------
(i) All Software (as defined herein) of the Company, when
operated on the computer hardware of the Company now used for that purpose:
(A) will operate before, during, and after January 1,
2000, without any errors relating to data, in the same manner as it presently
operates;
(B) will not abnormally end a process or provide
incorrect results as a result of date data which represents or references
different centuries or more than one century;
(C) recognizes the century in date data and performs
all date calculations in a manner which accommodates multi-century formulas and
date values;
(D) includes an indication of century in all date-
related user interfaces and data interfaces;
(E) recognizes and correctly processes date and data
involving leap years; and
(F) performs all sorting operations that include a
year category on the basis of four-digit dates.
(ii) Schedule 6(o)(ii) attached hereto contains a complete
description of the testing and analysis which the Company has performed or had
performed with respect to the matters described in Section 6(o)(i), including a
true and complete listing of each document setting forth any portion of that
analysis or any related test results. The Company has provided Parent with true
and complete copies of all documents listed in Schedule 6(o)(ii).
(iii) If any exceptions to the warranties and
representations in Section 6(o)(i) are disclosed in the Company Disclosure
Schedules, Schedule 6(o)(iii) attached hereto contains a summary of the
Company's plans for dealing with those exceptions, including a timetable and a
reasonably detailed estimate of the costs the Company will incur in doing so.
Any cost estimates shown in Schedule 6(o)(iii) are reasonable, based on sound
business practices and are based on reasonable assumptions supported by
objective facts.
(iv) "Software" means all computer software and subsequent
versions thereof used, developed or currently being developed, manufactured,
sold or marketed by the Company including, but not limited to, source code,
object code, objects, comments, screens, user interfaces, report formats,
templates, menus, buttons and icons, and all files, data, materials, manuals,
design notes and other items and documentation related thereto or associated
therewith.
24
<PAGE>
(p) Labor Matters
-------------
(i) Schedule 6.1(p)(i) attached hereto sets forth the
name, current annual compensation rate (including bonus and commissions), title,
current base salary rate, accrued bonus, accrued sick leave, accrued severance
pay and accrued vacation benefits of each present employee of the Company;
organizational charts of the Company; and lists any collective bargaining, union
or other employee association agreements, employee confidentiality or other
agreements protecting proprietary processes, formulae or information, employee
handbook and any reports and/or plans prepared or adopted pursuant to the Equal
Employment Opportunity Act of 1972, as amended. There are no leased employees
(within the meaning of Section 414(n) of the Code) who must be taken into
account in applying the requirements of Section 414(n)(3) of the Code.
(ii) Each of the Company and its Subsidiaries is in
compliance with all applicable laws and collective bargaining agreements
respecting employment and employment practices, terms and conditions of
employment and wages and hours and occupational safety and health, and is not
engaged in any unfair labor practice within the meaning of Section 8 of the
National Labor Relations Act, and there is no action, suit or legal,
administrative, arbitration, grievance or other proceeding pending or, to the
Company's Knowledge, threatened, or, any investigation pending or to the
Company's Knowledge, threatened against the Company or any Subsidiary relating
to any thereof, and, to the Company's Knowledge, no basis exists for any such
action, suit or legal, administrative, arbitration, grievance or other
proceeding or governmental investigation.
(iii) There is no labor strike, dispute, slowdown or
stoppage actually pending or, to the Company's Knowledge, threatened against the
Company or any Subsidiary.
(iv) None of the employees of the Company or any Subsidiary
is a member of or represented by any labor union and, to the Company's
Knowledge, there are no attempts of whatever kind and nature being made to
organize any of such employees.
(v) Without limiting the generality of paragraph (iv)
above, no certification or decertification is pending or was filed within the
past twelve months respecting the employees of the Company or any Subsidiary
and, to the Company's Knowledge, no certification or decertification petition is
being or was circulated among the employees of the Company or any Subsidiary
within the past twelve (12) months.
(vi) No agreement (including any collective bargaining
agreement), arbitration or court decision, decree or order or governmental order
which is binding on the Company or any Subsidiary in any way limits or restricts
the Company or any Subsidiary from relocating or closing any of its operations.
25
<PAGE>
(vii) Neither the Company nor any Subsidiary has
experienced any organized work stoppage in the last five years.
(viii) There are no charges, administrative proceedings or
formal complaints of discrimination (including but not limited to discrimination
based upon sex, age, marital status, race, national origin, sexual orientation,
handicap or veteran status) pending or, to the Company's Knowledge, threatened,
or any investigation pending or to the Company's Knowledge, threatened before
the Equal Employment Opportunity Commission or any federal, state or local
agency or court. There have been no audits of the equal employment opportunity
practices of the Company or any Subsidiary and, to the Company's Knowledge, no
basis for any such claim exists.
(q) Brokers and Finders. Neither the Company nor any of its
-------------------
Subsidiaries, officers, directors or employees has employed any broker or finder
or incurred any liability for any brokerage fees, commissions or finders' fees
in connection with the Offer and the Merger or the other transactions
contemplated by this Agreement, the Stock Option Agreement or the Shareholders
Agreement, except that the Company has employed DLJ as its financial advisor,
the arrangements with which have been disclosed to Parent prior to the date
hereof.
(r) Certain Agreements. (i) All contracts listed as exhibits to
------------------
the Company's Annual Report on Form 10-K for the year ended December 31, 1998
under the rules and regulations of the SEC relating to the business of the
Company and its Subsidiaries and (ii) any other agreement within the meaning set
forth in item 601(b)(10) of Regulation S-K of Title 17, Part 229 of the Code of
Federal Regulations (all of which are listed on Schedule 6.1(r)) (the "Company
Material Contracts") are valid and in full force and effect, except to the
extent they have previously expired in accordance with their terms and other
than as is not reasonably likely to have, individually or in the aggregate, a
Company Material Adverse Effect. Neither the Company nor its Subsidiaries has
violated any provision of, or committed or failed to perform any act which, with
or without notice, lapse of time, or both, is reasonably likely to constitute a
default under the provisions of, any such Company Material Contract, and neither
the Company nor any of its Subsidiaries has received notice that any party to
any Company Material Contract intends to cancel, terminate or otherwise modify
the terms of any applicable Company Material Contract, except in each case, as
is not reasonably likely to have, individually or in the aggregate, a Company
Material Adverse Effect. To the Company's Knowledge, no counterparty to any such
Company Material Contract has violated any provision of, or committed or failed
to perform any act which, with or without notice, lapse of time, or both, is
reasonably likely to constitute a default or other breach under the provisions
of, such Company Material Contract, except for defaults or breaches which are
not reasonably likely, individually or in the aggregate, to have a Company
Material Adverse Effect. Neither the Company nor any of its Subsidiaries is a
party to, nor are any of their assets bound by, any agreement, arrangement,
commitment or understanding with any company engaged primarily in the
pharmaceutical business, other than as listed on Schedule 6.1(r).
26
<PAGE>
(s) Schedule 14D-9; Offer Documents. Neither the Schedule 14D-
-------------------------------
9, any other documents required to be filed by the Company with the SEC in
connection with the transactions contemplated hereby, nor any information
supplied by the Company for inclusion in the Offer Documents shall, at the
respective times the Schedule 14D-9, any such other filings by the Company, the
Offer Documents or any amendments or supplements thereto are filed with the SEC
or are first published, sent or given to stockholders of the Company, as the
case may be, contain any untrue statement of a material fact or omit to state
any material fact required to be stated therein or necessary in order to make
the statements made therein, in light of the circumstances under which they are
made, not misleading. The Schedule 14D-9 and any other document required to be
filed by the Company with the SEC in connection with the transactions
contemplated by this Agreement will, when filed by the Company with the SEC,
comply as to form in all material respects with the applicable provisions of the
Exchange Act and the rules and regulations thereunder. Notwithstanding the
foregoing, the Company makes no representation or warranty with respect to the
statements made in any of the foregoing documents based on and in conformity
with information supplied by or on behalf of Parent or Merger Sub in writing
specifically for inclusion therein.
(t) Required Vote of Company Stockholders. Unless the Merger
-------------------------------------
may be consummated in accordance with Section 253 of the DGCL, the only vote of
the stockholders of the Company required to adopt this Agreement and the Stock
Option Agreement and to approve the Merger and the transactions contemplated
hereby and thereby, is the Company Requisite Vote.
(u) Foreign Corrupt Practices Act. Neither the Company nor any
-----------------------------
of its Subsidiaries, nor any director, officer or employee of the Company or any
of its Subsidiaries has, directly or indirectly, used any corporate funds for
unlawful contributions, gifts, entertainment, or other unlawful expenses
relating to political activity, made any unlawful payment to foreign or domestic
government officials or employees or to foreign or domestic political parties or
campaigns from corporate funds, violated any provision of the Foreign Corrupt
Practices Act of 1977, as amended, or the rules and regulations thereunder, or
made any bribe, rebate, payoff, influence payment, kickback or other unlawful
payment.
(v) Licenses and Permits. The Company and each Subsidiary has
--------------------
obtained all material licenses, registrations, permits, approvals and other
governmental authorizations required to conduct its business as described in the
Company Reports. Such licenses are in full force and effect and neither the
Company nor any Subsidiary has received notice of proceedings relating to the
revocation or modification of any such license, permit, approval and other
governmental authorization.
(w) Employment Agreements with Key Employees. The Employment
----------------------------------------
Agreements with the employees of the Company listed on Schedule 6.1(w) attached
hereto have been executed by such employees prior to or contemporaneously with
the execution of this Agreement and the Employment Agreements remain in full
force and effect and, to the
27
<PAGE>
Company's Knowledge, none of the employees listed on Schedule 6.1(w) is in
breach or violation of his or her Employment Agreement.
6.2. Representations and Warranties of Parent and Merger Sub.
-------------------------------------------------------
Parent and Merger Sub each hereby represent and warrant to the Company, except
as set forth in the Disclosure Schedules delivered to the Company on the date of
this Agreement and attached hereto (the "Parent Disclosure Schedules"), as
follows:
(a) Organization and Good Standing. Each of Merger Sub and
------------------------------
Parent is a corporation duly organized, validly existing and in good standing
under the laws of Delaware and each of them has all requisite corporate power
and authority to own and operate its properties and assets and to carry on its
business as presently conducted. Merger Sub has not, and prior to the Effective
Time will not have, conducted any activities other than those required for the
Merger and has no, and prior to the Effective Time will have no, assets,
liabilities or obligations except as contemplated in connection with its
execution, delivery and performance of this Agreement, the Stock Option
Agreement and the Shareholders Agreement and the transactions contemplated
hereby and thereby.
(b) Corporate Authority. No vote of holders of capital stock of
-------------------
Parent is necessary to approve this Agreement, the Offer and the Merger and the
other transactions contemplated hereby. Each of Parent and Merger Sub has all
requisite corporate power and authority and each has taken all corporate action
(including approval of the stockholder of Merger Sub) necessary in order to
execute, deliver and perform its obligations under this Agreement and to
consummate the Offer and the Merger. Parent has all requisite corporate power
and authority and has taken all corporate action necessary in order to execute,
deliver and perform its obligations under the Stock Option Agreement. This
Agreement is a valid and binding agreement of Parent and Merger Sub, enforceable
against each of Parent and Merger Sub in accordance with its terms subject to
(i) applicable bankruptcy, insolvency, reorganization, fraudulent transfer,
moratorium, or similar laws from time to time in effect affecting creditors'
rights generally, and (ii) general principles of equity, whether such principles
are considered in a proceeding at law or in equity. The Stock Option Agreement
is a valid and binding agreement of Parent, enforceable against Parent in
accordance with its terms subject to (i) applicable bankruptcy, insolvency,
reorganization, fraudulent transfer, moratorium, or similar laws from time to
time in effect affecting creditors' rights generally, and (ii) general
principles of equity, whether such principles are considered in a proceeding at
law or in equity.
(c) Governmental Filings; No Violations.
-----------------------------------
(i) Other than any filings and/or notices required (A)
pursuant to Section 2.3, (B) under the HSR Act and (C) the Exchange Act and the
"takeover" or "blue sky" laws of any state, no notices or other filings are
required to be made by Parent or Merger Sub with, nor are any consents,
registrations, approvals, permits or authorizations required to be obtained by
Parent or Merger Sub from, any Governmental Entity, in connection with the
execution and delivery of this Agreement by Parent and Merger Sub or the
execution and
28
<PAGE>
delivery of the Stock Option Agreement by Parent and the consummation by Parent
and Merger Sub of the Offer and the Merger and the other transactions
contemplated hereby and by the Stock Option Agreement, except those that the
failure to make or obtain are not, individually or in the aggregate, reasonably
likely to prevent, materially delay or materially impair the ability of Parent
or Merger Sub to consummate the transactions contemplated by this Agreement, the
Stock Option Agreement and the Shareholders Agreement.
(ii) The execution, delivery and performance of this Agreement
and the Stock Option Agreement, by Parent and Merger Sub, as the case may be, do
not and will not, and the consummation by Parent and Merger Sub of the Offer and
the Merger and the other transactions contemplated hereby and by the Stock
Option Agreement, will not, constitute or result in (A) a breach or violation
of, or a default under, the certificate or bylaws of Parent or Merger Sub, (B) a
breach or violation of, or a default under, the acceleration of any obligation
or the creation of a lien, pledge, security interest or other encumbrance on the
assets of Parent or Merger Sub (with or without notice, lapse of time or both)
pursuant to, any Contracts binding upon Parent or Merger Sub or any Law or
governmental or non-governmental permit or license to which Parent or Merger Sub
is subject, or (C) any change in the rights or obligations of any party under
any of the Contracts, except, in the case of clause (B) or (C) above, for
breach, violation, default, acceleration, creation or change that, individually
or in the aggregate, is not reasonably likely to prevent, materially delay or
materially impair the ability of Parent or Merger Sub to consummate the
transactions contemplated by this Agreement.
(d) Brokers and Finders. Neither Parent nor any of its
-------------------
Subsidiaries, officers, directors or employees has employed any broker or finder
or incurred any liability for any brokerage fees, commissions or finders' fees
in connection with the Offer and the Merger or the other transactions
contemplated by this Agreement, the Stock Option Agreement or the Shareholders
Agreement, except that the Company has employed Morgan Stanley & Co.
Incorporated as its financial advisor and as dealer manager in connection with
the Offer.
(e) Financing. Parent has the funds necessary to consummate the
---------
Offer and the Merger on the terms contemplated by this Agreement and will
provide such funds to Merger Sub at or prior to the consummation of the Offer
and the Merger, as applicable.
(f) Offer Documents. The Offer Documents and any other
---------------
documents to be filed by Parent with the SEC or any other Governmental Entity in
connection with the Offer and the Merger and the other transactions contemplated
hereby will (in the case of the Offer Documents and any such other documents
filed with the SEC under the Exchange Act) comply as to form in all material
respects with applicable provisions of the Exchange Act and the rules and
regulations thereunder. None of the Offer Documents, any other documents
required to be filed by Parent with the SEC in connection with the transactions
contemplated hereby, nor any information supplied by Parent for inclusion in the
Schedule 14D-9 or in the information required to be distributed to the
stockholders of the Company pursuant to Section 14(f) of the Exchange Act and
Rule 14f-1 promulgated thereunder as is necessary to enable Parent's designees
to be elected to the Company's Board pursuant to Section 1.4 hereof shall, at
the
29
<PAGE>
respective times the Offer Documents, any amendments and supplements thereto
or any such other filings by the Company, Parent or Merger Sub are filed with
SEC or are first published, sent or given to stockholders of the Company, as the
case may be, contain any untrue statement of a material fact, or omit to state
any material fact required to be stated therein or necessary in order to make
the statements made therein, in the light of the circumstances under which they
are made, not misleading. Notwithstanding the foregoing, neither Parent nor
Merger Sub makes any representation or warranty with respect to the statements
made in any of the foregoing documents based on and in conformity with
information supplied by or on behalf of the Company in writing specifically for
inclusion therein.
(g) No Litigation. There are no civil, criminal, administrative
-------------
or regulatory actions, suits, claims, hearings, investigations or proceedings
pending or, to the Knowledge of Parent or Merger Sub, threatened against Parent
or Merger Sub which, in the aggregate, are reasonably likely to prevent or
materially delay or materially impair the ability of Parent or Merger Sub to
consummate the transactions contemplated by this Agreement and the Stock Option
Agreement.
(h) Compliance. Neither Parent nor Merger Sub is in default or
----------
violation of (i) its certificate of incorporation or bylaws, (ii) any Laws
applicable to the Company or Merger Sub, or (iii) any material Contract to which
Parent or Merger Sub is a party, except for any such defaults or violations
that, in the aggregate, are not reasonably likely to prevent or materially delay
the transactions contemplated by this Agreement.
ARTICLE VII
Covenants
7.1. Company Interim Operations. The Company covenants and
--------------------------
agrees as to itself and its Subsidiaries that, after the date hereof and prior
to the Effective Time (unless Parent shall otherwise consent in writing (such
consent not to be unreasonably withheld or delayed) and except as otherwise
expressly set forth in Schedule 7.1 attached hereto or expressly contemplated by
this Agreement and the Stock Option Agreement):
(a) the business of it and its Subsidiaries shall be conducted,
in all material respects, in the ordinary and usual course and, to the extent
consistent therewith, it and its Subsidiaries shall use their respective
commercially reasonable best efforts to preserve its business organization
substantially intact and substantially maintain its existing relations and
goodwill with customers, suppliers, distributors, creditors, lessors, employees
and business associates;
(b) it shall not (i) issue, sell, pledge, dispose of or
encumber any capital stock owned by it in any of its Subsidiaries; (ii) amend
its certificate or bylaws; (iii) split, combine or reclassify its outstanding
shares of capital stock; (iv) declare, set aside or pay any dividend payable in
cash, stock or property in respect of any capital stock, or (v) repurchase,
30
<PAGE>
redeem or otherwise acquire, except in connection with the Stock Plans or
employment arrangements, or permit any of its Subsidiaries to purchase or
otherwise acquire, any shares of its capital stock or any securities convertible
into or exchangeable or exercisable for any shares of its capital stock;
(c) neither it nor any of its Subsidiaries shall (i) issue,
sell, pledge, dispose of or encumber any shares of, or securities convertible
into or exchangeable or exercisable for, or options, warrants, calls,
commitments or rights of any kind to acquire, any shares of its capital stock of
any class or any Voting Debt or any other property or assets (other than the
issuance of shares of Common Stock pursuant to the ESPP, the Company Options or
the Warrants); (ii) transfer, lease, license, guarantee, sell, mortgage, pledge,
dispose of or encumber any other property or assets (including capital stock of
any of its Subsidiaries) or incur or modify any material indebtedness or other
liability; or (iii) make any commitments for, make or authorize any capital
expenditures or, by any means, make any acquisition of, or investment in, assets
or stock of any other Person in each case, involving amounts in excess of
$50,000 in the aggregate;
(d) except as may be required by existing contractual
commitments or as required by applicable law, neither it nor any of its
Subsidiaries shall (i) enter into any new agreements or commitments for any
severance or termination pay to, or enter into employment or severance agreement
with, any of its directors, officers or employees or (ii) terminate, establish,
adopt, enter into, make any new grants or awards under, amend or otherwise
modify, any Compensation and Benefit Plans or increase or accelerate the salary,
wage, bonus or other compensation of any employees, officers or directors
(except for increases in salaries, wages and cash bonuses of nonexecutive
employees made in the ordinary course of business consistent with past practice)
or pay or agree to pay any pension, retirement allowance or other employee
benefit not required by any existing Compensation and Benefit Plan;
(e) neither it nor any of its Subsidiaries shall settle or
compromise any material claims or litigation or modify, amend or terminate any
of the Company Material Contracts or waive, release or assign any material
rights or claims;
(f) neither it nor any of its Subsidiaries shall make any Tax
election or permit any insurance policy naming it as a beneficiary or loss-
payable payee to be canceled or terminated, except in the ordinary and usual
course of business;
(g) except as may be required as a result of a change in law,
neither it nor any of its Subsidiaries shall change any of the accounting
practices or principles used by it;
(h) neither it nor any of its Subsidiaries shall adopt a plan of
complete or partial liquidation, dissolution, merger, consolidation,
restructuring, recapitalization, or other reorganization of the Company or any
of its subsidiaries not constituting an inactive Subsidiary (other than the
Merger);
31
<PAGE>
(i) it shall not suffer or permit capital expenditures made or
incurred by the Company and its Subsidiaries to exceed $50,000 except for
expenses incurred in connection with the transactions contemplated by this
Agreement;
(j) neither it nor any of its Subsidiaries will offer to, or
enter into an agreement to, do any of the foregoing; and
(k) it shall not, and shall not permit any of its Subsidiaries
to, take any action that would, or that could reasonably be expected to, result
in any of the representations or warranties of the Company becoming untrue.
7.2. Acquisition Proposals.
---------------------
(a) The Company shall, and it shall cause its affiliates and
the officers, directors, employees, representatives and agents of the Company
and its Subsidiaries (including, without limitation, any investment banker,
attorney or accountant retained by the Company or any of its Subsidiaries) to,
immediately cease and terminate any existing activities, discussions or
negotiations, if any, with any parties (other than Parent and Merger Sub, any
affiliate or associate of Parent and Merger Sub or any designees of Parent and
Merger Sub) conducted heretofore with respect to any acquisition or exchange of
all or any material portion of the assets of, or any equity interest in, the
Company or any of its Subsidiaries (by direct purchase from the Company, tender
or exchange offer or otherwise) or any business combination, merger or similar
transaction (including an exchange of stock or assets) with or involving the
Company or any Subsidiary of the Company (an "Acquisition Transaction"), other
than the Offer and the Merger.
(b) Except as set forth in Section 7.2(c), the Company shall
not, nor shall it permit its affiliates and the officers, directors, employees,
representatives and agents of the Company and its Subsidiaries (including,
without limitation, any investment banker, attorney or accountant retained by
the Company or any of its subsidiaries) to, directly or indirectly, encourage,
solicit, participate in or initiate discussions or negotiations with, or provide
any nonpublic information or data (other than the Company's standard public
information package) to, any corporation, partnership, Person or other entity or
group (other than Parent and Merger Sub, any affiliate or associate of Parent
and Merger Sub or any designees of Parent and Merger Sub) with respect to any
inquiries or the making of any offer or proposal (including, without limitation,
any offer or proposal to the stockholders of the Company) concerning an
Acquisition Transaction (an "Acquisition Proposal") or otherwise facilitate any
effort or attempt to make or implement an Acquisition Proposal.
(c) Prior to the consummation of the Offer, the Company may
furnish information and access, but only in response to a request for
information or access, to any Person making a bona fide written Acquisition
Proposal to the board of directors of the Company after the date hereof which
was not encouraged, solicited or initiated by the Company or any of its
affiliates or any director, employee, representative or agent of the Company or
any of its Subsidiaries (including, without limitation, any investment banker,
attorney or accountant
32
<PAGE>
retained by the Company or any of its Subsidiaries) on or after the date hereof
and may participate in discussions and negotiate with such Person concerning any
such Acquisition Proposal and may authorize the Company to enter into a binding
written agreement concerning a Superior Proposal (as defined below), if and only
if, in any such case, (i) the board of directors of the Company determines in
good faith, (A) after receiving advice of outside counsel to the Company to such
effect, that failing to provide such information or access or to participate in
such discussions or negotiations or to so authorize, as the case may be, would
constitute a breach of such board's fiduciary duties under applicable law, and
(B) after consultation with the financial advisors to the Company to such
effect, that such Acquisition Proposal, if accepted, is reasonably likely to be
consummated, taking into account all legal, financial and regulatory aspects of
the proposal and the Person making the proposal and would, if consummated,
result in a transaction more favorable to the Company's stockholders from a
financial point of view than the transaction contemplated by this Agreement (any
such more favorable Acquisition Proposal as to which both of the determinations
referred to in subclauses (A) and (B) above have been made being referred to in
this Agreement as a "Superior Proposal"), and (ii) the Company receives from the
Person making such bona fide written Acquisition Proposal an executed
confidentiality agreement.
(d) Nothing in this Agreement shall prohibit the Board of
Directors of the Company from, to the extent applicable, complying with Rule
14e-2 or 14D-9 promulgated under the Exchange Act with regard to an Acquisition
Proposal. The Company will notify Parent within twenty-four (24) hours if any
such inquiries or proposals are received by, any such information is requested
from, or any such negotiations or discussions are sought to be initiated or
continued with the Company and shall in such notice indicate the identity of the
offeror and the material terms and conditions of any such proposal and
thereafter shall keep Parent reasonably informed, on a current basis, of the
status and material terms of such proposals and the status of such negotiations
or discussions, providing copies to Parent of any Acquisition Proposals made in
writing.
(e) The Company shall provide Parent with three business days
advance notice of, in each and every case, its intention to either enter into
any agreement with or to provide any information to any Person making any such
inquiry or proposal. The Company agrees not to release any third party from, or
waive any provisions of, any confidentiality or standstill agreement to which
the Company is a party and will use its best efforts to enforce any such
agreements at the request of and on behalf of Parent.
(f) The Company will inform the individuals or entities referred
to in the first sentence of Section 7.2(a) of the obligations undertaken in this
Section 7.2.
7.3. Company Stockholder Approval; Proxy Statement.
---------------------------------------------
(a) If approval or action in respect of the Merger by the
stockholders of the Company is required by applicable law, the Company, acting
through the Company Board, shall (i) call as promptly as practicable following
consummation of the Offer, a meeting of its
33
<PAGE>
stockholders (the "Company Stockholders Meeting") for the purpose of voting upon
adopting this Agreement and approving the Merger, (ii) hold the Company
Stockholders Meeting as soon as practicable following the purchase of Shares
pursuant to the Offer, and (iii) recommend to its stockholders the approval of
the Merger. Notwithstanding the foregoing, the Company Board may withdraw,
modify or amend any recommendation that the stockholders approve the Merger if
the Company has received an Acquisition Proposal which in accordance with
Section 7.2(c) is a Superior Proposal. The record date for the Company
Stockholders Meeting shall be no earlier than close of business on the date on
which Parent or Merger Sub becomes a record holder of Shares purchased pursuant
to the Offer. At the Company Stockholders Meeting, Parent and Merger Sub shall
cause all shares then owned beneficially or of record by them to be voted in
favor of approval and adoption of this Agreement, the Merger and the
transactions contemplated hereby. Notwithstanding the foregoing, if Parent,
Merger Sub or any other subsidiary of Parent shall acquire at least ninety
percent (90%) of the outstanding Shares, the parties shall take all necessary
and appropriate action to cause the Merger to become effective as soon as
practicable after the expiration of the Offer without a stockholders meeting in
accordance with Section 253 of the DGCL.
(b) If required by applicable Law, the Company will, as soon as
practicable following the expiration of the Offer, prepare and file a
preliminary Proxy Statement (such proxy statement, and any amendments or
supplements thereto, the "Proxy Statement") or, if applicable, an information
statement with the SEC with respect to the Company Stockholders Meeting and will
use its best efforts to respond to any comments of the SEC or its staff and of
any request by the SEC or its staff for amendments or supplements to the Proxy
Statement or for additional information and will supply Parent with copies of
all correspondence between the Company or any of its representatives, on the one
hand, and the SEC or its staff, on the other hand, with respect to the Proxy
Statement or the Merger. Parent and Merger Sub shall furnish to the Company all
information regarding Parent, Merger Sub and their affiliates that may be
required (pursuant to the Exchange Act and other applicable Laws) to be set
forth in the Proxy Statement. The Company shall give Parent and its counsel the
opportunity to review the Proxy Statement prior to it being filed with the SEC
and shall give Parent and its counsel the opportunity to review all amendments
and supplements to the Proxy Statement and all responses to requests for
additional information and replies to comments prior to their being filed with,
or sent to, the SEC. Each of the Company and Parent agrees to use its best
efforts, after consultation with the other parties hereto, to respond promptly
to all such comments of and requests by the SEC. As promptly as practicable
after the Proxy Statement has been cleared by the SEC, the Company shall mail
the Proxy Statement to the stockholders of the Company. If at any time prior to
the approval of this Agreement by the Company's stockholders there shall occur
any event which should be set forth in an amendment or supplement to the Proxy
Statement, the Company will prepare and mail to its stockholders such an
amendment or supplement.
(c) The Company represents and warrants that the Proxy Statement
will comply in all material respects with the Exchange Act and, at the
respective times filed with the SEC and distributed to stockholders of the
Company, will not contain any untrue statement of a material fact or omit to
state any material fact required to be stated therein or necessary in order
34
<PAGE>
to make the statements therein, in light of the circumstances under which they
were made, not misleading; provided that the Company makes no representation or
warranty as to any information included in the Proxy Statement that was provided
by Parent or Merger Sub. Parent represents and warrants that none of the
information supplied by Parent or Merger Sub for inclusion in the Proxy
Statement will, at the respective times filed with the SEC and distributed to
stockholders of the Company, contain any untrue statement of a material fact or
omit to state any material fact required to be stated therein or necessary in
order to make the statements therein, in light of the circumstances under which
they were made, not misleading.
(d) Following the consummation of the Offer, the Company shall
use its best efforts to obtain the necessary approvals by its stockholders of
the Merger, this Agreement and the transactions contemplated hereby.
7.4. Approvals and Consents; Cooperation.
-----------------------------------
(a) The Company and Parent shall cooperate with each other and
use (and shall cause their respective Subsidiaries to use) their respective
commercially reasonable best efforts to take or cause to be taken all actions,
and do or cause to be done all things, necessary, proper or advisable under this
Agreement, the Stock Option Agreement, the Shareholders Agreement and applicable
Laws to consummate and make effective the Offer, the Merger and the other
transactions contemplated by this Agreement, the Stock Option Agreement and the
Shareholders Agreement as soon as practicable, including preparing and filing as
promptly as practicable all documentation to effect all necessary applications,
notices, petitions, filings and other documents and to obtain as promptly as
practicable all permits, consents, approvals and authorizations necessary or
advisable to be obtained from any third party and/or any Governmental Entity in
order to consummate the Offer and the Merger or any of the other transactions
contemplated by this Agreement, the Stock Option Agreement and the Shareholders
Agreement.
(b) In particular, the Company and Parent each agree to use
commercially reasonable efforts to take, or cause to be taken, all appropriate
action, and do, or cause to be done, such things as may be necessary under
federal or state securities laws or the HSR Act applicable to or necessary for,
and will file as soon as reasonably practicable and, if appropriate, use
commercially reasonable efforts to have declared effective or approved, all
documents and notifications with the SEC and other governmental or regulatory
bodies that they deem necessary or appropriate for, the consummation of the
Offer and the Merger or any of the other transactions contemplated hereby and
each party shall give the other information reasonably requested by such other
party pertaining to it and its subsidiaries and affiliates to enable such other
party to take such actions.
(c) Each of the Company, Parent and Merger Sub agrees to use
commercially reasonable efforts to contest and resist any action, including
legislative, administrative or judicial action, and to have vacated, lifted,
reversed or overturned any decree, judgment, injunction or other order (whether
temporary, preliminary or permanent) that is in
35
<PAGE>
effect and that restricts, prevents or prohibits the consummation of the Offer
and the Merger or any of the other transactions contemplated by this Agreement,
including, without limitation, by pursuing available avenues of administrative
and judicial appeal.
(d) Each of the Company, Parent and Merger Sub also agrees to
use commercially reasonable efforts to take any and all actions necessary to
avoid or eliminate each and every impediment under any antitrust law that may be
asserted by any governmental antitrust authority or any other party so as to
enable the parties to close by the date specified in Section 9.2(i) the
transactions contemplated hereby; provided, however, that nothing in this
Section 7.4 shall require, or be construed to require, Parent to proffer to, or
agree to, sell or hold separate and agree to sell, before or after the Effective
Time, any assets, businesses, or interest in any assets or businesses of Parent,
the Company or any of their respective affiliates (or to consent to any sale, or
agreement to sell, by the Company of any of its assets or businesses) or to
agree to any material changes or restriction in the operations of any such
assets or businesses; and provided, further, that nothing in this Section 7.4
shall require, or be construed to require, a proffer or agreement that would, in
the good faith judgment of Parent, be reasonably likely to have a material
adverse effect on the benefits to Parent of the transactions contemplated by
this Agreement.
(e) Subject to applicable Laws relating to the exchange of
information, Parent and the Company shall have the right to review in advance,
and to the extent practicable each will consult the other on, all the
information relating to Parent or the Company, as the case may be, and any of
their respective Subsidiaries, that appear in any filing made with, or written
materials submitted to, any third party and/or any Governmental Entity in
connection with the Offer or the Merger and the other transactions contemplated
by this Agreement, the Stock Option Agreement and the Shareholders Agreement.
In exercising the foregoing right, each of the Company and Parent shall act
reasonably and as promptly as practicable.
7.5. Filings; Other Actions; Notification.
------------------------------------
(a) The Company and Parent each shall, upon request by the
other, furnish the other with all information concerning itself, its
subsidiaries, directors, officers and stockholders and such other matters as may
be reasonably necessary or advisable in connection with the Proxy Statement, the
Offer Documents or any other statement, filing, notice or application made by or
on behalf of Parent, the Company or any of their respective subsidiaries to any
Governmental Entity in connection with the Offer or the Merger and the
transactions contemplated by this Agreement, the Stock Option Agreement and the
Shareholders Agreement.
(b) The Company and Parent each shall keep the other apprised
of the status of matters relating to completion of the transactions contemplated
hereby, including promptly furnishing the other with copies of notice or other
communications received by Parent or the Company, as the case may be, or any of
their respective subsidiaries, from any third party or any Governmental Entity
with respect to the Offer or the Merger and the other transactions contemplated
by this Agreement, the Stock Option Agreement and the Shareholders Agreement.
36
<PAGE>
The Company shall give prompt notice to Parent of any change that has resulted
in or is reasonably likely to result in a Company Material Adverse Effect and
Parent shall give the Company prompt notice of any event, fact, circumstance or
occurrence that would be reasonably likely to have an adverse effect on Parent's
or Merger Sub's ability to complete the Offer or the Merger or to comply with
their obligations contained in this Agreement or in the Stock Option Agreement.
7.6. Access. From the date hereof until the earlier of the
------
Effective Time or the termination of this Agreement, upon reasonable notice, the
Company shall afford to the officers, employees, accountants, counsel, financial
advisors and other representatives of Parent ("Parent Representatives")
reasonable access to all of its and its Subsidiaries properties, books,
contracts, commitments and records (including security position listings or
other information concerning beneficial and record owners of the Company's
securities) and its officers, management employees and representatives and,
during such period, the Company shall furnish promptly to Parent, consistent
with its obligations under this Agreement and other legal obligations, all
information concerning its business, properties and personnel as the other party
may reasonably request. Such information shall be held in confidence to the
extent required by, and in accordance with, the provisions of the Mutual Non-
Disclosure Agreement, dated March 10, 1999 (the "MNDA"), by and between the
Company and DuPont Pharmaceuticals Company, a Delaware general partnership and
wholly owned subsidiary of Parent ("DPC").
7.7. De-registration. The Company shall use its best efforts to
---------------
cause the Shares to be de-registered from the Nasdaq National Market and de-
registered under the Exchange Act as soon as practicable following the Effective
Time.
7.8. Publicity. The initial press release relating to the Offer
---------
and this Agreement shall be a joint press release, the content of which shall be
mutually agreed upon by Parent and the Company, and thereafter the Company shall
consult with and obtain approval of Parent prior to issuing any press releases
or otherwise making public statements with respect to the transactions
contemplated by this Agreement and the Stock Option Agreement and prior to
making any filings with any Governmental Entity with respect to the transactions
contemplated by this Agreement, provided that such approval shall not be
required if obtaining such approval would cause the Company to be in violation
of any Laws or the rules of the Nasdaq National Market.
7.9. Benefits.
--------
(a) Stock Options.
-------------
(1) Prior to the consummation of the Offer, the Board of
Directors of the Company (or, if appropriate, any committee administering the
Stock Plans) shall adopt such resolutions or take such other actions as are
required to adjust the terms of all outstanding Company Options to provide that,
at the Effective Time, each Company Option outstanding immediately prior to the
acceptance for payment of Shares pursuant to the Offer
37
<PAGE>
(whether or not vested) shall be canceled in exchange for a cash payment of, or
can only be exercised for net cash equal to, an amount equal to (i) the excess,
if any, of (A) the Price Per Share over (B) the exercise price per share of
Common Stock subject to such Company Option, multiplied by (ii) the number of
shares of Common Stock for which such Company Option shall not theretofore have
been exercised. Upon surrender to Parent at the address set forth in Section
10.6 of Company Options and/or such other documents as may reasonably be
requested by Parent, Parent hereby agrees to deliver to the registered holders
of such Company Options (as indicated in the records of the Company) such cash
payment. The Company represents and warrants that no consents of the holders of
the Company Options are necessary to effectuate the foregoing cash-out except as
disclosed in Schedule 6.1(d)(ii). After the date of this Agreement, neither the
Board of Directors of the Company nor any committee thereof shall cause any
Company Option to become exercisable as a result of the execution of this
Agreement or the Stock Option Agreement or the consummation of the transactions
contemplated hereby. If there is no excess of the Price Per Share over the
exercise price per share of Common Stock subject to a Company Option, such
Company Option shall be canceled for no consideration.
(2) All amounts payable pursuant to this Section 7.9 shall
be subject to any required withholding of taxes and shall be paid without
interest.
(3) The Stock Plans shall terminate as of the Effective
Time and the provisions in any other Compensation and Benefit Plan providing for
the issuance, transfer or grant of any capital stock of the Company or any
interest in respect of any capital stock of the Company shall be deleted as of
the Effective Time, and the Company shall ensure that following the Effective
Time no holder of a Stock Option or any participant in any Stock Plan or other
Compensation and Benefit Plan shall have any right thereunder to acquire any
capital stock of the Company or the Surviving Corporation. A purchase date under
the ESPP will occur immediately prior to the consummation of the Offer. The
payroll deductions for the purchase period ending with that purchase date will
be applied to the purchase of CombiChem Shares at eighty five percent (85%) of
the fair market value of the Shares on the start date of the offering period.
The employees will, thereafter, be free to tender the purchased shares in the
Offer.
(b) Employee Benefits. Parent agrees that, for a period of at
-----------------
least one year from the Effective Date, it will cause the Surviving Corporation
to maintain, and the employees of the Company on the date of this Agreement (the
"Current Employees") will be eligible for, the employee benefit plans of the
Company as of the Effective Date until it develops alternative plans (other than
stock options or other plans involving the issuance of securities of the Company
or Parent) which in the aggregate are substantially comparable to those
maintained by the Company as of the date of this Agreement. Parent will use its
best efforts to cause each employee benefit plan of DPC in which the Current
Employees are eligible to participate to take into account for purposes of
eligibility and vesting thereunder the service of such Current Employees with
the Company as if such service were with DPC, to the same extent that such
service was credited under a comparable plan of the Company and such service
period would have been credited to an employee of DPC participating in the
relevant plan. The Current
38
<PAGE>
Employees shall be entitled to the vacation time and holidays provided for under
plans applicable to employees of DPC. In no event, however, shall a Current
Employee's vacation time or ability to accrue or carry over vacation be less
than that to which such Current Employee was entitled under the Company's
vacation plan. For the first plan year ending after the Effective Time, any pre-
existing condition exclusion under any plan providing medical or dental benefits
shall be no more restrictive for any Current Employee who, immediately prior to
commencing participation in such plan, was participating in a Company plan
providing medical or dental benefits and had satisfied any pre-existing
condition provision under such Company plan. Parent agrees to provide any
Current Employee whose employment with the Company is terminated as a result of
the Merger with at the least the minimum severance benefits provided to
employees of DPC.
If required by Parent, the Company shall, immediately prior
to the Closing Date, terminate the Company's 401(k) plan (the "Company 401(k)")
and no further contributions shall be made to the Company 401(k), provided that
Parent provides the Current Employees the opportunity to participate in a 401(k)
plan immediately following the Closing Date. The Company shall provide to Parent
(i) resolutions of the Board of Directors of the Company authorizing the
termination and (ii) an executed amendment to the Company 401(k) sufficient to
ensure compliance with all applicable requirements of the Code and regulations
thereunder so that the tax-qualified status of the Company 401(k) will be
maintained at the time of termination.
7.10. Expenses. The Surviving Corporation shall pay all charges and
--------
expenses, including those of the Depositary, in connection with the
transactions contemplated in Article V, and Parent shall reimburse the Surviving
Corporation for such charges and expenses. Except as otherwise provided in
Section 9.5(b), whether or not the Merger is consummated, all costs and expenses
incurred in connection with this Agreement, the Stock Option Agreement, the
Shareholders Agreement, the Offer and the Merger and the other transactions
contemplated by this Agreement, the Stock Option Agreement and the Shareholders
Agreement shall be paid by the party incurring such expense.
7.11. Indemnification; Directors' and Officers' Insurance.
---------------------------------------------------
(a) From and after consummation of the Offer and compliance by
the Company with Section 1.4, Parent will cause and ensure that the Surviving
Corporation has sufficient funds available, if necessary, to fulfill and honor
in all respects the obligations of the Company to each person who is or was a
director or officer of the Company and who is entitled to indemnification or
advance of expenses pursuant to each indemnification agreement listed in
Schedule 7.11(a) or any indemnification provision or any exculpation provision
set forth in the Company's certificate of incorporation or bylaws in effect on
the date hereof, each in accordance with their terms for a period of not less
than six (6) years. The certificate of incorporation and bylaws of the Surviving
Corporation shall contain the provisions with respect to indemnification and
exculpation from liability no less favorable than those set forth in the
Company's certificate
39
<PAGE>
of incorporation and bylaws on the date of this Agreement for a period of not
less than six (6) years.
(b) Notwithstanding any contrary provision of this Agreement,
prior to the consummation of the Offer, the Company may purchase insurance
coverage extending for a period of three years after the Effective Time the
level and scope of the Company's directors' and officers' liability insurance
coverage in effect as of the date hereof; provided that the aggregate annual
premium payable for such insurance shall not exceed 125% of the last annual
premium paid for such coverage prior to the date hereof. Through the third
anniversary of the Effective Time, Parent shall maintain in effect such
insurance coverage, and subject to the limitations in the preceding sentence,
shall pay the annual premium for such insurance coverage. In the event the
annual premium payable for such insurance coverage exceeds 125% of the last
annual premium paid by the Company for such coverage, Parent shall be obligated
to obtain and maintain in effect a policy with the greatest amount of coverage
available for a cost not exceeding 125% of such amount.
(c) The provisions of this Section 7.11 are intended to be for
the benefit of, and shall be enforceable by, each of the individuals entitled to
indemnification or advance of expenses under Section 7.11(a) or insurance
coverage under Section 7.11(b) as intended third party beneficiaries and their
heirs and estates and shall be binding on all successors and assigns of Parent
and the Surviving Corporation.
7.12. Antitakeover Statutes. If any Antitakeover Statute is or
---------------------
may become applicable to the Offer or the Merger or the other transactions
contemplated by this Agreement, the Stock Option Agreement, or the Shareholders
Agreement, each of Parent and the Company and their board of directors shall
grant such approvals and take such lawful actions as are necessary so that such
transactions may be consummated as promptly as practicable on the terms
contemplated by this Agreement, the Stock Option Agreement or the Shareholders
Agreement or by the Offer or the Merger and otherwise act to eliminate or
minimize the effects of such statute or regulation on such transactions.
ARTICLE VIII
Conditions
8.1. Conditions to Each Party's Obligation to Effect the Merger.
----------------------------------------------------------
The respective obligation of each party to effect the Merger is subject to the
satisfaction or waiver at or prior to the Closing of each of the following
conditions:
(a) Stockholder Approval. If the approval of this Agreement
--------------------
and the Merger by the holders of Shares is required by applicable law, this
Agreement shall have been duly adopted by holders of Shares constituting the
Company Requisite Vote.
40
<PAGE>
(b) Regulatory Consents. Any waiting period applicable to the
-------------------
consummation of the Merger under the HSR Act shall have expired or been
terminated.
(c) No Injunctions or Restraints. (i) No court or Governmental
----------------------------
Entity of competent jurisdiction shall have enacted, issued, enforced or entered
any statute, rule, regulation, judgment, decree, injunction or other order
(whether temporary, preliminary or permanent) that is in effect and restrains,
enjoins or otherwise prohibits consummation of the Offer or Merger
(collectively, an "Order"); provided however, that prior to invoking this
provision, each party shall use its commercially reasonable best efforts to have
any such Order lifted or withdrawn, and (ii) no Governmental Entity shall have
instituted any proceeding seeking any such Order.
(d) Completion of the Offer. Merger Sub shall have (i)
-----------------------
commenced the Offer pursuant to Section 1.1 hereof and (ii) purchased, pursuant
to the terms and conditions of such Offer, all shares of Company Common Stock
duly tendered and not withdrawn; provided, however, that neither Parent nor
Merger Sub shall be entitled to rely on the condition in clause (ii) above if
either of them shall have failed to purchase shares of Company Common Stock
pursuant to the Offer in breach of their obligations under this Agreement.
(e) Merger Sub Nominees Elected. The Company shall have
---------------------------
complied with its obligations under Section 1.4 hereof.
(f) Opinion of Counsel. Parent and Merger Sub shall have
------------------
received the opinion of Brobeck, Phleger and Harrison LLP in substantially the
form attached hereto as Exhibit 8.1(f).
ARTICLE IX
Termination
9.1. Termination by Mutual Consent. This Agreement may be
-----------------------------
terminated and the Merger may be abandoned at any time prior to the Effective
Time, whether before or after the approval by stockholders of the Company
referred to in Section 8.1(a), by mutual written consent of the Company, Parent
and Merger Sub, by action of their respective boards of directors.
9.2. Termination by Either Parent or the Company. This Agreement
-------------------------------------------
may be terminated and the Merger may be abandoned at any time prior to the
Effective Time by action of Parent or the board of directors of the Company if
(i) the Merger shall not have been consummated by April 30, 2000, whether such
date is before or after the date of approval by the stockholders of the Company
referred to in Section 8.1(a); provided, however, that if a request for
additional information is received from the United States Federal Trade
Commission or the Antitrust Division of the United States Department of Justice
pursuant to the HSR Act or additional information is requested by a governmental
authority (a "Foreign Authority") pursuant to the antitrust, competition,
foreign investment, or similar laws or any foreign countries or
41
<PAGE>
supranational commissions or boards that require pre-merger notifications or
filings with respect to the Merger (collectively, "Foreign Merger Laws"), then
such date shall be extended to the 30th day following the date when the United
States Federal Trade Commission or the Antitrust Division of the United States
Department of Justice has deemed the Parent and/or the Company, as applicable,
to be in substantial compliance with such request for additional information,
but in any event not later than May 31, 2000, (ii) the Company Stockholders
Meeting shall have been convened, held and completed and the approval referred
to in Section 8.1(a) shall not have been obtained thereat or at any adjournment
or postponement thereof; provided however, that Parent shall not be permitted to
terminate the Agreement pursuant to this clause (ii) if Parent or Merger Sub
shall not have voted all Shares then owned beneficially or of record by them in
favor of approval and adoption of this Agreement, the Merger and the
transactions contemplated hereby as required by Section 7.3(a), (iii) any Order
permanently restraining, enjoining or otherwise prohibiting the Offer or the
Merger shall become final and non-appealable (whether before or after the
approval referred to in Section 8.1(a)) or (iv) if the Offer terminates or
expires on account of the failure of any of the Offer Conditions; provided that
the right to terminate this Agreement pursuant to clause (i) above shall not be
available to any party that has breached in any material respect its obligations
under this Agreement in any manner that shall have been the proximate cause of,
or resulted in, the failure to consummate the Merger by the date referred to in
clause (i) of this Section 9.2 and, provided, further, that the right to
terminate this Agreement pursuant to clause (iii) of this Section 9.2 shall not
be available to any party that has breached its covenant in Section 7.4 to use
commercially reasonable best efforts to prevent such Order from being issued and
to use commercially reasonable best efforts to cause such Order to be vacated,
withdrawn or lifted.
9.3. Termination by the Company. This Agreement may be terminated
--------------------------
and the Merger may be abandoned at any time prior to the Effective Time, whether
before or after the approval by stockholders of the Company referred to in
Section 8.1(a), by action of the board of directors of the Company, if:
(a) (i) The Company is not in material breach of any of its
representations, warranties, covenants or agreements in this Agreement, (ii) the
board of directors of the Company authorizes the Company, prior to the
consummation of the Offer and the Company's compliance with Section 1.4 hereof,
and subject to complying with the terms of this Agreement, to enter into a
binding written agreement concerning a Superior Proposal and the Company
notifies Parent in writing that it intends to enter into such an agreement,
attaching the most current version of such agreement to such notice, and (iii)
Parent does not make, within three business days of receipt of the Company's
written notification of its intention to enter into such an agreement, a written
offer that is at least as favorable to the stockholders of the Company as the
Superior Proposal. The Company agrees (x) that it will not enter into a binding
agreement referred to in clause (ii) of the previous sentence until at least the
first calendar day following the third business day after it has provided the
written notice to Parent required thereby, (y) to notify Parent promptly if its
intention to enter into a written agreement referred to in such notice shall
change at any time after giving such notification and (z) that it will not
terminate this Agreement or enter into a binding agreement referred to in clause
(ii) of the previous sentence if Parent has,
42
<PAGE>
within the period referred to in clause (x) of this sentence, made a written
offer that is at least as favorable to the Company's stockholders as the
Superior Proposal; or
(b) The Company is not in material breach of any of its
representations, warranties, covenants or agreements in this Agreement and prior
to the consummation of the Offer, there has been a material breach by Parent or
Merger Sub of any representation, warranty, covenant or agreement of Parent or
Merger Sub contained in this Agreement which has had, or is reasonably likely to
have, the effect of materially impairing the ability of Parent or Merger Sub to
consummate the Offer or the Merger (a "Terminating Parent Breach"); provided,
however, that, if such Terminating Parent Breach is curable by Parent through
the exercise of reasonable best efforts and such cure is reasonably likely to be
completed prior to the applicable date specified in Section 9.2(i), then for so
long as Parent continues to exercise reasonable best efforts to cure such
Terminating Parent Breach, the Company may not terminate this Agreement under
this Section 9.3(b); or
(c) The Company is not in material breach of any of its
representations, warranties, covenants or agreements in this Agreement and
Merger Sub shall have failed to commence the Offer within five (5) Business Days
after the date of this Agreement.
9.4. Termination by Parent. This Agreement may be terminated and
---------------------
the Merger may be abandoned at any time until the Offer has been consummated and
the Company has complied with its obligations under Section 1.4, by Parent:
(a) If the board of directors of the Company shall have failed
to recommend, or shall have withdrawn or adversely modified its approval or
recommendation of, the Offer or the Merger or failed to reconfirm its
recommendation of the Offer or the Merger within two calendar days after a
written request by Parent to do so, or shall have resolved to do any of the
foregoing; or
(b) If there has been a material breach by the Company of any
representation, warranty, covenant or agreement of the Company contained in this
Agreement which would give rise to the failure of a condition set forth in
paragraph (c) of Annex A (a "Terminating Company Breach"); provided, however,
that, if such Terminating Company Breach is curable by the Company through the
exercise of reasonable best efforts and such cure is reasonably likely to be
completed prior to the applicable date specified in Section 9.2(i), then for so
long as the Company continues to exercise reasonable best efforts, Parent may
not terminate this Agreement under this Section 9.4(b). For the purposes of
this Section 9.4(b), any breach of a representation or warranty which is
qualified or limited in any manner as to materiality shall be deemed to be a
material breach.
43
<PAGE>
9.5. Effect of Termination and Abandonment.
-------------------------------------
(a) In the event of termination of this Agreement and the
abandonment of the Merger pursuant to this Article IX, this Agreement (other
than as set forth in Section 10.1) shall become void and of no effect with no
liability of any party hereto (or any of its directors, officers, employees,
agents, legal and financial advisors or other representatives); provided,
however, that except as otherwise provided herein, no such termination shall
relieve any party hereto of any liability or damages resulting from any willful
breach of this Agreement.
(b) In the event that (i)(A) a bona fide Acquisition Proposal
shall have been made to the Company or any of its stockholders or any Person
shall have announced an intention (whether or not conditional) to make an
Acquisition Proposal with respect to the Company, and on or following the date
of this Agreement but prior to the date that the Offer is consummated, such
Acquisition Proposal, announcement or intention is or becomes publicly known,
and (B) on or following the date on which such Acquisition Proposal,
announcement or intention is or becomes publicly known, this Agreement is
terminated by either Parent or the Company pursuant to Section 9.2(i), or (ii)
this Agreement is terminated (x) by the Company pursuant to Section 9.3, or (y)
by Parent pursuant to Section 9.4, or (z) pursuant to Section 9.2(iv) as a
result of the failure of the Company to satisfy any one of the conditions set
forth in paragraphs (c), (e) or (f) of Annex A, then the Company shall promptly,
but in no event later than two (2) Business Days after the date of notification
by Parent of the amount, reimburse Parent for all costs, charges and expenses
incurred by Parent or Merger Sub in connection with this Agreement, the Stock
Option Agreement and the Shareholders Agreement and the transactions
contemplated by this Agreement and the Stock Option Agreement and the
Shareholders Agreement, including, without limitation, fees and expenses of
accountants, attorneys and financial advisors, up to a maximum of $1,000,000 in
the aggregate. Such amount shall be payable in cash by wire transfer of same day
funds. The Company acknowledges that the agreements contained in this Section
9.5(b) are an integral part of the transactions contemplated by this Agreement,
and that, without these agreements, Parent and Merger Sub would not enter into
this Agreement; accordingly, if the Company fails to promptly pay the amount due
pursuant to this Section 9.5(b), and, in order to obtain such payment, Parent or
Merger Sub commences a suit which results in a binding nonappealable judgment
rendered by a court of competent jurisdiction against the Company for the fee
set forth in this paragraph (b) the Company shall pay to Parent or Merger Sub
its costs and expenses (including reasonable attorneys' fees) in connection with
such suit, together with interest on the amount of the fee at the prime rate of
Chase Manhattan Bank in effect on the date such payment was required to be made.
ARTICLE X
Miscellaneous and General
10.1. Survival. This Article X and the agreements of the Company,
--------
Parent and Merger Sub contained in Articles I, II, III, IV and V and Sections
7.9 (Benefits), 7.10 (Expenses), and 7.11 (Indemnification; Directors' and
Officers' Insurance) shall survive the consummation of
44
<PAGE>
the Offer and the Merger. This Article X and the agreements of the Company,
Parent and Merger Sub contained in Section 7.10 (Expenses), and Section 9.5
(Effect of Termination and Abandonment) shall survive the termination of this
Agreement. All other agreements and covenants in this Agreement and all
representations and warranties contained herein shall not survive the
consummation of the Merger or the termination of this Agreement.
10.2. Modification or Amendment. Subject to the provisions of
-------------------------
applicable law, at any time prior to the Effective Time, the parties hereto may
modify or amend this Agreement, by written agreement executed and delivered by
duly authorized officers of the respective parties.
10.3. Waiver of Conditions. The conditions to each of the
--------------------
parties' obligations to consummate the Merger are for the sole benefit of such
party and may be waived by such party in whole or in part to the extent
permitted by applicable law.
10.4. Counterparts. This Agreement may be executed in any number
------------
of counterparts, each such counterpart being deemed to be an original
instrument, and all such counterparts shall together constitute the same
agreement.
10.5. GOVERNING LAW AND VENUE; WAIVER OF JURY TRIAL.
---------------------------------------------
(a) THIS AGREEMENT SHALL BE DEEMED TO BE MADE IN AND IN ALL
RESPECTS SHALL BE INTERPRETED, CONSTRUED AND GOVERNED BY AND IN ACCORDANCE WITH
THE LAWS OF THE STATE OF DELAWARE WITHOUT REGARD TO THE CONFLICT OF LAW
PRINCIPLES THEREOF. THE PARTIES HEREBY IRREVOCABLY SUBMIT TO THE JURISDICTION OF
THE COURTS OF THE STATE OF DELAWARE AND THE FEDERAL COURTS OF THE UNITED STATES
OF AMERICA LOCATED IN THE COUNTY OF NEW CASTLE, DELAWARE SOLELY IN RESPECT OF
THE INTERPRETATION AND ENFORCEMENT OF THE PROVISIONS OF THIS AGREEMENT, THE
STOCK OPTION AGREEMENT AND THE SHAREHOLDERS AGREEMENT AND OF THE DOCUMENTS
REFERRED TO IN THIS AGREEMENT, THE STOCK OPTION AGREEMENT AND THE SHAREHOLDERS
AGREEMENT, AND IN RESPECT OF THE TRANSACTIONS CONTEMPLATED HEREBY AND THEREBY,
AND HEREBY WAIVE, AND AGREE NOT TO ASSERT, AS A DEFENSE IN ANY ACTION, SUIT OR
PROCEEDING FOR THE INTERPRETATION OR ENFORCEMENT HEREOF OR OF ANY SUCH DOCUMENT,
THAT IT IS NOT SUBJECT THERETO OR THAT SUCH ACTION, SUIT OR PROCEEDING MAY NOT
BE BROUGHT OR IS NOT MAINTAINABLE IN SAID COURTS OR THAT THE VENUE THEREOF MAY
NOT BE APPROPRIATE OR THAT THIS AGREEMENT, THE STOCK OPTION AGREEMENT OR THE
SHAREHOLDERS AGREEMENT OR ANY SUCH DOCUMENT MAY NOT BE ENFORCED IN OR BY SUCH
COURTS, AND THE PARTIES HERETO IRREVOCABLY AGREE THAT ALL CLAIMS WITH RESPECT TO
SUCH ACTION OR PROCEEDING SHALL BE HEARD AND DETERMINED IN SUCH A DELAWARE STATE
OR FEDERAL COURT. THE PARTIES HEREBY CONSENT TO AND GRANT ANY SUCH COURT
JURISDICTION OVER THE PERSON OF SUCH PARTIES AND OVER THE
45
<PAGE>
SUBJECT MATTER OF SUCH DISPUTE AND AGREE THAT MAILING OF PROCESS OR OTHER PAPERS
IN CONNECTION WITH ANY SUCH ACTION OR PROCEEDING IN THE MANNER PROVIDED IN
SECTION 10.6 OR IN SUCH OTHER MANNER AS MAY BE PERMITTED BY LAW, SHALL BE VALID
AND SUFFICIENT SERVICE THEREOF.
(b) EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY
WHICH MAY ARISE UNDER THIS AGREEMENT, THE STOCK OPTION AGREEMENT OR THE
SHAREHOLDERS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES,
AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY
RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION
DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE STOCK
OPTION AGREEMENT OR THE SHAREHOLDERS AGREEMENT, OR THE TRANSACTIONS CONTEMPLATED
HEREBY OR THEREBY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO
REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY
OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK
TO ENFORCE THE FOREGOING WAIVER, (II) EACH SUCH PARTY UNDERSTANDS AND HAS
CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (III) EACH SUCH PARTY MAKES THIS
WAIVER VOLUNTARILY, AND (IV) EACH SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS
AGREEMENT OR THE STOCK OPTION AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL
WAIVERS AND CERTIFICATIONS IN THIS SECTION 10.5.
10.6. Notices. Any notice, request, instruction or other document
-------
to be given hereunder by any party to the others shall be in writing and
delivered personally or sent by registered or certified mail, postage prepaid,
or by facsimile:
if to Parent or Merger Sub
E. I. du Pont de Nemours and Company
1007 Market Street
Wilmington, Delaware 19898
Attention: General Counsel
Fax: (302) 773-5176
with copies to:
Justin P. Klein, Esq.
Ballard Spahr Andrews & Ingersoll, LLP
1735 Market Street, 51st Floor
Philadelphia, PA 19103-7599
Fax: (215) 864-8999
46
<PAGE>
if to the Company
Dr. Vicente Anido, Jr.
CombiChem, Inc.
9050 Camino Santa Fe
San Diego, CA 92121
Fax: (858) 271-9339
with copies to:
Faye H. Russell, Esq.
Brobeck Phleger & Harrison LLP
550 West C Street, Suite 1300
San Diego, California 92101-3532
Fax: (619) 234-3848
or to such other persons or addresses as may be designated in writing by the
party to receive such notice as provided above.
10.7. Entire Agreement. This Agreement (including any exhibits
----------------
hereto), the Stock Option Agreement and the MNDA constitute the entire
agreement, and supersede all other prior agreements, understandings,
representations and warranties both written and oral, among the parties, with
respect to the subject matter hereof.
10.8. No Third Party Beneficiaries. Except as provided in Section
----------------------------
7.11 (Indemnification; Directors' and Officers' Insurance), this Agreement is
not intended to confer upon any Person other than the parties hereto any rights
or remedies hereunder.
10.9. Obligations of Parent and of the Company. Whenever this
----------------------------------------
Agreement requires a Subsidiary of Parent to take any action, such requirement
shall be deemed to include an undertaking on the part of Parent to cause such
Subsidiary to take such action. Whenever this Agreement requires a Subsidiary
of the Company to take any action, such requirement shall be deemed to include
an undertaking on the part of the Company to cause such Subsidiary to take such
action and, after the Effective Time, on the part of the Surviving Corporation
to cause such Subsidiary to take such action.
10.10. Severability. The provisions of this Agreement shall be
------------
deemed severable and the invalidity or unenforceability of any provision shall
not affect the validity or enforceability of the other provisions hereof. If
any provision of this Agreement, or the application thereof to any Person or any
circumstance, is invalid or unenforceable, (a) a suitable and equitable
provision shall be substituted therefor in order to carry out, so far as may be
valid and enforceable, the intent and purpose of such invalid or unenforceable
provision and (b) the remainder of this Agreement and the application of such
provision to other Persons or circumstances shall not be affected by such
invalidity or unenforceability, nor shall such
47
<PAGE>
invalidity or unenforceability affect the validity or enforceability of such
provision, or the application thereof, in any other jurisdiction.
10.11. Specific Performance. The parties hereto each acknowledge
--------------------
that, in view of the uniqueness of the subject matter hereof, the parties hereto
would not have an adequate remedy at law for money damages if this Agreement
were not performed in accordance with its terms, and therefore agree that the
parties hereto shall be entitled to specific enforcement of the terms hereof in
addition to any other remedy to which the parties hereto may be entitled at law
or in equity.
10.12. Interpretation. The table of contents and headings herein
--------------
are for convenience of reference only, do not constitute part of this Agreement
and shall not be deemed to limit or otherwise affect any of the provisions
hereof. Where a reference in this Agreement is made to a Section, Schedule or
Exhibit, such reference shall be to a Section of or Schedule or Exhibit to this
Agreement unless otherwise indicated. Whenever the words "include," "includes"
or "including" are used in this Agreement, they shall be deemed to be followed
by the words "without limitation."
10.13. Assignment. This Agreement shall not be assignable by
----------
operation of law or otherwise; provided, however, that Parent may (i) assign its
rights and obligations under this Agreement to DPC or any of Parent's direct or
indirect wholly owned subsidiaries or affiliates with a net worth of
$100,000,000 or more or (ii) designate, by written notice to the Company,
another direct or indirect wholly owned subsidiary of Parent to be a Constituent
Corporation in lieu of Merger Sub, in the event of which, all references herein
to Merger Sub shall be deemed references to such other subsidiary. Any
purported assignment made in contravention of this Agreement shall be null and
void.
10.14. Captions. The Article, Section and Paragraph captions
--------
herein are for convenience of reference only and do not constitute part of this
Agreement and shall not be deemed to limit or otherwise affect any of the
provisions hereof.
[Remainder of page intentionally left blank]
48
<PAGE>
IN WITNESS WHEREOF, this Agreement has been duly executed and
delivered by duly authorized officers of the parties hereto as of the date
hereof.
COMBICHEM, INC.
By:/s/ Vicente Anido, Jr.
-----------------------------------------
Name: Vicente Anido, Jr.
Title: President and Chief Executive Officer
E. I. DU PONT DE NEMOURS AND
COMPANY
By:/s/ Kurt M. Landgraf
-----------------------------------------
Name: Kurt M. Landgraf
Title: Executive Vice President and
Chief Operating Officer
DPC NEWCO, INC.
By:/s/ Richard E. Gies
----------------------------------------
Name: Richard E. Gies
Title: President
49
<PAGE>
ANNEX A
CONDITIONS TO THE OFFER
Notwithstanding any other provision of the Offer, and subject to the
terms and conditions of the Agreement, Merger Sub shall not be obligated to
accept for payment any Shares until the expiration or termination of any waiting
periods applicable under the HSR Act and Merger Sub shall not be required to
accept for payment or, subject to any applicable rules and regulations of the
SEC (including Rule 14e-l(c) under the Exchange Act) pay for, and may delay the
acceptance for payment of or payment for, any Shares tendered in the Offer and
(subject to the terms and conditions of the Agreement, including Section 1.1(b))
may amend, extend or terminate the Offer if, (i) immediately prior to the
Scheduled Expiration Date (as extended in accordance with clauses (x), (y) or
(z) of Section 1.1(b)(ii) of the Agreement) the Minimum Condition shall not have
been satisfied or (ii) prior to the expiration of the Offer any of the following
shall exist and be continuing:
(a) there shall be threatened or pending any action, litigation
or proceeding (hereinafter, an "Action") brought by any Governmental Entity: (i)
that would reasonably be expected to challenge the acquisition by Parent or
Merger Sub of shares of Company Common Stock or seek to restrain or prohibit the
consummation of the Offer or the Merger; (ii) that would reasonably be expected
to seek to prohibit or impose any material limitation on Parent's, Merger Sub's
or any of their respective affiliates' ownership or operation of all or any
material portion of the business or assets of the Company and its Subsidiaries
taken as a whole or Parent and its Subsidiaries taken as a whole that, in each
case referred to in this clause (ii) individually or in the aggregate, is
reasonably likely to have a Company Material Adverse Effect or a material
adverse effect on Parent; or (iii) that would reasonably be expected to seek to
impose material limitations on the ability of Parent or Merger Sub effectively
to acquire or hold, or to exercise full rights of ownership of, the shares of
Common Stock, including the right to vote the shares of Common Stock purchased
by them on an equal basis with all other shares of Common Stock on all matters
properly presented to the stockholders of the Company; or
(b) there shall be any statute, rule, regulation, order or
injunction threatened, proposed, sought, enacted, promulgated, entered, enforced
or deemed to or become applicable to the Offer or the Merger (and in each case,
remain in effect), or any other action shall have been taken, by any court of
competent jurisdiction or other U.S. Governmental Entity, that has any of the
consequences referred to in clauses (i) through (iii) of paragraph (a) above; or
(c) (i) Any of the representations and warranties of the Company
set forth in this Agreement shall not be true and correct in all material
respects when considered without regard to any qualification by, or reference
to, materiality in any manner (except for those representations and warranties
made as of a specific date, which shall be true and correct as of such date) and
except for such failures of any representations or warranties, when so
considered, to be true and correct that individually or in the aggregate do not
have, and are not
A-1
<PAGE>
reasonably likely to have, a Company Material Adverse Effect; or (ii) the
Company shall have breached or failed to comply in any material respect with any
of its obligations, covenants or agreements under the Agreement and any such
breach or failure shall not have been substantially cured by the Company within
five (5) Business Days after Parent provides written notice to the Company of
such breach or failure; or
(d) the Agreement shall have been terminated in accordance with
its terms; or
(e) any corporation, entity, "group" or "person" (as defined in
the Exchange Act), other than Parent, Merger Sub or any of the stockholders that
are party to the Shareholders Agreement (so long as such stockholders do not
become beneficial owners of any additional Shares after the date hereof and so
long as such stockholders do not breach any of the provisions of the
Shareholders Agreement), shall have acquired beneficial ownership (as defined in
Rule 13d-3 under the Exchange Act) of more than 20% of the outstanding Shares;
or
(f) the Company's Board shall have modified or amended its
recommendation of the Offer in any manner adverse to Parent or Merger Sub or
shall have withdrawn its recommendation of the Offer or shall have recommended
acceptance of any Acquisition Proposal or shall have failed to reconfirm its
recommendation of the Offer within five (5) calendar days after a written
request by Parent to do so, or shall have resolved to do any of the foregoing;
or
(g) there shall exist (i) any general suspension of, or
limitation on prices for, trading in securities on the Nasdaq National Market
for more than one full trading day (other than shortening of trading hours or
any trading halt resulting from a specified increase or decrease in a market
index), (ii) a declaration of any banking moratorium by federal or state
authorities or any suspension of payments in respect of banks or any limitation
(whether or not mandatory) imposed by federal or state authorities on the
extension of credit by lending institutions in the United States, or (iii) in
the case of any of the foregoing existing at the time of the commencement of the
Offer, a material acceleration or worsening thereof.
The conditions set forth in clauses (a) through (g) are for the sole
benefit of Parent and Merger Sub and may be asserted by Parent and Merger Sub
regardless of the circumstances giving rise to such conditions and may be waived
by Parent and Merger Sub in whole or in part at any time and from time to time,
by express and specific action to that effect, in their reasonable discretions.
The failure by Parent or Merger Sub at any time to exercise any of the foregoing
rights shall not be deemed a waiver of any such right, the waiver of any such
right with respect to particular facts and other circumstances shall not be
deemed a waiver with respect to any other facts and circumstances, and each such
right shall be deemed an ongoing right that may be asserted at any time and from
time to time.
The capitalized terms used in this Annex A shall have the meanings set
forth in the Agreement to which it is annexed.
A-2
<PAGE>
Exhibit 2
SHAREHOLDERS AGREEMENT
This Shareholders Agreement (this "Agreement") dated as of October 5,
1999, among the persons listed on Schedule 1 hereto (each, a "Holder" and,
collectively, the "Holders"), E. I. du Pont de Nemours and Company, a Delaware
corporation ("Parent"), and DPC Newco, Inc., a Delaware corporation and a wholly
owned subsidiary of Parent ("Merger Sub").
WHEREAS, Parent, Merger Sub and CombiChem, Inc., a Delaware
corporation (the "Company"), propose to enter into an Agreement and Plan of
Merger (the "Merger Agreement") providing for the making of a tender offer by
Merger Sub (the "Offer") for shares of Common Stock, par value $0.001 per share,
of the Company (the "Common Stock"), at a purchase price of $6.75 per share and
a subsequent merger (the "Merger") between the Company and Merger Sub.
WHEREAS, each Holder owns the number of shares of Common Stock (the
"Shares") or options to purchase Common Stock (the "Stock Options" and,
collectively with the Shares, the "Optioned Securities"), or has the right to
vote the number of Shares or other securities (the "Voting Securities"), listed
opposite the name of such Holder on Schedule 1.
WHEREAS, Parent and Merger Sub have required, as a condition to
entering into the Merger Agreement, that the Holders enter into this Agreement.
WHEREAS, the Holders believe that it is in the best interest of the
Company and its stockholders to induce Parent and Merger Sub to enter into the
Merger Agreement and, therefore, the Holders are willing to enter into this
Agreement.
NOW, THEREFORE, in consideration of the foregoing and the mutual
covenants and agreements set forth herein and such other valuable consideration
the receipt of which is hereby acknowledged, the parties hereto, intending to be
legally bound hereby, agree as follows:
1. The Option. Each Holder hereby grants Merger Sub an irrevocable
----------
option (the "Option") to purchase all of the Optioned Securities of such Holder
at the price of $6.75 per share (or such higher price as may be paid pursuant to
the Offer), payable in cash, without interest.
2. Exercise of the Option; Term.
----------------------------
(a) On the terms and subject to the conditions of this Agreement,
Merger Sub may exercise the Option at any time after the date on which all
waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act of 1976,
as amended (the "HSR Act"), applicable to the Merger have expired or been
terminated, by written notice to each Holder specifying a date and time for the
closing not later than thirty (30) business days from the date of such notice
(which date and time may be one day after the delivery of such notice), but only
if:
<PAGE>
(i) (A) a bona fide Acquisition Proposal (as defined in the Merger
Agreement) shall have been made to the Company or any of its stockholders or any
person or entity shall have announced an intention (whether or not conditional)
to make an Acquisition Proposal with respect to the Company, and on or following
the date of the Merger Agreement but prior to the date that the Offer is
consummated, such Acquisition Proposal, announcement or intention is or becomes
publicly known, (B) no event shall have become publicly known prior to the time
that such Acquisition Proposal, announcement or intention is or becomes publicly
known that would have a material adverse effect on the ability of Parent or
Merger Sub to consummate the Merger (other than any event related to such
Acquisition Proposal, announcement or intention or any event related to a breach
of the Merger Agreement or this Agreement by the Company) and (C) on or
following the date on which such Acquisition Proposal, announcement or intention
is or becomes publicly known, the Merger Agreement is terminated by either the
Company or the Parent pursuant to Section 9.2(i) of the Merger Agreement, unless
Merger Sub has consummated the Offer and the Company has complied with Section
1.4 of the Merger Agreement; or
(ii) the Merger Agreement is terminated (x) by the Company pursuant to
Section 9.3(a) of the Merger Agreement, or (y) by the Parent pursuant to Section
9.4(a) of the Merger Agreement or (z) pursuant to Section 9.2(iv) of the Merger
Agreement as a result of the failure to satisfy any one of the conditions set
forth in paragraphs (c), (e) or (f) of Annex A of the Merger Agreement.
(b) As used in this Agreement, "person" shall have the meaning
specified in Sections 3(a)(9) and 13(d)(3) of the Exchange Act. Notwithstanding
any other provision of this Agreement, the Merger Agreement or the Stock Option
Agreement, any reference to a majority of the total issued and outstanding
shares or Shares, or shares or Shares outstanding on a fully diluted basis, or
similar references, shall, for purposes of such agreements, exclude from the
determination thereof any shares of Common Stock issuable upon exercise of or
subject to the Stock Option Agreement and any reference to beneficial ownership
of shares of Common Stock or similar references shall, for purposes of such
agreements, exclude from the determination thereof any shares of Common Stock
issuable upon exercise of or subject to the Stock Option Agreement and/or this
Agreement.
(c) The Option shall expire on the earliest of (1) the Effective Time
(as defined in the Merger Agreement), (2) January 31, 2000 or, if the Offer is
extended past January 31, 2000 because the waiting period applicable to the
transactions contemplated by this Agreement under the HSR Act has not terminated
or expired, immediately after the expiration of the Offer, and (3) the thirtieth
day following the termination of the Merger Agreement if prior to such thirtieth
day the events set forth in any of clauses (i) or (ii) of Section 9.5(b) of the
Merger Agreement shall not have occurred (such earliest date being referred to
in this Agreement as the "Expiration Date"); provided that, if the Option cannot
be exercised or the Optioned Securities cannot be delivered to Merger Sub upon
such exercise because (x) there shall be in effect a preliminary or permanent
injunction or other order issued by any federal or state court of competent
jurisdiction prohibiting delivery of the Optioned Securities or (y) any
applicable
2
<PAGE>
waiting periods under the HSR Act shall not have expired or been terminated,
then the Expiration Date shall be extended until thirty days after such
impediment to exercise or delivery has been removed.
3. Closing. At the closing:
-------
(a) against delivery of the Optioned Securities, free and clear of all
liens, claims, charges and encumbrances of any kind or nature whatsoever, Parent
shall cause Merger Sub to make payment of the aggregate price for each Holder's
Optioned Securities by wire transfer of immediately available funds to such
Holder; and
(b) each Holder shall deliver to Merger Sub a duly executed
certificate or certificates representing the number of Optioned Securities
purchased from such Holder, together with transfer powers endorsed in blank
relating to such certificates and, if requested by Merger Sub, an irrevocable
proxy duly executed by such Holder, authorizing such persons as Merger Sub shall
designate to act for such Holder as his lawful agents, attorneys and proxies,
with full power of substitution, to vote in such manner as each such agent,
attorney and proxy or his substitute shall in his sole discretion deem proper,
and otherwise act with respect to the Optioned Securities at any meeting
(whether annual or special and whether or not an adjourned meeting) of the
Company's Holders or otherwise, and revoking any prior proxies granted by such
Holder with respect to the Holder's Optioned Securities.
Notwithstanding any provision of this Agreement to the contrary, the
Holders shall validly tender their Shares pursuant to the Offer and shall not
withdraw such Shares prior to the expiration of the Offer, and their obligation
to sell any Optioned Securities shall be satisfied, solely with respect to the
Shares so tendered, upon the purchase of such Shares by Merger Sub pursuant to
the Offer.
4. Covenants of the Holders.
------------------------
(a) During the period from the date of this Agreement until the
expiration of this Agreement, except in accordance with the provisions of this
Agreement, each Holder severally and not jointly agrees that he will not:
(i) sell, sell short, transfer, pledge, hypothecate, assign or
otherwise dispose of, or enter into any contract, option, hedging arrangement or
other arrangement or understanding with respect to the sale, transfer, pledge,
hypothecation, assignment or other disposition of, any Optioned Securities or
Voting Securities;
(ii) deposit any Optioned Securities or Voting Securities into a
voting trust, or grant any proxies or enter into a voting agreement with respect
to any Optioned Securities or Voting Securities; or
3
<PAGE>
(iii) initiate, solicit or encourage, directly or indirectly, any
inquiries or the making or implementation of any proposal that constitutes, or
may reasonably be expected to lead to, any Acquisition Proposal (as defined in
the Merger Agreement) or enter into discussions or negotiate with any person or
entity in furtherance of such inquiries or to obtain an Acquisition Proposal, or
agree to or endorse any Acquisition Proposal; except that any Holder who is a
member of the board of directors of the Company may conduct himself in the
manner expressly permitted under Section 7.2 of the Merger Agreement.
(b) Any additional shares of Common Stock, warrants, options or other
securities or rights exercisable for, exchangeable for or convertible into
shares of Common Stock (collectively, "Equity Securities") acquired by any
Holder, or with respect to which any Holder obtains voting power, will become
subject to this Agreement and shall, for all purposes of this Agreement, be
considered Optioned Securities or Voting Securities, as the case may be.
(c) Each Holder agrees not to engage in any action or omit to take any
action which would have the effect of preventing or disabling such Holder from
delivering his Optioned Securities to Merger Sub or otherwise performing his
obligations under this Agreement. To the extent that any Optioned Securities
(other than Company Common Stock) may not be assigned by such Holder to Merger
Sub without exercising, exchanging or converting such Optioned Securities for or
into Company Common Stock, each Holder agrees to exercise, exchange or convert
such Optioned Securities for or into Company Common Stock prior to the closing
of the purchase of such Optioned Securities upon exercise of the Option.
5. Representations and Warranties of each Holder. Each Holder
---------------------------------------------
severally and not jointly represents and warrants to Parent and Merger Sub as
follows:
(a) (i) such Holder is the record or beneficial owner of the Optioned
Securities, or has the right to vote the Voting Securities, listed opposite the
name of such Holder on Schedule 1, (ii) such Optioned Securities or Voting
Securities are the only Equity Securities owned of record or beneficially by
such Holder or in which such Holder has any interest or which such Holder has
the right to vote, as the case may be, and (iii) such Holder does not have any
option or other right to acquire any other Equity Securities;
(b) such Holder has the right, power and authority to execute and
deliver this Agreement and to perform his obligations hereunder; the execution,
delivery and performance of this Agreement by such Holder will not require the
consent of any other person and will not constitute a violation of, conflict
with or result in a default under (i) any contract, understanding or arrangement
to which such Holder is a party or by which such Holder is bound, (ii) any
judgment, decree or order applicable to such Holder or (iii) to the Holder's
knowledge, any law, rule or regulation of any governmental body applicable to
such Holder; and this Agreement constitutes a valid and binding agreement on the
part of such Holder, enforceable in accordance with its terms, subject to
applicable bankruptcy, insolvency, moratorium or other similar laws relating to
creditors' rights and general principles of equity;
4
<PAGE>
(c) to the Holder's knowledge, any Shares included in the Optioned
Securities owned by such Holder have been validly issued and are fully paid and
nonassessable and any shares of Common Stock issuable upon exercise of the Stock
Options or Warrants, when issued and upon payment of the exercise price
therefor, will be validly issued, fully paid and nonassessable;
(d) except as set forth on Schedule 1, the Optioned Securities owned
by such Holder are now, and at all times during the term of this Agreement will
be, held by such Holder free and clear of all adverse claims, liens,
encumbrances and security interests, and none of the Optioned Securities or
Voting Securities are subject to any voting trust or other agreement or
arrangement (except as created by this Agreement) with respect to the voting or
disposition of the Optioned Securities or Voting Securities; and there are no
outstanding options, warrants or rights to purchase or acquire, or agreements
(except for this Agreement) relating to, such Optioned Securities or Voting
Securities; and
(e) upon purchase of the Optioned Securities owned by such Holder,
Merger Sub will obtain good and marketable title to such Optioned Securities,
free and clear of all adverse claims, liens, encumbrances and security interests
(except any created by Merger Sub).
6. Effect of Representations, Warranties and Covenants of Holders.
--------------------------------------------------------------
The representations, warranties and covenants of the Holders shall be several
and not joint. The liability of each individual Holder shall extend only to the
representations, warranties and covenants of such Holder and not to any
representation, warranty or covenant of any other Holder.
7. Representations and Warranties of Parent and Merger Sub. Each of
-------------------------------------------------------
Parent and Merger Sub represents and warrants to each Holder that: it is a
corporation duly incorporated under the laws of the State of Delaware; it has
all requisite corporate power and authority to enter into and perform all its
obligations under this Agreement; the execution and delivery of this Agreement
and the consummation of the transactions contemplated hereby have been duly
authorized by all necessary corporate action on its part; this Agreement has
been duly executed and delivered by it; and this Agreement constitutes a valid
and binding agreement on its part, enforceable in accordance with its terms,
subject to applicable bankruptcy, insolvency, moratorium or other similar laws
relating to creditors' rights and general principles of equity.
8. Voting of Equity Securities. Each Holder hereby agrees that,
---------------------------
during the period from the date of this Agreement until the expiration of this
Agreement, at any meeting of the stockholders of the Company, however called,
and in any action by written consent of the stockholders of the Company, he
shall (a) vote all Voting Securities of such Holder in favor of the Merger; (b)
not vote any Voting Securities in favor of any action or agreement which would
result in a breach in any material respect of any covenant, representation or
warranty or any other obligation of the Company under the Merger Agreement; and
(c) vote all Voting Securities of such Holder against any action or agreement
which would impede, interfere with or attempt to
5
<PAGE>
discourage the Offer or the Merger, including, but not limited to: (i) any
proposal opposed by Parent or Merger Sub; (ii) any Acquisition Proposal (other
than the Offer and the Merger) involving the Company or any of its subsidiaries;
(iii) any change in the management or board of directors of the Company, except
as otherwise agreed to in writing by Merger Sub; (iv) any material change in the
present capitalization or dividend policy of the Company; or (v) any other
material change in the Company's corporate structure or business. Each Holder
hereby irrevocably appoints designees of Merger Sub, its attorneys, agents and
proxies, with full power of substitution, for the undersigned and in the name,
place and stead of the undersigned to vote in such manner as such attorneys,
agents and proxies or their substitutes shall in their sole discretion deem
proper and otherwise act, including the execution of written consents, with
respect to all Voting Securities of the Company which the undersigned is or may
be entitled to vote at any meeting of the Company held after the date hereof,
whether annual or special and whether or not an adjourned meeting, or in respect
of which the undersigned is or may be entitled to act by written consent. This
proxy is coupled with an interest and shall be irrevocable and binding on any
successor in interest of the undersigned. This proxy shall operate to revoke any
prior proxy as to Voting Securities heretofore granted by the Holder. Such proxy
shall terminate upon the expiration of this Agreement.
9. Adjustments. In the event of any increase or decrease or other
-----------
change in the Optioned Securities by reason of stock dividend, stock split,
recapitalizations, combinations, exchanges of shares or the like, the number of
Optioned Securities and Voting Securities subject to this Agreement shall be
adjusted appropriately.
10. Governing Law. This Agreement shall be governed by and
-------------
construed in accordance with the law of the State of Delaware without regard to
its rules of conflict of laws.
11. VENUE. THE PARTIES HEREBY IRREVOCABLY SUBMIT TO THE JURISDICTION
-----
OF THE COURTS OF THE STATE OF DELAWARE AND THE FEDERAL COURTS OF THE UNITED
STATES OF AMERICA LOCATED IN THE COUNTY OF NEW CASTLE, DELAWARE SOLELY IN
RESPECT OF THE INTERPRETATION AND ENFORCEMENT OF THE PROVISIONS OF THIS
AGREEMENT AND OF THE OTHER DOCUMENTS REFERRED TO IN THIS AGREEMENT, AND IN
RESPECT OF THE TRANSACTIONS CONTEMPLATED HEREBY AND THEREBY, AND HEREBY WAIVE,
AND AGREE NOT TO ASSERT, AS A DEFENSE IN ANY ACTION, SUIT OR PROCEEDING FOR THE
INTERPRETATION OR ENFORCEMENT HEREOF OR OF ANY SUCH DOCUMENT, THAT IT IS NOT
SUBJECT THERETO OR THAT SUCH ACTION, SUIT OR PROCEEDING MAY NOT BE BROUGHT OR IS
NOT MAINTAINABLE IN SAID COURTS OR THAT THE VENUE THEREOF MAY NOT BE APPROPRIATE
OR THAT THIS AGREEMENT OR ANY SUCH DOCUMENT MAY NOT BE ENFORCED IN OR BY SUCH
COURTS, AND THE PARTIES HERETO IRREVOCABLY AGREE THAT ALL CLAIMS WITH RESPECT TO
SUCH ACTION OR PROCEEDING SHALL BE HEARD AND DETERMINED IN SUCH A DELAWARE STATE
OR FEDERAL COURT. THE PARTIES HEREBY CONSENT TO AND GRANT ANY SUCH COURT
JURISDICTION OVER THE PERSON OF SUCH PARTIES AND OVER THE SUBJECT MATTER OF SUCH
6
<PAGE>
DISPUTE AND AGREE THAT MAILING OF PROCESS OR OTHER PAPERS IN CONNECTION WITH ANY
SUCH ACTION OR PROCEEDING IN THE MANNER PROVIDED IN SECTION 16 OR IN SUCH OTHER
MANNER AS MAY BE PERMITTED BY LAW, SHALL BE VALID AND SUFFICIENT SERVICE
THEREOF.
12. Further Assurances. Each party hereto shall perform such
------------------
further acts and execute such further documents as may reasonably be required to
carry out the provisions of this Agreement.
13. Restrictions on Transfer.
------------------------
(a) As soon as practicable after the execution of this Agreement, the
following legend shall be placed on the certificates representing the Optioned
Securities:
"The Securities represented by this certificate are subject to
certain transfer and other restrictions contained in a Shareholders
Agreement, dated as of October 5, 1999, among E. I. du Pont de Nemours and
Company, a Delaware corporation, DPC Newco, Inc., a Delaware corporation,
and certain stockholders of the Corporation."
(b) The Company shall instruct its transfer agent not to permit any
transfers of the Optioned Securities in contravention of this Agreement.
14. Assignment. This Agreement may not be assigned by any party
----------
hereto, except that Parent may assign its rights and obligations under this
Agreement to DuPont Pharmaceuticals Company, a Delaware general partnership and
wholly owned subsidiary of Parent, or any of Parent's direct or indirect wholly
owned subsidiaries or affiliates with a net worth of more than $100,000,000.
15. Remedies. The parties agree that legal remedies for breach
--------
of this Agreement will be inadequate and that this Agreement may be enforced by
Parent and Merger Sub by injunctive or other equitable relief.
16. Notices. All notices or other communications required or
-------
permitted hereunder shall be in writing (except as otherwise provided herein)
and shall be deemed duly given if delivered in person, by confirmed facsimile
transmission or by overnight courier service, addressed as follows:
To Parent or Merger Sub:
E. I. du Pont de Nemours and Company
1007 Market Street
Wilmington, Delaware 19898
Attention: General Counsel
Fax: (302) 773-5176
7
<PAGE>
With a copy to:
Ballard Spahr Andrews & Ingersoll
1735 Market Street, 51st Floor
Philadelphia, PA 19103-7599
Attention: Justin P. Klein, Esq.
Fax: (215) 864-8999
To each Holder:
At the address set forth on the
signature pages hereto
With copies to:
Brobeck, Phleger & Harrison LLP
550 West C Street, Suite 1300
San Diego, CA 92101
Attention: Faye H. Russell, Esq.
Fax: (619) 234-3848
17. Severability. If any term or other provision of this Agreement
------------
is invalid, illegal or incapable of being enforced by any rule of law or public
policy, all other conditions and provisions of this Agreement shall nevertheless
remain in full force and effect so long as the economic or legal substance of
the transactions contemplated hereby is not affected in any manner adverse to
any party. Upon such determination that any term or other provision is invalid,
illegal or incapable of being enforced, the parties hereto shall negotiate in
good faith to modify this Agreement so as to effect the original intent of the
parties as closely as possible in an acceptable manner to the end that the
transactions contemplated hereby are fulfilled to the extent possible.
18. Counterparts. This Agreement may be executed in counterparts,
------------
each of which shall be deemed to be an original, but all of which together shall
constitute one and the same agreement.
19. Binding Effect; Benefits. This Agreement shall survive the death
------------------------
or incapacity of any Holder and shall inure to the benefit of and be binding
upon the parties hereto and their respective heirs, legal representatives,
successors and permitted assigns. Nothing in this Agreement, expressed or
implied, is intended to or shall confer on any person other than the parties
hereto and their respective heirs, legal representatives and successors and
permitted assigns any rights, remedies, obligations or liabilities under or by
reason of this Agreement.
20. Waiver of Conflicts. The Company and each Holder severally
-------------------
acknowledge and represent (i) that Brobeck, Phleger & Harrison LLP has in the
past and may continue to
8
<PAGE>
perform legal services for the Company and certain of the Holders in matters
unrelated to the transactions described in this Agreement; (ii) that Brobeck,
Phleger & Harrison LLP is representing both the Company and the Holders in the
transaction contemplated by this Agreement; (iii) that they have been given the
opportunity to ask for information relevant to the representation by Brobeck,
Phleger & Harrison LLP of both the Company and the Holders in connection with
the transaction contemplated by this Agreement. Each Holder represents that,
after such disclosure, each Holder has requested that Brobeck, Phleger &
Harrison LLP represent such Holder in connection with the transactions
contemplated by this Agreement and each of the Holders hereby gives its informed
consent to the representation by Brobeck, Pleger & Harrison LLP of the Company
and the Holders in connection with the transactions contemplated hereby.
21. Termination. This Agreement shall commence on the date hereof
-----------
and terminate upon the expiration of the Option.
[Remainder of page intentionally left blank]
9
<PAGE>
IN WITNESS WHEREOF, the Holders, Parent and Merger Sub have entered
into this Agreement as of the date first written above.
E. I. DU PONT DE NEMOURS AND
COMPANY
By: /s/ Kurt M. Landgraf
-------------------------------------
Name: Kurt M. Landgraf
Title: Executive Vice President and
Chief Operating Officer
DPC NEWCO, INC.
By: /s/ Richard E. Gies
--------------------------------------
Name: Richard E. Gies
Title: President
[Remainder of page intentionally left blank]
10
<PAGE>
HOLDERS:
First Union Trust Company,
National Association
as Voting Trustee under that Certain
Voting Trust Dated May 5, 1998
(Sprout Capital VII, L.P.)
By: /s/ Edward L. Truitt
-------------------------------------
Name: Edward L. Truitt
Title: Vice President
DLJ Capital Corp.
By: /s/ Arthur S. Zuckerman
-------------------------------------
Arthur S. Zuckerman
Vice President
SEQUOIA CAPITAL VI
SEQUOIA TECHNOLOGY
PARTNERS VI
SEQUOIA XXIV
SEQUOIA 1995
By: /s/ Thomas F. Stephenson
-------------------------------------
Name: Thomas F. Stephenson
Title: General Partner
BVCF III, L.P.
By: J.W. Puth Associates, LLC,
its General Partner
Brinson Venture Management, LLC,
its Attorney-in-fact
By: Brinson Partners, Inc.,
its Managing Member
By: /s/ Terry P. Gould
-------------------------------------
Terry P. Gould
Executive Director
Brinson Trust Company as Trustee of the
Brinson MAP Venture Capital Fund III
By: /s/ Terry P. Gould
-------------------------------------
Terry P. Gould
Executive Director
/s/ Vicente Anido, Jr.
-------------------------------------
Vicente Anido, Jr.
/s/ Peter L. Myers
-------------------------------------
Peter L. Myers
11
<PAGE>
/s/ Michael J. Pazzani
-------------------------------------
Michael J. Pazzani
/s/ Philippe O. Chambon
-------------------------------------
Philippe O. Chambon
/s/ William Scott
-------------------------------------
William Scott
/s/ Arthur Reidel
-------------------------------------
Arthur Reidel
/s/ Lee R. McCracken
-------------------------------------
Lee R. McCracken
/s/ Klaus Gubernator
-------------------------------------
Klaus Gubernator
12
<PAGE>
SCHEDULE 1
<TABLE>
<CAPTION>
Total
Shares Unexercised Unexercised Voting
Held Options Warrants Securities
--------- ----------- ----------- ----------
<S> <C> <C> <C> <C>
First Union Trust Company, 1,386,331 0 0 1,386,331
National Association, as
Voting Trustee Under that
Certain Voting Trust Agreement
dated May 5, 1998 (Sprout
Capital VII, L.P.)
DLJ Capital Corporation 115,398 0 0 115,398
Sequoia Capital VI 1,109,962 0 16,613 1,126,575
Sequoia Technology Partners VI 60,988 0 913 61,901
Sequoia XXIV 33,012 0 730 33,742
Sequoia 1995 15,780 0 0 15,780
BVCF III, L.P. 822,340 0 0 822,340
Brinson Trust Company, as Trustee 134,113 0 0 134,113
of the Brinson MAP Venture Capital
Fund III
Vicente Anido 480,417 150,001 0 630,418
Peter Myers 225,000 150,001 0 375,001
Michael Pazzani 0 20,000 0 20,000
Phillippe Chambon 0 25,000 0 25,000
William Scott 0 25,000 0 25,000
Arthur Reidel 20,000 25,000 0 45,000
Lee McCracken 93,750 15,000 0 108,750
Klaus Gubernator 52,500 0 0 52,500
--------- ------- ------ ---------
4,549,591 410,002 18,256 4,977,849
========= ======= ====== =========
</TABLE>
13
<PAGE>
Exhibit 3
STOCK OPTION AGREEMENT
STOCK OPTION AGREEMENT (the "Agreement"), dated as of October 5, 1999,
among E. I. du Pont de Nemours and Company, a Delaware corporation (the
"Grantee"), DPC Newco, Inc., a Delaware corporation and a wholly owned
subsidiary of the Grantee ("Merger Sub"), and CombiChem, Inc., a Delaware
corporation (the "Grantor"). Capitalized terms used herein and not otherwise
defined shall have the meanings given to such terms in the Merger Agreement (as
defined below).
WHEREAS, the Grantee, Merger Sub, and the Grantor are entering into an
Agreement and Plan of Merger, dated as of the date hereof (the "Merger
Agreement"), which provides, among other things, for the merger of Merger Sub
and Grantor (the "Merger");
WHEREAS, the Grantee and Merger Sub have requested that the Grantor
grant to the Grantee an option to purchase up to 2,684,431 shares of Common
Stock, par value $0.001 per share, of the Grantor (the "Common Stock"), on the
terms and subject to the conditions hereof; and
WHEREAS, the Grantor is willing to grant the Grantee the requested
option.
NOW, THEREFORE, in consideration of the premises and the mutual
covenants and agreements set forth herein, the parties hereto, intending to be
legally bound hereby, agree as follows:
1. The Option; Exercise; Adjustments; Payment of Spread.
----------------------------------------------------
(a) Contemporaneously herewith the Grantee, Merger Sub and the
Grantor are entering into the Merger Agreement. Subject to the other terms and
conditions set forth herein, the Grantor hereby grants to the Grantee an
irrevocable option (the "Option") to purchase up to 2,684,431 shares of Common
Stock (the "Shares") at a cash purchase price equal to $6.75 per share (the
"Purchase Price"). The Option may be exercised by the Grantee, in whole or in
part, at any time, but only on one occasion, following (but not prior to) the
occurrence of the events set forth in any of clauses (i) or (ii) of Section 2(d)
hereof, and prior to the Termination Date (as defined below).
(b) In the event the Grantee wishes to exercise the Option, the
Grantee shall send a written notice to the Grantor (the "Stock Exercise Notice")
specifying the total number of Shares it wishes to purchase and a date (subject
to the expiration or termination of any applicable waiting period under the HSR
Act (as defined below)) not later than ten (10) business days and not earlier
than three (3) business days following the date such notice is given for the
closing of such purchase. In the event of any change in the number of issued
and outstanding shares of capital stock of the Company (by reason of any stock
dividend, stock split, recapitalization, merger, issuance of capital stock upon
exercise of warrants or options or any
<PAGE>
other event), the number of Shares subject to this Option and the Purchase Price
shall be appropriately adjusted to restore the Grantee to its rights hereunder,
including its right to purchase Shares representing 19.9% of the capital stock
of the Grantor entitled to vote generally for the election of the directors of
the Grantor which is issued and outstanding immediately prior to the exercise of
the Option.
(c) If at any time the Option is exercisable pursuant to the
terms of Section 1(a) hereof and at or prior to such time the payment referred
to in Section 9.5(b) of the Merger Agreement shall have become payable, the
Grantee may on one occasion elect, in lieu of exercising the Option to purchase
Shares provided in Section 1(a) hereof, to send a written notice to the Grantor
(a "Cash Exercise Notice") specifying a date not later than twenty (20) business
days and not earlier than ten (10) business days following the date such notice
is given on which date the Grantor shall pay to the Grantee an amount in cash
(the "Cancellation Amount") equal to the Spread (as defined below) multiplied by
all or such portion of the Shares subject to the Option as Grantee shall
specify.
As used herein "Spread" shall mean the excess, if any, over
the Purchase Price of the higher of (x) if applicable, the highest price per
share of Common Stock (including any brokerage commissions, transfer taxes and
soliciting dealers' fees) paid or proposed to be paid by any person pursuant to
any Acquisition Proposal occurring after the date of this Agreement and prior to
the Termination Date (the "Alternative Purchase Price") or (y) the average of
the closing bid and asked prices of the Common Stock on the Nasdaq National
Market ("Nasdaq") or on such other national securities exchange on which the
shares of Common Stock are then listed for the last five (5) trading days
immediately prior to the date of the Cash Exercise Notice (the "Closing Price").
If the Alternative Purchase Price includes any property other
than cash, the Alternative Purchase Price shall be the sum of (i) the fixed cash
amount, if any, included in the Alternative Purchase Price plus (ii) the fair
market value of such other property. If such other property consists of
securities with an existing public trading market, the average of the closing
prices (or the average of the closing bid and asked prices if closing prices are
unavailable) for such securities in their principal public trading market on the
five trading days ending five (5) days prior to the date the Cash Exercise
Notice is given shall be deemed to equal the fair market value of such property.
If such other property consists of something other than cash or securities with
an existing public trading market and, as of the payment date for the Spread,
agreement on the value of such other property has not been reached, the
Alternative Purchase Price shall be deemed to equal the Closing Price.
Upon exercise of its right to receive cash pursuant to this
Section 1(c), the obligations of the Grantor to deliver Shares pursuant to
Section 3 shall be terminated with respect to such number of Shares for which
the Grantee shall have elected to be paid the Spread.
2
<PAGE>
2. Conditions to Delivery of Shares. The Grantor's obligation to
--------------------------------
deliver Shares upon exercise of the Option is subject only to the conditions
that:
(a) No preliminary or permanent injunction or other order issued
by any federal or state court of competent jurisdiction prohibiting the delivery
of the Shares shall be in effect; and
(b) Any applicable waiting periods under the Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended (the "HSR Act"), shall have
expired or been terminated; and
(c) the representations and warranties of the Grantee made in
Section 5 of this Agreement shall be true and correct in all material respects
as of the date of the closing of the issuance of the Shares; and
(d) (i) (A) a bona fide Acquisition Proposal shall have been
made to the Grantor or any of its stockholders or any Person shall have
announced an intention (whether or not conditional) to make an Acquisition
Proposal with respect to the Grantor, and on or following the date of the Merger
Agreement but prior to the date that the Offer is consummated, such Acquisition
Proposal, announcement or intention is or becomes publicly known, (B) no event
shall have become publicly known prior to the time that such Acquisition
Proposal, announcement or intention is or becomes publicly known that would have
a material adverse effect on the ability of Grantee or Merger Sub to consummate
the Merger (other than any event related to such Acquisition Proposal,
announcement or intention or any event related to a breach of the Merger
Agreement or this Agreement by Grantor) and (C) on or following the date on
which such Acquisition Proposal, announcement or intention is or becomes
publicly known, the Merger Agreement is terminated by either the Grantee or the
Grantor pursuant to Section 9.2(i) of the Merger Agreement, unless Merger Sub
has consummated the Offer and Grantor has complied with Section 1.4 of the
Merger Agreement; or
(ii) the Merger Agreement is terminated (x) by the Grantor
pursuant to Section 9.3(a) of the Merger Agreement, or (y) by the Grantee
pursuant to Section 9.4(a) of the Merger Agreement, or (z) pursuant to Section
9.2(iv) of the Merger Agreement as a result of the failure to satisfy any one of
the conditions set forth in paragraphs (c), (e) or (f) of Annex A of the Merger
Agreement.
(e) As used in this Agreement, "person" shall have the meaning
specified in Sections 3(a)(9) and 13(d)(3) of the Exchange Act. Notwithstanding
any other provision of this Stock Option Agreement, the Merger Agreement or the
Shareholders Agreement, any reference to a majority of the total issued and
outstanding shares or Shares, or shares or Shares outstanding on a fully diluted
basis, or similar references, shall, for purposes of such agreements, exclude
from the determination thereof any shares of Common Stock issuable upon exercise
of or subject to this Stock Option Agreement and any reference to beneficial
ownership of shares of Common Stock or similar references shall, for purposes of
such
3
<PAGE>
agreements, exclude from the determination thereof any shares of Common
Stock issuable upon exercise of or subject to this Stock Option Agreement and/or
the Shareholders Agreement.
3. The Closing.
-----------
(a) Any closing hereunder shall take place on the date specified
by the Grantee in its Stock Exercise Notice or Cash Exercise Notice or as
specified in Section 1(c), as the case may be, at 10:00 A.M., local time, at the
offices of Ballard Spahr Andrews & Ingersoll, LLP, 1735 Market Street,
Philadelphia, Pennsylvania, or, if the conditions set forth in Section 2(a), (b)
or (c) have not then been satisfied, on the second business day following the
satisfaction of such conditions, or at such other time and place as the parties
hereto may agree (the "Closing Date"). On the Closing Date, (i) in the event of
a closing pursuant to Section 1(b) hereof, the Grantor will deliver to the
Grantee a certificate or certificates, representing the Shares in the
denominations designated by the Grantee in its Stock Exercise Notice and the
Grantee will purchase such Shares from the Grantor at the price per Share equal
to the Purchase Price, or (ii) in the event of a closing pursuant to Section
1(c) hereof, the Grantor will deliver to the Grantee cash in an amount
determined pursuant to Section 1(c) hereof. Any payment made by the Grantee to
the Grantor, or by the Grantor to the Grantee, pursuant to this Agreement shall
be made by wire transfer of federal funds to a bank designated by the party
receiving such funds.
(b) The Grantee agrees not to transfer or otherwise dispose of
the Option or the Shares, or any interest therein, except in compliance with the
Securities Act of 1933, as amended (the "Securities Act") and any applicable
state securities law. The Grantee further agrees that the certificates
representing the Shares shall bear an appropriate legend relating to the fact
that such Shares have not been registered under the Securities Act.
4. Representations and Warranties of the Grantor. The Grantor
---------------------------------------------
represents and warrants to the Grantee that (a) the Grantor is a corporation
duly organized, validly existing and in good standing under the laws of the
State of Delaware and has the requisite corporate power and authority to enter
into and perform this Agreement; (b) the execution and delivery of this
Agreement by the Grantor and the consummation by it of the transactions
contemplated hereby have been duly authorized by the Board of Directors of the
Grantor and this Agreement has been duly executed and delivered by a duly
authorized officer of the Grantor and constitutes a valid and binding obligation
of the Grantor, enforceable against Grantor in accordance with its terms,
subject to bankruptcy, insolvency, fraudulent transfer, reorganization,
moratorium and similar laws of general applicability relating to or affecting
creditors' rights and to general equity principles; (c) the Grantor has taken
all necessary corporate action to authorize and reserve the Shares issuable upon
exercise of the Option and the Shares, when issued and delivered by the Grantor
upon exercise of the Option and paid for by the Grantee as contemplated hereby,
will be duly authorized, validly issued, fully paid and non-assessable and free
of preemptive rights; (d) except as otherwise required by the HSR Act or the
rules and regulations of Nasdaq, the execution and delivery of this Agreement by
the Grantor and the consummation by it of the transactions contemplated hereby
do not require the consent, waiver, approval or authorization of or any filing
with any person or public authority (other than those that have been obtained
prior
4
<PAGE>
to the date of this Agreement or will have been obtained prior to the
Closing Date) and will not violate, result in a breach of or the acceleration of
any obligation under, or constitute a default under, any provision of the
Grantor's certificate of incorporation or bylaws, or any indenture, mortgage,
lien, lease, agreement, contract, instrument, order, rule, regulation, judgment,
ordinance, or decree, or restriction by which the Grantor or any of its
subsidiaries or any of their respective properties or assets is bound, except as
set forth in Schedule 4(d) attached hereto; and (e) no "fair price,"
"moratorium," "control share acquisition," "interested shareholder" or other
form of antitakeover statute or regulation (including but not limited to Section
203 of the Delaware General Corporation Law) is or shall be applicable to the
grant of the Option or the acquisition of Shares pursuant to this Agreement.
5. Representations and Warranties of the Grantee. The Grantee
---------------------------------------------
represents and warrants to the Grantor that (a) the Grantee is a corporation
duly incorporated and validly existing and in good standing under the laws of
the State of Delaware and has the requisite corporate power and authority to
enter into and perform this Agreement, (b) the execution and delivery of this
Agreement by the Grantee and the consummation by it of the transactions
contemplated hereby have been duly authorized by all necessary corporate action
on the part of the Grantee and this Agreement has been duly executed and
delivered by a duly authorized officer of the Grantee and constitutes a valid
and binding obligation of the Grantee, enforceable in accordance with its terms,
subject to bankruptcy, insolvency, fraudulent transfer, reorganization,
moratorium and similar laws of general applicability relating to or affecting
creditors' rights and to general equity principles; and (c) the Grantee is
acquiring the Option and, if and when it exercises the Option, will be acquiring
the Shares issuable upon the exercise thereof for its own account and not with a
view to distribution or resale in any manner which would be in violation of the
Securities Act.
6. Listing of Shares; Filings; Governmental Consents. Subject to
-------------------------------------------------
applicable law and the rules and regulations of Nasdaq or such other national
securities exchange on which the shares of the Grantor's Common Stock are then
listed, after the Option becomes exercisable hereunder, the Grantor will
promptly file an application to list the Shares on Nasdaq or on such other
national securities exchange on which the shares of Common Stock are then listed
and will use its reasonable best efforts to obtain approval of such listing and
to effect all necessary filings by the Grantor under the HSR Act; provided,
however, that if the Grantor is unable to effect such listing on Nasdaq by the
Closing Date, the Grantor will nevertheless be obligated to deliver the Shares
on the Closing Date and to continue its efforts to effect such listing on Nasdaq
or such other national securities exchange on which the shares of the Grantor's
Common Stock are then listed. Each of the parties hereto will use its
reasonable best efforts to obtain consents of all third parties and governmental
authorities, if any, necessary to the consummation of the transactions
contemplated by this Agreement.
5
<PAGE>
7. Registration Rights.
-------------------
(a) In the event that the Grantee shall desire to sell any of
the Shares after the purchase of such Shares pursuant to this Agreement, and
such sale requires, in the reasonable opinion of counsel to the Grantee (which
opinion must be reasonably satisfactory to Grantor and its counsel),
registration of such Shares under the Securities Act, the Grantor will cooperate
with the Grantee and any underwriters selected by the Grantee (which
underwriters must be reasonably satisfactory to Grantor) in registering such
Shares for resale for a period of at least forty-five (45) days, including,
without limitation, promptly filing a registration statement which complies with
the requirements of applicable federal and state securities laws and entering
into an underwriting agreement with such underwriters upon such terms and
conditions as are customarily contained in underwriting agreements with respect
to secondary distributions; provided that the Grantor shall not be required to
have declared effective more than two (2) registration statements hereunder and
shall be entitled to delay the filing or effectiveness of any registration
statement and may suspend the use of any registration statement (and related
prospectus) for one or more periods of time not exceeding an aggregate of sixty
(60) days in any one year period if the offering would, in the judgment of the
board of directors of the Grantor in consultation with counsel to Grantor,
require premature disclosure of any material corporate development or material
transaction involving the Grantor or interfere with any previously planned
securities offering by the Grantor. In addition, upon receipt of notice of the
occurrence of any event as a result of which any registration statement,
prospectus or prospectus supplement, contains any untrue statements of material
fact or fails or omits to state any material fact required to be stated therein
or necessary to make the statements therein, in light of the circumstances under
which they are made, not misleading, the Grantee shall forthwith discontinue the
disposition of any Shares under such registration statement, prospectus or
prospectus supplement until the Grantee receives from the Grantor copies (which
subject to the limitations on suspension set forth above shall promptly be made
available by the Grantor) of an amended or supplemented registration statement,
prospectus or supplement so that, as thereafter delivered to purchasers of such
Shares, such registration statement, prospectus or prospectus supplement shall
not contain any untrue statement of material fact or fail or omit to state any
material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they are made, not
misleading.
(b) If the Shares are registered pursuant to the provisions of
this Section 7, the Grantor agrees (i) to furnish copies of the registration
statement and the prospectus relating to the Shares covered thereby in such
numbers as the Grantee may from time to time reasonably request and (ii) if any
event shall occur as a result of which it becomes necessary to amend or
supplement any registration statement or prospectus, to prepare and file under
the applicable securities laws such amendments and supplements as may be
necessary to keep available for at least forty-five (45) days a prospectus
covering the Shares meeting the requirements of such securities laws, and to
furnish the Grantee such numbers of copies of the registration statement and
prospectus as amended or supplemented as may reasonably be requested. The
Grantor shall bear the cost of the registration, including, but not limited to,
all registration and filing fees, printing expenses, and fees and disbursements
of counsel and
6
<PAGE>
accountants for the Grantor, except that the Grantee shall pay the fees and
disbursements of its counsel and the underwriting fees and selling commissions
applicable to the shares of Common Stock sold by the Grantee. The Grantor shall
indemnify and hold harmless (i) the Grantee, its affiliates and its officers and
directors and (ii) each underwriter and each person who controls any underwriter
within the meaning of the Securities Act or the Securities Exchange Act of 1934,
as amended (collectively, the "Underwriters") ((i) and (ii) being referred to as
"Indemnified Parties") against any losses, claims, damages, liabilities or
expenses to which the Indemnified Parties may become subject, insofar as such
losses, claims, damages, liabilities (or actions in respect thereof) and
expenses arise out of or are based upon any untrue statement or alleged untrue
statement of any material fact contained or incorporated by reference in any
registration statement filed pursuant to this Section 7 or arise out of or are
based upon the omission or alleged omission to state therein a material fact
required to be stated therein or necessary to make the statements therein not
misleading; provided, however, that the Grantor will not be liable in any such
case to the extent that any such loss, liability, claim, damage or expense
arises out of or is based upon (A) an untrue statement or alleged untrue
statement in or omission or alleged omission from any such documents in reliance
upon and in conformity with written information furnished to the Grantor by the
Indemnified Parties expressly for use or incorporation by reference therein, or
(B) the fact that the person asserting any such loss, liability, claim, damage
or expense did not receive a copy of an amended preliminary prospectus or the
final prospectus (or the final prospectus as amended or supplemented) at or
prior to the written confirmation of the sale of the Shares to such person
because of the failure of the Grantee to so provide such amended preliminary or
final prospectus.
(c) The Grantee and the Underwriters shall indemnify and hold
harmless the Grantor, its affiliates and its officers and directors against any
losses, claims, damages, liabilities or expenses to which the Grantor, its
affiliates and its officers and directors may become subject, insofar as such
losses, claims, damages, liabilities (or actions in respect thereof) and
expenses arise out of or are based upon (i) any untrue statement of any material
fact contained or incorporated by reference in any registration statement filed
pursuant to this Section 7, or arise out of or are based upon the omission or
alleged omission to state therein a material fact required to be stated therein
or necessary to make the statements therein not misleading, in each case to the
extent, but only to the extent, that such untrue statement or alleged untrue
statement or omission or alleged omission was made in reliance upon and in
conformity with written information furnished to the Grantor by the Indemnified
Parties, as applicable, specifically for use or incorporation by reference
therein or (ii) the fact that the person asserting any such loss, liability,
claim, damage or expense did not receive a copy of an amended preliminary
prospectus or the final prospectus (or the final prospectus as amended or
supplemented) at or prior to the written confirmation of the sale of the Shares
to such person because of the failure of the Grantee to so provide such amended
preliminary or final prospectus.
(d) Promptly after receipt by an indemnified party under
subsection (b) or (c) above of notice of the commencement of any action, such
indemnified party shall, if a claim in respect thereof is to be made against the
indemnifying party under such subsection, notify the indemnifying party in
writing of the commencement thereof; but the omission so to
7
<PAGE>
notify the indemnifying party shall not relieve it from any liability which it
may have to any indemnified party otherwise than under such subsection. In case
any such action shall be brought against any indemnified party and it shall
notify the indemnifying party of the commencement thereof, the indemnifying
party shall be entitled to participate therein and, to the extent that it shall
wish, jointly with any other indemnifying party similarly notified, to assume
the defense thereof, with counsel satisfactory to such indemnified party, and,
after notice from the indemnifying party to such indemnified party of its
election so to assume the defense thereof, the indemnifying party shall not be
liable to such indemnified party under such subsection for any legal expenses of
other counsel or any other expenses, in each case subsequently incurred by such
indemnified party, in connection with the defense thereof other than reasonable
costs of investigation. No indemnified party shall settle any action or claim
without the consent of the indemnifying party, which consent shall not be
unreasonably withheld or delayed.
8. Expenses. Each party hereto shall pay its own expenses incurred
--------
in connection with this Agreement, except as otherwise specifically provided
herein.
9. Modification or Amendment. Subject to the provisions of
-------------------------
applicable law, the parties hereto may modify or amend this Agreement, by
written agreement executed and delivered by duly authorized officers of the
respective parties.
10. Counterparts. This Agreement may be executed in any number of
------------
counterparts, each such counterpart being deemed to be an original instrument,
and all such counterparts shall together constitute the same agreement.
11. GOVERNING LAW AND VENUE; WAIVER OF JURY TRIAL.
---------------------------------------------
(a) THIS AGREEMENT SHALL BE DEEMED TO BE MADE IN AND IN ALL
RESPECTS SHALL BE INTERPRETED, CONSTRUED AND GOVERNED BY AND IN ACCORDANCE WITH
THE LAWS OF THE STATE OF DELAWARE WITHOUT REGARD TO THE CONFLICT OF LAW
PRINCIPLES THEREOF. THE PARTIES HEREBY IRREVOCABLY SUBMIT TO THE JURISDICTION OF
THE COURTS OF THE STATE OF DELAWARE AND THE FEDERAL COURTS OF THE UNITED STATES
OF AMERICA LOCATED IN THE COUNTY OF NEW CASTLE, DELAWARE SOLELY IN RESPECT OF
THE INTERPRETATION AND ENFORCEMENT OF THE PROVISIONS OF THIS AGREEMENT, THE
MERGER AGREEMENT AND OF THE OTHER DOCUMENTS REFERRED TO IN THIS AGREEMENT AND
THE MERGER AGREEMENT, AND IN RESPECT OF THE TRANSACTIONS CONTEMPLATED HEREBY AND
THEREBY, AND HEREBY WAIVE, AND AGREE NOT TO ASSERT, AS A DEFENSE IN ANY ACTION,
SUIT OR PROCEEDING FOR THE INTERPRETATION OR ENFORCEMENT HEREOF OR OF ANY SUCH
DOCUMENT, THAT IT IS NOT SUBJECT THERETO OR THAT SUCH ACTION, SUIT OR PROCEEDING
MAY NOT BE BROUGHT OR IS NOT MAINTAINABLE IN SAID COURTS OR THAT THE VENUE
THEREOF MAY NOT BE APPROPRIATE OR THAT THIS AGREEMENT, THE MERGER AGREEMENT, OR
ANY SUCH DOCUMENT MAY NOT BE ENFORCED IN OR BY SUCH COURTS, AND
8
<PAGE>
THE PARTIES HERETO IRREVOCABLY AGREE THAT ALL CLAIMS WITH RESPECT TO SUCH ACTION
OR PROCEEDING SHALL BE HEARD AND DETERMINED IN SUCH A DELAWARE STATE OR FEDERAL
COURT. THE PARTIES HEREBY CONSENT TO AND GRANT ANY SUCH COURT JURISDICTION OVER
THE PERSON OF SUCH PARTIES AND OVER THE SUBJECT MATTER OF SUCH DISPUTE AND AGREE
THAT MAILING OF PROCESS OR OTHER PAPERS IN CONNECTION WITH ANY SUCH ACTION OR
PROCEEDING IN THE MANNER PROVIDED IN SECTION 12 OR IN SUCH OTHER MANNER AS MAY
BE PERMITTED BY LAW, SHALL BE VALID AND SUFFICIENT SERVICE THEREOF.
(b) EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY
WHICH MAY ARISE UNDER THIS AGREEMENT OR THE MERGER AGREEMENT OR THE OTHER
DOCUMENTS REFERRED TO IN THIS AGREEMENT AND THE MERGER AGREEMENT, OR THE
TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY, IS LIKELY TO INVOLVE COMPLICATED
AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND
UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN
RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO
THIS AGREEMENT, THE MERGER AGREEMENT, THE OTHER DOCUMENTS REFERRED TO IN THIS
AGREEMENT AND THE MERGER AGREEMENT, OR THE TRANSACTIONS CONTEMPLATED HEREBY OR
THEREBY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT
OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT
SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE
FOREGOING WAIVER, (II) EACH SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE
IMPLICATIONS OF THIS WAIVER, (III) EACH SUCH PARTY MAKES THIS WAIVER VOLUNTARILY
AND (IV) EACH SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG
OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.
12. Notices. Any notice, request, instruction or other document to
-------
be given hereunder by any party to the others shall be in writing and delivered
personally or sent by registered or certified mail, postage prepaid, or by
facsimile:
if to the Grantee or Merger Sub:
E. I. du Pont de Nemours and Company
1007 Market Street
Wilmington, Delaware 19898
Attention: General Counsel
Fax: (302) 773-5176
with copies to:
9
<PAGE>
Justin P. Klein, Esq.
Ballard Spahr Andrews & Ingersoll, LLP
1735 Market Street, 51st Floor
Philadelphia, PA 19103-7599
Fax: (215) 864-8999
if to the Grantor:
Dr. Vicente Anido, Jr.
CombiChem, Inc.
9050 Camino Santa Fe
San Diego, CA 92121
Fax: (858) 271-9339
with copies to:
Faye H. Russell, Esq.
Brobeck Phleger & Harrison LLP
550 West C Street, Suite 1300
San Diego, CA 92101-3532
Fax: (619) 234-3848
or to such other persons or addresses as may be designated in writing by the
party to receive such notice as provided above.
13. Entire Agreement. This Agreement (including any exhibits and
----------------
schedules hereto), the Merger Agreement and the other documents referred to in
this Agreement and the Merger Agreement, constitute the entire agreement, and
supersede all other prior agreements, understandings, representations and
warranties both written and oral, among the parties, with respect to the subject
matter hereof.
14. No Third Party Beneficiaries. This Agreement is not intended to
----------------------------
confer upon any person or entity other than the parties hereto any rights or
remedies hereunder.
15. Severability. The provisions of this Agreement shall be deemed
------------
severable and the invalidity or unenforceability of any provision shall not
affect the validity or enforceability of the other provisions hereof. If any
provision of this Agreement, or the application thereof to any person or entity
or any circumstance, is invalid or unenforceable, (a) a suitable and equitable
provision shall be substituted therefor in order to carry out, so far as may be
valid and enforceable, the intent and purpose of such invalid or unenforceable
provision and (b) the remainder of this Agreement and the application of such
provision to other persons or entities or circumstances shall not be affected by
such invalidity or unenforceability, nor shall such invalidity or
unenforceability affect the validity or enforceability of such provision, or the
application thereof, in any other jurisdiction.
10
<PAGE>
16. Specific Performance. The parties hereto each acknowledge that,
--------------------
in view of the uniqueness of the subject matter hereof, the parties hereto would
not have an adequate remedy at law for money damages if this Agreement were not
performed in accordance with its terms, and therefore agree that the parties
hereto shall be entitled to specific enforcement of the terms hereof in addition
to any other remedy to which the parties hereto may be entitled at law or in
equity.
17. Assignment. This Agreement shall not be assignable by operation
----------
of law or otherwise; provided, however, that the Grantee may assign its rights
and obligations under this Agreement to DuPont Pharmaceuticals Company, a
Delaware general partnership and wholly owned subsidiary of Grantee, or any of
Grantee's direct or indirect wholly owned subsidiaries or affiliates with a net
worth of more than $100,000,000. Any purported assignment made in contravention
of this Agreement shall be null and void.
18. Captions. The Section captions herein are for convenience of
--------
reference only and do not constitute part of this Agreement and shall not be
deemed to limit or otherwise affect any of the provisions hereof.
19. Termination.
-----------
(a) The right to exercise the Option granted pursuant to this
Agreement shall terminate at (and the Option shall no longer be exercisable
after) the earliest of (i) the Effective Time (as defined in the Merger
Agreement), (ii) the nine month anniversary of the earliest to occur of the
events set forth in any of clauses (i) or (ii) of Section 2(d), and (iii) the
fifteenth day following the termination of the Merger Agreement if prior to such
fifteenth day the events set forth in any of clauses (i) or (ii) of Section 2(d)
shall not have occurred (such earliest date being referred to in this Agreement
as the "Termination Date"); provided that, if the Option cannot be exercised or
the Shares cannot be delivered to the Grantee upon such exercise because one or
more of the conditions set forth in Section 2(a) or (b) hereof have not yet been
satisfied, the Termination Date shall be extended until fifteen (15) days after
such impediment to exercise or delivery has been removed.
(b) All representations and warranties contained in this
Agreement shall survive delivery of and payment for the Shares.
[Remainder of page intentionally left blank]
11
<PAGE>
IN WITNESS WHEREOF, this Agreement has been duly executed and
delivered by duly authorized officers of the parties hereto as of the date
hereof.
COMBICHEM, INC.
By: /s/ Vicente Anido, Jr.
-----------------------------------------
Name: Vicente Anido, Jr.
Title: President and Chief Executive Officer
E. I. DU PONT DE NEMOURS AND
COMPANY
By: /s/ Kurt M. Landgraf
----------------------------------------
Name: Kurt M. Landgraf
Title: Executive Vice President and
Chief Operating Officer
DPC NEWCO, INC.
By: /s/ Richard E. Gies
-----------------------------------------
Name: Richard E. Gies
Title: President
12
<PAGE>
Exhibit 4
JOINT FILING AGREEMENT
The undersigned acknowledge and agree that the foregoing statement on
Schedule 13D is filed on behalf of each of the undersigned and that all
subsequent amendments to this statement shall be filed on behalf of each of the
undersigned without the necessity of filing additional joint filing agreements.
The undersigned acknowledge that each shall be responsible for the timely filing
of such amendments, and for the completeness and accuracy of the information
concerning it contained therein, but shall not be responsible for the
completeness and accuracy of the information concerning the others, except to
the extent that it knows or has reason to believe that such information is
inaccurate.
This Agreement may be executed counterparts and each of such counterparts
taken together shall constitute one and the same instrument.
Dated: October 14, 1999
E.I. DU PONT DE NEMOURS AND COMPANY
By: /s/ John P. Jessup
--------------------------
Name: John P. Jessup
Title: Vice President and Controller
DUPONT PHARMA, INC.
By: /s/ A. Lloyd Adams
--------------------------
Name: A. Lloyd Adams
Title: Vice President and
Assistant Treasurer
DPC NEWCO, INC.
By: /s/ Steven J. Capolarello
-------------------------
Name: Steven J. Capolarello
Title: Vice President and
Treasurer
